Unnamed: 0,activity_comment,activity_id,assay_chembl_id,assay_description,assay_type,bao_endpoint,bao_format,bao_label,canonical_smiles,document_chembl_id,document_journal,document_year,molecule_chembl_id,molecule_pref_name,parent_molecule_chembl_id,potential_duplicate,qudt_units,record_id,relation,src_id,standard_flag,standard_relation,standard_type,standard_units,standard_value,target_chembl_id,target_organism,target_pref_name,target_tax_id,toid,type,units,uo_units,value
26000,,13868792,CHEMBL3101232,Bactericidal activity against Bacillus cereus ATCC 11778 after 24 hrs by CFU counting assay,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3098034,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1955829,=,1,0,=,MBC,ug ml-1,4.0,CHEMBL613070,Bacillus cereus,Bacillus cereus,1396.0,,MBC,ug ml-1,UO_0000274,4.0
26001,,13868796,CHEMBL3101365,Bactericidal activity against multidrug-resistant Pseudomonas aeruginosa PAO1 after 24 hrs by CFU counting assay,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3098034,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1955829,=,1,0,=,MBC,ug ml-1,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MBC,ug ml-1,UO_0000274,4.0
26002,,13868800,CHEMBL3101366,Bactericidal activity against multidrug-resistant Stenotrophomonas maltophilia D457R after 24 hrs by CFU counting assay,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3098034,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1955829,=,1,0,=,MBC,ug ml-1,256.0,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,MBC,ug ml-1,UO_0000274,256.0
26003,,13869391,CHEMBL3101367,Bactericidal activity against vancomycin-resistant Acinetobacter haemolyticus BW62 after 24 hrs by CFU counting assay,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3098034,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1955829,=,1,0,=,MBC,ug ml-1,4.0,CHEMBL613782,Acinetobacter haemolyticus,Acinetobacter haemolyticus,29430.0,,MBC,ug ml-1,UO_0000274,4.0
26004,,13869395,CHEMBL3101368,Bactericidal activity against ESBL-producing Escherichia coli BW55 after 24 hrs by CFU counting assay,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3098034,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1955829,=,1,0,=,MBC,ug ml-1,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MBC,ug ml-1,UO_0000274,1.0
26005,,13869399,CHEMBL3101369,Bactericidal activity against multidrug-resistant Escherichia coli BW54 after 24 hrs by CFU counting assay,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3098034,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1955829,=,1,0,=,MBC,ug ml-1,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MBC,ug ml-1,UO_0000274,4.0
26006,,13869403,CHEMBL3101370,Antibacterial activity against methicillin-resistant Staphylococcus aureus BW61 after 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3098034,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1955829,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,4.0
26007,,13869407,CHEMBL3101371,Antibacterial activity against Staphylococcus aureus ATCC 29213 after 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3098034,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1955829,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,4.0
26008,,13869411,CHEMBL3101372,Antibacterial activity against Bacillus cereus ATCC 11778 after 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3098034,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1955829,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL613070,Bacillus cereus,Bacillus cereus,1396.0,,MIC,ug ml-1,UO_0000274,4.0
26009,,13869415,CHEMBL3101373,Antibacterial activity against multidrug-resistant Pseudomonas aeruginosa PAO1 after 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3098034,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1955829,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,4.0
26010,,13869419,CHEMBL3101374,Antibacterial activity against multidrug-resistant Stenotrophomonas maltophilia D457R after 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3098034,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1955829,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,MIC,ug ml-1,UO_0000274,4.0
26011,,13869423,CHEMBL3101375,Antibacterial activity against vancomycin-resistant Acinetobacter haemolyticus BW62 after 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3098034,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1955829,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL613782,Acinetobacter haemolyticus,Acinetobacter haemolyticus,29430.0,,MIC,ug ml-1,UO_0000274,4.0
26012,,13869427,CHEMBL3101376,Antibacterial activity against ESBL-producing Escherichia coli BW55 after 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3098034,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1955829,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,2.0
26013,,13869431,CHEMBL3101377,Antibacterial activity against multidrug-resistant Escherichia coli BW54 after 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3098034,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1955829,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,4.0
26014,Not Determined,13869628,CHEMBL3101391,Antimicrobial activity against Rhizopus sp. after 3 to 4 days by serial plate dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3097988,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,1955849,,1,0,,MIC,,,CHEMBL612430,Rhizopus,Rhizopus,4842.0,,MIC,,,
26015,Not Determined,13869629,CHEMBL3101392,Antimicrobial activity against Aspergillus flavus after 3 to 4 days by serial plate dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3097988,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,1955849,,1,0,,MIC,,,CHEMBL614955,Aspergillus flavus,Aspergillus flavus,5059.0,,MIC,,,
26016,Not Determined,13869630,CHEMBL3101393,Antimicrobial activity against Candida albicans after 3 to 4 days by serial plate dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3097988,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,1955849,,1,0,,MIC,,,CHEMBL366,Candida albicans,Candida albicans,5476.0,,MIC,,,
26017,,13870435,CHEMBL3101394,Antimicrobial activity against Klebsiella pneumoniae ATCC 13883 after 16 to 18 hrs by serial plate dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3097988,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1955849,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,16.0
26018,,13870465,CHEMBL3101396,Antimicrobial activity against Staphylococcus aureus ATCC 25923 after 16 to 18 hrs by serial plate dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3097988,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1955849,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,8.0
26019,,13870483,CHEMBL3101395,Antimicrobial activity against Escherichia coli ATCC 25922 after 16 to 18 hrs by serial plate dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3097988,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1955849,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,4.0
26020,,13873538,CHEMBL3106601,Antimicrobial activity against Pseudomonas aeruginosa MTCC 2453 assessed as growth inhibition after 24 hrs by well diffusion method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3102771,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1960016,=,1,1,=,MIC,ug.mL-1,0.58,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.58
26021,,13874136,CHEMBL3106602,Antimicrobial activity against Bacillus subtilis MTCC 121 assessed as growth inhibition after 24 hrs by well diffusion method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3102771,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1960016,=,1,1,=,MIC,ug.mL-1,0.58,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MIC,ug ml-1,UO_0000274,0.58
26022,,13874159,CHEMBL3106603,Antimicrobial activity against Staphylococcus aureus MLS-16 MTCC 2940 assessed as growth inhibition after 24 hrs by well diffusion method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3102771,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1960016,=,1,1,=,MIC,ug.mL-1,0.58,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.58
26023,,13874182,CHEMBL3107160,Antimicrobial activity against Staphylococcus aureus MTCC 96 assessed as growth inhibition after 24 hrs by well diffusion method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3102771,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1960016,=,1,1,=,MIC,ug.mL-1,0.58,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.58
26024,,13874205,CHEMBL3107161,Antimicrobial activity against Micrococcus luteus MTCC 2470 assessed as growth inhibition after 24 hrs by well diffusion method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3102771,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1960016,=,1,1,=,MIC,ug.mL-1,0.58,CHEMBL614421,Micrococcus luteus,Micrococcus luteus,1270.0,,MIC,ug ml-1,UO_0000274,0.58
26025,,13880179,CHEMBL3108622,Antibacterial activity against Staphylococcus epidermidis H 6966/08 after 48 hrs by microdilution broth method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3102810,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Micromolar,1960912,=,1,0,=,MIC95,uM,250.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC95,uM,UO_0000064,250.0
26026,,13880183,CHEMBL3106062,Antibacterial activity against Staphylococcus epidermidis H 6966/08 after 24 hrs by microdilution broth method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3102810,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Micromolar,1960912,=,1,0,=,MIC95,uM,250.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC95,uM,UO_0000064,250.0
26027,,13950664,CHEMBL3129636,Antibacterial activity against Bacillus subtilis NCIM 2063 by standard agar method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3124928,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1973447,=,1,1,=,MIC,ug.mL-1,50.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MIC,ug ml-1,UO_0000274,50.0
26028,,13950672,CHEMBL3129637,Antibacterial activity against Staphylococcus aureus NCIM 2901 by standard agar method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3124928,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1973447,=,1,1,=,MIC,ug.mL-1,50.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,50.0
26029,,13950683,CHEMBL3129638,Antibacterial activity against Pseudomonas aeruginosa NCIM 2036 by standard agar method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3124928,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1973447,=,1,1,=,MIC,ug.mL-1,25.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,25.0
26030,,13950693,CHEMBL3129639,Antibacterial activity against Escherichia coli NCIM 2256 by standard agar method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3124928,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1973447,=,1,1,=,MIC,ug.mL-1,25.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,25.0
26031,,13951975,CHEMBL3129661,Cytotoxicity against human MCF10A cells after 48 hrs by WST1 assay,A,BAO_0000190,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3124853,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,1973489,>,1,1,>,IC50,nM,300000.0,CHEMBL612558,,ADMET,,,IC50,uM,UO_0000065,300.0
26032,,13959360,CHEMBL3129492,Antibacterial activity against Escherichia coli by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3124818,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1974094,=,1,1,=,MIC,ug.mL-1,15.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,15.0
26033,,13959361,CHEMBL3129494,Antibacterial activity against Staphylococcus aureus by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3124818,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1974094,=,1,1,=,MIC,ug.mL-1,5.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,5.0
26034,,13959362,CHEMBL3129491,Antibacterial activity against Pseudomonas aeruginosa by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3124818,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1974094,=,1,1,=,MIC,ug.mL-1,7.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,7.5
26035,,13959363,CHEMBL3129493,Antibacterial activity against Bacillus subtilis by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3124818,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1974094,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MIC,ug ml-1,UO_0000274,2.0
26036,Not Determined,13960914,CHEMBL3128813,Antifungal activity against Candida albicans assessed as growth inhibition by NCCLS broth dilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3124903,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,1974283,,1,0,,MIC,,,CHEMBL366,Candida albicans,Candida albicans,5476.0,,MIC,,,
26037,Not Determined,13960926,CHEMBL3128814,Antifungal activity against Aspergillus flavus assessed as growth inhibition by NCCLS broth dilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3124903,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,1974283,,1,0,,MIC,,,CHEMBL614955,Aspergillus flavus,Aspergillus flavus,5059.0,,MIC,,,
26038,,13960938,CHEMBL3128815,Antibacterial activity against Escherichia coli assessed as growth inhibition by microdilution broth susceptibility assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3124903,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1974283,=,1,1,=,MIC,ug.mL-1,6.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,6.25
26039,,13961205,CHEMBL3131570,Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 27294 after 28 days by two-fold serial dilution method in presence of efflux pump inhibitor verapamil,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3124864,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,1972313,=,1,1,=,MIC,nM,9410.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,uM,UO_0000065,9.41
26040,,13961206,CHEMBL3131571,Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 27294 after 28 days by two-fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3124864,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,1972313,=,1,1,=,MIC,nM,9410.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,uM,UO_0000065,9.41
26041,,13962153,CHEMBL3128816,Antibacterial activity against Klebsiella pneumoniae assessed as growth inhibition by microdilution broth susceptibility assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3124903,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1974283,=,1,1,=,MIC,ug.mL-1,6.25,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,6.25
26042,,13962165,CHEMBL3128817,Antibacterial activity against Bacillus subtilis assessed as growth inhibition by microdilution broth susceptibility assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3124903,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1974283,=,1,1,=,MIC,ug.mL-1,6.25,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MIC,ug ml-1,UO_0000274,6.25
26043,,13962177,CHEMBL3128818,Antibacterial activity against Staphylococcus aureus assessed as growth inhibition by microdilution broth susceptibility assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3124903,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1974283,=,1,1,=,MIC,ug.mL-1,6.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,6.25
26044,,13964286,CHEMBL3135037,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33591 assessed as growth inhibition after 16-20 hrs by CLSI method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3132745,Medchemcomm,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1975816,=,1,0,=,MBC,ug ml-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MBC,ug ml-1,UO_0000274,0.5
26045,,13964343,CHEMBL3135038,Antibacterial activity against Staphylococcus aureus ATCC 29213 assessed as growth inhibition after 16-20 hrs by CLSI method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3132745,Medchemcomm,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1975816,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
26046,,13964344,CHEMBL3135037,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33591 assessed as growth inhibition after 16-20 hrs by CLSI method,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3132745,Medchemcomm,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1975816,=,1,1,=,IC50,ug.mL-1,0.09,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,IC50,ug ml-1,UO_0000274,0.09
26047,,13964401,CHEMBL3135038,Antibacterial activity against Staphylococcus aureus ATCC 29213 assessed as growth inhibition after 16-20 hrs by CLSI method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3132745,Medchemcomm,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1975816,=,1,0,=,MBC,ug ml-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MBC,ug ml-1,UO_0000274,0.5
26048,Not Determined,13973692,CHEMBL3136342,Antimicrobial activity against Cryptococcus neoformans by NCCLS method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3132801,Medchemcomm,2013.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,1975609,,1,0,,MBC,,,CHEMBL365,Cryptococcus neoformans,Cryptococcus neoformans,5207.0,,MBC,,,
26049,,13973702,CHEMBL3136343,Antimicrobial activity against methicillin-resistant Staphylococcus aureus by NCCLS method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3132801,Medchemcomm,2013.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Micromolar,1975609,=,1,0,=,MBC,uM,1.51,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MBC,uM,UO_0000064,1.51
26050,,13973712,CHEMBL3136344,Antimicrobial activity against Staphylococcus aureus by NCCLS method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3132801,Medchemcomm,2013.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Micromolar,1975609,=,1,0,=,MBC,uM,1.51,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MBC,uM,UO_0000064,1.51
26051,Not Determined,13973722,CHEMBL3136342,Antimicrobial activity against Cryptococcus neoformans by NCCLS method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3132801,Medchemcomm,2013.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,1975609,,1,0,,MIC,,,CHEMBL365,Cryptococcus neoformans,Cryptococcus neoformans,5207.0,,MIC,,,
26052,,13973732,CHEMBL3136343,Antimicrobial activity against methicillin-resistant Staphylococcus aureus by NCCLS method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3132801,Medchemcomm,2013.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,1975609,=,1,1,=,MIC,nM,1510.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,uM,UO_0000065,1.51
26053,,13973742,CHEMBL3136344,Antimicrobial activity against Staphylococcus aureus by NCCLS method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3132801,Medchemcomm,2013.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,1975609,=,1,1,=,MIC,nM,1510.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,uM,UO_0000065,1.51
26054,Not Determined,13973767,CHEMBL3136342,Antimicrobial activity against Cryptococcus neoformans by NCCLS method,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3132801,Medchemcomm,2013.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,1975609,,1,0,,IC50,,,CHEMBL365,Cryptococcus neoformans,Cryptococcus neoformans,5207.0,,IC50,,,
26055,,13973777,CHEMBL3136343,Antimicrobial activity against methicillin-resistant Staphylococcus aureus by NCCLS method,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3132801,Medchemcomm,2013.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,1975609,=,1,1,=,IC50,nM,390.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,IC50,uM,UO_0000065,0.39
26056,,13973787,CHEMBL3136344,Antimicrobial activity against Staphylococcus aureus by NCCLS method,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3132801,Medchemcomm,2013.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,1975609,=,1,1,=,IC50,nM,390.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,IC50,uM,UO_0000065,0.39
26057,,13975428,CHEMBL3135037,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33591 assessed as growth inhibition after 16-20 hrs by CLSI method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3132745,Medchemcomm,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1975816,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
26058,,13975485,CHEMBL3135038,Antibacterial activity against Staphylococcus aureus ATCC 29213 assessed as growth inhibition after 16-20 hrs by CLSI method,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3132745,Medchemcomm,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1975816,=,1,1,=,IC50,ug.mL-1,0.08,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,IC50,ug ml-1,UO_0000274,0.08
26059,inactive,14008528,CHEMBL3214945,PubChem BioAssay. qHTS profiling of the MIPE4 collection as inhibitors of Plasmodium falciparum (3D7) proliferation.   (Class of assay: confirmatory) ,F,BAO_0000186,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1201862,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2041236,,7,1,,Potency,nM,3346.9,CHEMBL3879801,,NON-PROTEIN TARGET,,,Potency,uM,UO_0000065,3.3469
26060,inactive,14084943,CHEMBL3215001,PubChem BioAssay. qHTS profiling of the MIPE4 collection as inhibitors of Plasmodium falciparum (DD2) proliferation.   (Class of assay: confirmatory) ,F,BAO_0000186,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1201862,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2041236,,7,1,,Potency,nM,1.7,CHEMBL3879801,,NON-PROTEIN TARGET,,,Potency,uM,UO_0000065,0.0017
26061,inactive,14087069,CHEMBL3214990,PubChem BioAssay. qHTS profiling for inhibitors of Plasmodium falciparum (3D7) proliferation.   (Class of assay: confirmatory) ,F,BAO_0000186,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1201862,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,1856601,,7,1,,Potency,nM,133.2,CHEMBL3879801,,NON-PROTEIN TARGET,,,Potency,uM,UO_0000065,0.1332
26062,inactive,14108607,CHEMBL3215086,PubChem BioAssay. qHTS profiling for inhibitors of Plasmodium falciparum (HB3) proliferation.   (Class of assay: confirmatory) ,F,BAO_0000186,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1201862,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,1856601,,7,1,,Potency,nM,943.3,CHEMBL3879801,,NON-PROTEIN TARGET,,,Potency,uM,UO_0000065,0.9433
26063,inactive,14338687,CHEMBL3214813,PubChem BioAssay. qHTS profiling of the MIPE4 collection as inhibitors of Plasmodium falciparum (DD2) proliferation (Rep 2).   (Class of assay: confirmatory) ,F,BAO_0000186,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1201862,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2041236,,7,1,,Potency,nM,21117.7,CHEMBL3879801,,NON-PROTEIN TARGET,,,Potency,uM,UO_0000065,21.1177
26064,inactive,14401907,CHEMBL3214842,PubChem BioAssay. qHTS profiling of the MIPE4 collection as inhibitors of Plasmodium falciparum (HB3) proliferation.   (Class of assay: confirmatory) ,F,BAO_0000186,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1201862,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2041236,,7,1,,Potency,nM,595.2,CHEMBL3879801,,NON-PROTEIN TARGET,,,Potency,uM,UO_0000065,0.5952
26065,inactive,14440654,CHEMBL3214892,PubChem BioAssay. qHTS profiling for inhibitors of Plasmodium falciparum (DD2) proliferation.   (Class of assay: confirmatory) ,F,BAO_0000186,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL1201862,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,1856601,,7,1,,Potency,nM,8407.1,CHEMBL3879801,,NON-PROTEIN TARGET,,,Potency,uM,UO_0000065,8.4071
26066,,14527979,CHEMBL3223021,Antimicrobial activity against Bacillus subtilis ATCC 6633 assessed as inhibition zone at 5 ug/ml at 37 degC for 24 hrs by agar diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3217698,Medchemcomm,2010.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,2074351,=,1,1,=,IZ,mm,31.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,IZ,mm,UO_0000016,31.0
26067,,14527986,CHEMBL3223023,Antimicrobial activity against Staphylococcus aureus SG511 assessed as inhibition zone at 5 ug/ml at 37 degC for 24 hrs by agar diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3217698,Medchemcomm,2010.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,2074351,=,1,1,=,IZ,mm,18.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,IZ,mm,UO_0000016,18.0
26068,,14527993,CHEMBL3223026,Antimicrobial activity against Staphylococcus aureus Efs1 assessed as inhibition zone at 5 ug/ml at 37 degC for 24 hrs by agar diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3217698,Medchemcomm,2010.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,2074351,=,1,1,=,IZ,mm,0.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,IZ,mm,UO_0000016,0.0
26069,,14528003,CHEMBL3223029,Antimicrobial activity against Staphylococcus aureus Efs4 assessed as inhibition zone at 5 ug/ml at 37 degC for 24 hrs by agar diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3217698,Medchemcomm,2010.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,2074351,=,1,1,=,IZ,mm,0.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,IZ,mm,UO_0000016,0.0
26070,,14528010,CHEMBL3223031,Antimicrobial activity against methicillin-resistant Staphylococcus aureus 134/93 assessed as inhibition zone at 5 ug/ml at 37 degC for 24 hrs by agar diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3217698,Medchemcomm,2010.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,2074351,=,1,1,=,IZ,mm,0.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,IZ,mm,UO_0000016,0.0
26071,,14528017,CHEMBL3223033,Antimicrobial activity against vancomycin-resistant Enterococcus faecalis 1528 assessed as inhibition zone at 5 ug/ml at 37 degC for 24 hrs by agar diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3217698,Medchemcomm,2010.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,2074351,=,1,1,=,IZ,mm,15.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,IZ,mm,UO_0000016,15.0
26072,,14528029,CHEMBL3223036,Antimicrobial activity against Micrococcus luteus ATCC 10240 assessed as inhibition zone at 5 ug/ml at 37 degC for 24 hrs by agar diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3217698,Medchemcomm,2010.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,2074351,=,1,1,=,IZ,mm,0.0,CHEMBL614421,Micrococcus luteus,Micrococcus luteus,1270.0,,IZ,mm,UO_0000016,0.0
26073,,14528031,CHEMBL3223039,Antimicrobial activity against Pseudomonas aeruginosa K799/WT assessed as inhibition zone at 5 ug/ml at 37 degC for 24 hrs by agar diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3217698,Medchemcomm,2010.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,2074351,=,1,1,=,IZ,mm,29.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,IZ,mm,UO_0000016,29.0
26074,,14528039,CHEMBL3223042,Antimicrobial activity against Pseudomonas aeruginosa K799/61 assessed as inhibition zone at 5 ug/ml at 37 degC for 24 hrs by agar diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3217698,Medchemcomm,2010.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,2074351,=,1,1,=,IZ,mm,35.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,IZ,mm,UO_0000016,35.0
26075,,14528046,CHEMBL3227337,Antimicrobial activity against Escherichia coli SG458 assessed as inhibition zone at 5 ug/ml at 37 degC for 24 hrs by agar diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3217698,Medchemcomm,2010.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,2074351,=,1,1,=,IZ,mm,34.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,IZ,mm,UO_0000016,34.0
26076,,14528309,CHEMBL3223351,Antibacterial activity against multidrug-resistant Acinetobacter baumannii ATCC BAA-747 assessed as growth inhibition measured over 400 generation period by standard broth microdilution assay relative to 50% growth inhibition after first day,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3217498,Medchemcomm,2011.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,2075568,=,1,0,=,FC,,43.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,FC,,,43.0
26077,,14530099,CHEMBL3227835,Antimycobacterial against Mycobacterium smegmatis,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3217550,Medchemcomm,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Micromolar,2076247,=,1,0,=,MIC99,uM,0.63,CHEMBL613088,Mycolicibacterium smegmatis,Mycolicibacterium smegmatis,1772.0,,MIC99,uM,UO_0000064,0.63
26078,,14530181,CHEMBL3227339,Antimicrobial activity against Mycobacterium vaccae IMET assessed as inhibition zone at 5 ug/ml at 37 degC for 24 hrs by agar diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3217698,Medchemcomm,2010.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,2074351,=,1,1,=,IZ,mm,23.0,CHEMBL613224,Mycolicibacterium vaccae,Mycolicibacterium vaccae,1810.0,,IZ,mm,UO_0000016,23.0
26079,,14537873,CHEMBL3227022,Antibacterial activity against Escherichia coli,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3217667,Medchemcomm,2011.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2072566,=,1,0,=,MBC,ug ml-1,0.016,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MBC,ug ml-1,UO_0000274,0.016
26080,,14537885,CHEMBL3227022,Antibacterial activity against Escherichia coli,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3217667,Medchemcomm,2011.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2072566,=,1,1,=,IC50,ug.mL-1,0.003,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,IC50,ug ml-1,UO_0000274,0.003
26081,,14537886,CHEMBL3227022,Antibacterial activity against Escherichia coli,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3217667,Medchemcomm,2011.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2072566,=,1,1,=,MIC,ug.mL-1,0.016,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.016
26082,,14537891,CHEMBL3227017,Antibacterial activity against Staphylococcus aureus,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3217667,Medchemcomm,2011.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2072566,=,1,1,=,IC50,ug.mL-1,0.12,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,IC50,ug ml-1,UO_0000274,0.12
26083,,14537892,CHEMBL3227017,Antibacterial activity against Staphylococcus aureus,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3217667,Medchemcomm,2011.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2072566,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
26084,,14537893,CHEMBL3227017,Antibacterial activity against Staphylococcus aureus,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3217667,Medchemcomm,2011.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2072566,=,1,0,=,MBC,ug ml-1,50.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MBC,ug ml-1,UO_0000274,50.0
26085,,14537894,CHEMBL3227018,Antibacterial activity against methicillin-resistant Staphylococcus aureus,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3217667,Medchemcomm,2011.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2072566,=,1,1,=,IC50,ug.mL-1,0.09,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,IC50,ug ml-1,UO_0000274,0.09
26086,,14537895,CHEMBL3227018,Antibacterial activity against methicillin-resistant Staphylococcus aureus,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3217667,Medchemcomm,2011.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2072566,=,1,1,=,MIC,ug.mL-1,0.31,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.31
26087,,14537896,CHEMBL3227018,Antibacterial activity against methicillin-resistant Staphylococcus aureus,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3217667,Medchemcomm,2011.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2072566,=,1,0,=,MBC,ug ml-1,2.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MBC,ug ml-1,UO_0000274,2.5
26088,,14537897,CHEMBL3227019,Antibacterial activity against Mycobacterium intracellulare,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3217667,Medchemcomm,2011.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2072566,=,1,1,=,IC50,ug.mL-1,0.3,CHEMBL612640,Mycobacterium intracellulare,Mycobacterium intracellulare,1767.0,,IC50,ug ml-1,UO_0000274,0.3
26089,,14537898,CHEMBL3227019,Antibacterial activity against Mycobacterium intracellulare,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3217667,Medchemcomm,2011.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2072566,=,1,1,=,MIC,ug.mL-1,0.63,CHEMBL612640,Mycobacterium intracellulare,Mycobacterium intracellulare,1767.0,,MIC,ug ml-1,UO_0000274,0.63
26090,,14537899,CHEMBL3227019,Antibacterial activity against Mycobacterium intracellulare,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3217667,Medchemcomm,2011.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2072566,=,1,0,=,MBC,ug ml-1,2.5,CHEMBL612640,Mycobacterium intracellulare,Mycobacterium intracellulare,1767.0,,MBC,ug ml-1,UO_0000274,2.5
26091,,14542717,CHEMBL3223443,Antimalarial activity against schizont stage of chloroquine-susceptible Plasmodium falciparum 3D7 infected in erythrocytes assessed as inhibition of [3H]hypoxanthine incorporation after 48 hrs by scintillation counting analysis,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3217739,Medchemcomm,2011.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2074048,=,1,1,=,IC50,nM,47000.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,IC50,uM,UO_0000065,47.0
26092,,14542725,CHEMBL3223444,Antimalarial activity against schizont stage of chloroquine-susceptible Plasmodium falciparum 3D7 infected in erythrocytes assessed as inhibition of [3H]hypoxanthine incorporation after 96 hrs by scintillation counting analysis,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3217739,Medchemcomm,2011.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2074048,=,1,1,=,IC50,nM,12800.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,IC50,uM,UO_0000065,12.8
26093,,14542733,CHEMBL3223445,Antimalarial activity against schizont stage of chloroquine-resistant Plasmodium falciparum W2 infected in erythrocytes assessed as inhibition of [3H]hypoxanthine incorporation after 48 hrs by scintillation counting analysis,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3217739,Medchemcomm,2011.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2074048,=,1,1,=,IC50,nM,122300.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,IC50,uM,UO_0000065,122.3
26094,,14542741,CHEMBL3223446,Antimalarial activity against schizont stage of chloroquine-resistant Plasmodium falciparum W2 infected in erythrocytes assessed as inhibition of [3H]hypoxanthine incorporation after 96 hrs by scintillation counting analysis,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3217739,Medchemcomm,2011.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2074048,=,1,1,=,IC50,nM,16800.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,IC50,uM,UO_0000065,16.8
26095,,14542749,CHEMBL3223447,Antimalarial activity against schizont stage of atovaquone-resistant Plasmodium falciparum Tm90C2b infected in erythrocytes assessed as inhibition of [3H]hypoxanthine incorporation after 48 hrs by scintillation counting analysis,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3217739,Medchemcomm,2011.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2074048,=,1,1,=,IC50,nM,71800.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,IC50,uM,UO_0000065,71.8
26096,,14542757,CHEMBL3223448,Antimalarial activity against schizont stage of atovaquone-resistant Plasmodium falciparum Tm90C2b infected in erythrocytes assessed as inhibition of [3H]hypoxanthine incorporation after 96 hrs by scintillation counting analysis,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3217739,Medchemcomm,2011.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2074048,=,1,1,=,IC50,nM,15300.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,IC50,uM,UO_0000065,15.3
26097,,14542771,CHEMBL3223457,Antitoxoplasma activity against Toxoplasma gondii RH tachyzoites isolated from human brain assessed as parasite growth inhibition after 24 hrs by hematoxylin-eosin staining based light microscopy,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3217739,Medchemcomm,2011.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2074048,>,1,1,>,IC50,nM,20000.0,CHEMBL612888,Toxoplasma gondii,Toxoplasma gondii,5811.0,,IC50,uM,UO_0000065,20.0
26098,,14542776,CHEMBL3223458,Antitoxoplasma activity against Toxoplasma gondii RH tachyzoites isolated from human brain assessed as parasite growth inhibition after 48 hrs by hematoxylin-eosin staining based light microscopy,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3217739,Medchemcomm,2011.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2074048,>,1,1,>,IC50,nM,20000.0,CHEMBL612888,Toxoplasma gondii,Toxoplasma gondii,5811.0,,IC50,uM,UO_0000065,20.0
26099,,14566490,CHEMBL3243363,Antibacterial activity against Staphylococcus aureus MTCC 96 assessed as growth inhibition at 4 mg/mL after 24 hrs by agar well diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3232914,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,2085972,=,1,1,=,IZ,mm,26.6,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,DIZ,mm,UO_0000016,26.6
26100,,14566506,CHEMBL3243364,Antibacterial activity against Bacillus subtilis MTCC 121 assessed as growth inhibition at 4 mg/mL after 24 hrs by agar well diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3232914,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,2085972,=,1,1,=,IZ,mm,24.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,DIZ,mm,UO_0000016,24.0
26101,,14566522,CHEMBL3243365,Antibacterial activity against Escherichia coli MTCC 1652 assessed as growth inhibition at 4 mg/mL after 24 hrs by agar well diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3232914,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,2085972,=,1,1,=,IZ,mm,25.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,DIZ,mm,UO_0000016,25.0
26102,,14566538,CHEMBL3243366,Antibacterial activity against Pseudomonas aeruginosa MTCC 741 assessed as growth inhibition at 4 mg/mL after 24 hrs by agar well diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3232914,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,2085972,=,1,1,=,IZ,mm,22.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,DIZ,mm,UO_0000016,22.0
26103,,14566554,CHEMBL3243367,Antibacterial activity against Staphylococcus aureus MTCC 96 assessed as growth inhibition after 24 hrs by macrodilution tube method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3232914,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2085972,=,1,1,=,MIC,ug.mL-1,6.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,6.25
26104,,14566570,CHEMBL3243368,Antibacterial activity against Bacillus subtilis MTCC 121 assessed as growth inhibition after 24 hrs by macrodilution tube method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3232914,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2085972,=,1,1,=,MIC,ug.mL-1,6.25,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MIC,ug ml-1,UO_0000274,6.25
26105,,14568729,CHEMBL3242492,Antimicrobial activity against Staphylococcus aureus at 25 ug/well after 24 hrs by agar well diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3233012,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,2087046,=,1,1,=,IZ,mm,22.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,DIZ,mm,UO_0000016,22.0
26106,,14568742,CHEMBL3242493,Antimicrobial activity against Staphylococcus aureus at 50 ug/well after 24 hrs by agar well diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3233012,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,2087046,=,1,1,=,IZ,mm,24.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,DIZ,mm,UO_0000016,24.0
26107,,14568755,CHEMBL3242494,Antimicrobial activity against Staphylococcus aureus at 100 ug/well after 24 hrs by agar well diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3233012,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,2087046,=,1,1,=,IZ,mm,27.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,DIZ,mm,UO_0000016,27.0
26108,,14568768,CHEMBL3242495,Antimicrobial activity against Escherichia coli at 25 ug/well after 24 hrs by agar well diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3233012,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,2087046,=,1,1,=,IZ,mm,30.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,DIZ,mm,UO_0000016,30.0
26109,,14568781,CHEMBL3242496,Antimicrobial activity against Escherichia coli at 50 ug/well after 24 hrs by agar well diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3233012,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,2087046,=,1,1,=,IZ,mm,35.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,DIZ,mm,UO_0000016,35.0
26110,,14568794,CHEMBL3242497,Antimicrobial activity against Escherichia coli at 100 ug/well after 24 hrs by agar well diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3233012,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,2087046,=,1,1,=,IZ,mm,38.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,DIZ,mm,UO_0000016,38.0
26111,,14568807,CHEMBL3242498,Antimicrobial activity against Pseudomonas aeruginosa at 25 ug/well after 24 hrs by agar well diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3233012,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,2087046,=,1,1,=,IZ,mm,25.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,DIZ,mm,UO_0000016,25.0
26112,,14568820,CHEMBL3242499,Antimicrobial activity against Pseudomonas aeruginosa at 50 ug/well after 24 hrs by agar well diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3233012,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,2087046,=,1,1,=,IZ,mm,28.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,DIZ,mm,UO_0000016,28.0
26113,,14568833,CHEMBL3242500,Antimicrobial activity against Pseudomonas aeruginosa at 100 ug/well after 24 hrs by agar well diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3233012,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,2087046,=,1,1,=,IZ,mm,30.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,DIZ,mm,UO_0000016,30.0
26114,,14568915,CHEMBL3242507,Antimicrobial activity against Staphylococcus aureus ATCC 25923 after 24 hrs by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3233012,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2087046,=,1,1,=,MIC,ug.mL-1,12.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,12.5
26115,,14568920,CHEMBL3242508,Antimicrobial activity against Escherichia coli ATCC 25922 after 24 hrs by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3233012,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2087046,=,1,1,=,MIC,ug.mL-1,12.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,12.5
26116,,14569221,CHEMBL3243369,Bactericidal activity against Staphylococcus aureus MTCC 96 after 24 hrs,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3232914,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2085972,=,1,0,=,MBC,ug ml-1,6.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MBC,ug ml-1,UO_0000274,6.25
26117,,14569237,CHEMBL3243370,Bactericidal activity against Bacillus subtilis MTCC 121 after 24 hrs,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3232914,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2085972,=,1,0,=,MBC,ug ml-1,6.25,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MBC,ug ml-1,UO_0000274,6.25
26118,,14571571,CHEMBL3242509,Antimicrobial activity against Pseudomonas aeruginosa ATCC 27853 after 24 hrs by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3233012,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2087046,=,1,1,=,MIC,ug.mL-1,12.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,12.5
26119,Not Active,14571576,CHEMBL3242510,Antimicrobial activity against Aspergillus niger after 24 hrs by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3233012,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,2087046,,1,0,,MIC,,,CHEMBL358,Aspergillus niger,Aspergillus niger,5061.0,,MIC,,,
26120,Not Active,14571581,CHEMBL3242511,Antimicrobial activity against Penicillium chrysogenum after 24 hrs by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3233012,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,2087046,,1,0,,MIC,,,CHEMBL612847,Penicillium chrysogenum,Penicillium chrysogenum,5076.0,,MIC,,,
26121,,14574165,CHEMBL3239108,Inhibition of protein synthesis in methicillin-sensitive wild type Staphylococcus aureus over 1 hr by [14C]leucine incorporation assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3232928,J Med Chem,2013.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2083843,>,1,1,>,IC50,nM,174000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,IC50,uM,UO_0000065,174.0
26122,,14574166,CHEMBL3239107,Inhibition of RNA synthesis in methicillin-sensitive wild type Staphylococcus aureus over 1 hr by [3H]uridine incorporation assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3232928,J Med Chem,2013.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2083843,>,1,1,>,IC50,nM,195000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,IC50,uM,UO_0000065,195.0
26123,,14574167,CHEMBL3239106,Inhibition of DNA synthesis in methicillin-sensitive wild type Staphylococcus aureus over 1 hr by [3H]thymidine incorporation assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3232928,J Med Chem,2013.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2083843,=,1,1,=,IC50,nM,3900.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,IC50,uM,UO_0000065,3.9
26124,,14574168,CHEMBL3239109,Inhibition of protein synthesis in methicillin-sensitive wild type Staphylococcus aureus over 1 hr by [14C]valine incorporation assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3232928,J Med Chem,2013.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2083843,>,1,1,>,IC50,nM,195000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,IC50,uM,UO_0000065,195.0
26125,,14574169,CHEMBL3239111,Inhibition of cell wall synthesis in methicillin-sensitive wild type Staphylococcus aureus over 1 hr by [14C]N-acetyl glucosamine incorporation assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3232928,J Med Chem,2013.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2083843,>,1,1,>,IC50,nM,195000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,IC50,uM,UO_0000065,195.0
26126,,14577115,CHEMBL3239110,Inhibition of fatty acid synthesis in methicillin-sensitive wild type Staphylococcus aureus over 1 hr by [14C]acetic acid incorporation assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3232928,J Med Chem,2013.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2083843,>,1,1,>,IC50,nM,195000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,IC50,uM,UO_0000065,195.0
26127,,14580285,CHEMBL3239112,Inhibition of DNA synthesis in Streptococcus pneumoniae D39 over 1 hr by [3H]thymidine incorporation assay,F,BAO_0000190,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3232928,J Med Chem,2013.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2083843,=,1,1,=,IC50,nM,28000.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,IC50,uM,UO_0000065,28.0
26128,,14580287,CHEMBL3239113,Inhibition of RNA synthesis in Streptococcus pneumoniae D39 over 1 hr by [3H]uridine incorporation assay,F,BAO_0000190,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3232928,J Med Chem,2013.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2083843,>,1,1,>,IC50,nM,200000.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,IC50,uM,UO_0000065,200.0
26129,,14580289,CHEMBL3239114,Inhibition of protein synthesis in Streptococcus pneumoniae D39 over 1 hr by [14C]leucine incorporation assay,F,BAO_0000190,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3232928,J Med Chem,2013.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2083843,=,1,1,=,IC50,nM,110000.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,IC50,uM,UO_0000065,110.0
26130,,14580291,CHEMBL3239115,Inhibition of protein synthesis in Streptococcus pneumoniae D39 over 1 hr by [14C]valine incorporation assay,F,BAO_0000190,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3232928,J Med Chem,2013.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2083843,>,1,1,>,IC50,nM,200000.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,IC50,uM,UO_0000065,200.0
26131,,14580293,CHEMBL3239116,Inhibition of fatty acid synthesis in Streptococcus pneumoniae D39 over 1 hr by [14C]acetic acid incorporation assay,F,BAO_0000190,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3232928,J Med Chem,2013.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2083843,>,1,1,>,IC50,nM,200000.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,IC50,uM,UO_0000065,200.0
26132,,14580295,CHEMBL3239117,Inhibition of cell wall synthesis in Streptococcus pneumoniae D39 over 1 hr by [14C]N-acetyl glucosamine incorporation assay,F,BAO_0000190,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3232928,J Med Chem,2013.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2083843,>,1,1,>,IC50,nM,200000.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,IC50,uM,UO_0000065,200.0
26133,,14581627,CHEMBL3242859,Antimycobacterial activity against Mycobacterium tuberculosis H37Rv by microplate alamar blue assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3232798,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2085076,=,1,1,=,MIC,nM,4710.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,uM,UO_0000065,4.71
26134,,14582713,CHEMBL3239557,Antibacterial activity against Streptococcus pneumoniae MTCC 1936 assessed as growth inhibition after 24 to 48 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3232885,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2087284,=,1,1,=,MIC,ug.mL-1,250.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,250.0
26135,,14582717,CHEMBL3239558,Antibacterial activity against Bacillus subtilis MTCC 441 assessed as growth inhibition after 24 to 48 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3232885,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2087284,=,1,1,=,MIC,ug.mL-1,100.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MIC,ug ml-1,UO_0000274,100.0
26136,,14582721,CHEMBL3239559,Antibacterial activity against Clostridium tetani MTCC 449 assessed as growth inhibition after 24 to 48 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3232885,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2087284,=,1,1,=,MIC,ug.mL-1,25.0,CHEMBL613073,Clostridium tetani,Clostridium tetani,1513.0,,MIC,ug ml-1,UO_0000274,25.0
26137,,14582725,CHEMBL3239560,Antibacterial activity against Escherichia coli MTCC 443 assessed as growth inhibition after 24 to 48 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3232885,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2087284,=,1,1,=,MIC,ug.mL-1,100.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,100.0
26138,,14582729,CHEMBL3239561,Antibacterial activity against Salmonella typhi MTCC 98 assessed as growth inhibition after 24 to 48 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3232885,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2087284,=,1,1,=,MIC,ug.mL-1,10.0,CHEMBL614448,Salmonella enterica subsp. enterica serovar Typhi,Salmonella typhi,90370.0,,MIC,ug ml-1,UO_0000274,10.0
26139,,14582733,CHEMBL3239562,Antibacterial activity against Vibrio cholerae MTCC 3906 assessed as growth inhibition after 24 to 48 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3232885,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2087284,=,1,1,=,MIC,ug.mL-1,50.0,CHEMBL614402,Vibrio cholerae,Vibrio cholerae,666.0,,MIC,ug ml-1,UO_0000274,50.0
26140,,14582988,CHEMBL3242180,Antibacterial activity against Escherichia coli after 24 hrs by spectrophotometric analysis,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3232987,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2082913,=,1,1,=,MIC,ug.mL-1,0.015,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.015
26141,,14582989,CHEMBL3242179,Antibacterial activity against Klebsiella pneumoniae by NCCLS two-fold dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3232987,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2082913,=,1,1,=,MIC,ug.mL-1,0.012,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.012
26142,,14582990,CHEMBL3242178,Antibacterial activity against Escherichia coli by NCCLS two-fold dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3232987,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2082913,=,1,1,=,MIC,ug.mL-1,0.012,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.012
26143,,14582991,CHEMBL3242180,Antibacterial activity against Escherichia coli after 24 hrs by spectrophotometric analysis,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3232987,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2082913,=,1,1,=,IC50,ug.mL-1,0.007,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,IC50,ug ml-1,UO_0000274,0.007
26144,,14582992,CHEMBL3242181,Antibacterial activity against Klebsiella pneumoniae after 24 hrs by spectrophotometric analysis,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3232987,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2082913,=,1,1,=,IC50,ug.mL-1,0.02,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,IC50,ug ml-1,UO_0000274,0.02
26145,,14582993,CHEMBL3242181,Antibacterial activity against Klebsiella pneumoniae after 24 hrs by spectrophotometric analysis,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3232987,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2082913,=,1,1,=,MIC,ug.mL-1,0.049,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.049
26146,,14582995,CHEMBL3242040,Antibacterial activity against gentamicin-resistant Staphylococcus aureus ATCC 33592 by NCCLS two-fold dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3232987,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2082913,=,1,1,=,MIC,ug.mL-1,0.19,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.19
26147,,14583004,CHEMBL3242177,Antibacterial activity against gentamicin-resistant Staphylococcus aureus ATCC 33592 after 24 hrs by spectrophotometric analysis,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3232987,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2082913,=,1,1,=,IC50,ug.mL-1,0.2,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,IC50,ug ml-1,UO_0000274,0.2
26148,,14583008,CHEMBL3242041,Antibacterial activity against Staphylococcus aureus ATCC 25923 after 24 hrs by spectrophotometric analysis,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3232987,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2082913,=,1,1,=,IC50,ug.mL-1,0.3,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,IC50,ug ml-1,UO_0000274,0.3
26149,,14583019,CHEMBL3242177,Antibacterial activity against gentamicin-resistant Staphylococcus aureus ATCC 33592 after 24 hrs by spectrophotometric analysis,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3232987,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2082913,=,1,1,=,MIC,ug.mL-1,0.4,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.4
26150,,14583051,CHEMBL3242037,Antibacterial activity against Staphylococcus aureus ATCC 25923 by NCCLS two-fold dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3232987,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2082913,=,1,1,=,MIC,ug.mL-1,0.78,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.78
26151,,14583076,CHEMBL3242041,Antibacterial activity against Staphylococcus aureus ATCC 25923 after 24 hrs by spectrophotometric analysis,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3232987,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2082913,=,1,1,=,MIC,ug.mL-1,0.9,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.9
26152,,14585963,CHEMBL3242175,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 700699 after 24 hrs by spectrophotometric analysis,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3232987,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2082913,=,1,1,=,IC50,ug.mL-1,16.7,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,IC50,ug ml-1,UO_0000274,16.7
26153,,14585964,CHEMBL3242176,Antibacterial activity against Staphylococcus aureus ATCC 29213 after 24 hrs by spectrophotometric analysis,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3232987,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2082913,=,1,1,=,IC50,ug.mL-1,16.7,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,IC50,ug ml-1,UO_0000274,16.7
26154,,14585969,CHEMBL3242175,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 700699 after 24 hrs by spectrophotometric analysis,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3232987,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2082913,=,1,1,=,MIC,ug.mL-1,20.2,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,20.2
26155,,14585970,CHEMBL3242176,Antibacterial activity against Staphylococcus aureus ATCC 29213 after 24 hrs by spectrophotometric analysis,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3232987,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2082913,=,1,1,=,MIC,ug.mL-1,20.2,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,20.2
26156,,14585982,CHEMBL3242038,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 700699 by NCCLS two-fold dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3232987,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2082913,=,1,1,=,MIC,ug.mL-1,25.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,25.0
26157,,14585986,CHEMBL3242039,Antibacterial activity against Staphylococcus aureus ATCC 29213 by NCCLS two-fold dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3232987,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2082913,=,1,1,=,MIC,ug.mL-1,25.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,25.0
26158,,14587545,CHEMBL3241813,Antibacterial activity against Staphylococcus aureus NCTC 4163,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3232897,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2085526,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
26159,,14587551,CHEMBL3241814,Antibacterial activity against Staphylococcus aureus ATCC 25923,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3232897,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2085526,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
26160,,14587557,CHEMBL3241815,Antibacterial activity against Staphylococcus aureus ATCC 6538,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3232897,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2085526,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
26161,,14587563,CHEMBL3241816,Antibacterial activity against Staphylococcus aureus ATCC 29213,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3232897,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2085526,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
26162,,14587569,CHEMBL3241817,Antibacterial activity against Staphylococcus epidermidis ATCC 12228,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3232897,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2085526,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.25
26163,,14587575,CHEMBL3241818,Antibacterial activity against Staphylococcus epidermidis ATCC 35984,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3232897,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2085526,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.125
26164,,14587581,CHEMBL3241965,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis 459/11,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3232897,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2085526,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,16.0
26165,,14587587,CHEMBL3241966,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis 460/11,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3232897,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2085526,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.125
26166,,14587593,CHEMBL3241967,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis 461/11,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3232897,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2085526,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.25
26167,,14587599,CHEMBL3241968,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis 466/11,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3232897,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2085526,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,2.0
26168,,14587605,CHEMBL3241969,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis 467/11,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3232897,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2085526,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,16.0
26169,,14587611,CHEMBL3241970,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis 468/11,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3232897,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2085526,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,16.0
26170,,14587617,CHEMBL3241971,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis 469/11,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3232897,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2085526,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,8.0
26171,,14587623,CHEMBL3241972,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis 470/11,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3232897,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2085526,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.125
26172,,14587629,CHEMBL3241973,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis 488/11,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3232897,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2085526,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,16.0
26173,,14587635,CHEMBL3241974,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis 489/11,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3232897,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2085526,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.25
26174,,14587877,CHEMBL3241914,Antibacterial activity against Pseudomonas aeruginosa PAO1 assessed as growth inhibition at 20 ug/ml after 16 hrs by spectrophotometric analysis,F,BAO_0000096,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3232791,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,2087166,=,1,0,=,GI,%,91.01,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,GI,%,UO_0000187,91.00924
26175,,14587906,CHEMBL3241735,Antibacterial activity against Staphylococcus aureus RN4220 assessed as growth inhibition at 4 ug/ml after 16 hrs by spectrophotometric analysis,F,BAO_0000096,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3232791,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,2087166,=,1,0,=,GI,%,63.93,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,GI,%,UO_0000187,63.93
26176,,14587907,CHEMBL3241903,Antibacterial activity against Staphylococcus aureus RN4220 assessed as growth inhibition at 8 ug/ml after 16 hrs by spectrophotometric analysis,F,BAO_0000096,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3232791,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,2087166,=,1,0,=,GI,%,75.35,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,GI,%,UO_0000187,75.35
26177,,14587909,CHEMBL3241913,Antibacterial activity against Pseudomonas aeruginosa PAO1 assessed as growth inhibition at 40 ug/ml after 16 hrs by spectrophotometric analysis,F,BAO_0000096,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3232791,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,2087166,=,1,0,=,GI,%,89.77,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,GI,%,UO_0000187,89.76546
26178,,14587933,CHEMBL3241904,Antibacterial activity against Staphylococcus aureus RN4220 assessed as growth inhibition at 2 ug/ml after 16 hrs by spectrophotometric analysis,F,BAO_0000096,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3232791,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,2087166,=,1,0,=,GI,%,48.41,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,GI,%,UO_0000187,48.41
26179,,14588367,CHEMBL3243794,Antimicrobial activity against LS2 Efflux knock-out Haemophilus influenzae,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3232809,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2085698,<=,1,1,<=,MIC,ug.mL-1,0.06,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC,ug ml-1,UO_0000274,0.06
26180,,14588368,CHEMBL3243786,Antimicrobial activity against methicillin-sensitive Staphylococcus aureus ATCC 13709,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3232809,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2085698,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.12
26181,,14588369,CHEMBL3243788,Antimicrobial activity against Staphylococcus aureus Oxford,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3232809,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2085698,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.12
26182,,14588370,CHEMBL3243787,Antimicrobial activity against vancomycin-susceptible Staphylococcus aureus ATCC 25923,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3232809,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2085698,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
26183,,14588373,CHEMBL3243793,Antimicrobial activity against Haemophilus influenzae ATCC 31517 MMSA,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3232809,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2085698,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC,ug ml-1,UO_0000274,0.5
26184,,14588374,CHEMBL3243790,Antimicrobial activity against vancomycin-susceptible Enterococcus faecalis ATCC 29212,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3232809,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2085698,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,1.0
26185,,14588379,CHEMBL3243792,Antimicrobial activity against erythromycin-susceptible Streptococcus pneumoniae ATCC 49619,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3232809,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2085698,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
26186,,14588382,CHEMBL3243109,Antimicrobial activity against penicillin- and erythromycin-resistant Streptococcus pneumoniae,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3232809,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2085698,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
26187,,14588383,CHEMBL3243785,Antimicrobial activity against penicillin- and erythromycin-resistant Streptococcus pneumoniae in presence of 2.5% horse blood,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3232809,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2085698,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
26188,,14588453,CHEMBL3243789,Antimicrobial activity against methicillin-resistant Staphylococcus aureus,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3232809,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2085698,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,16.0
26189,,14588485,CHEMBL3243791,Antimicrobial activity against vancomycin-resistant Enterococcus faecium,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3232809,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2085698,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,32.0
26190,,14589418,CHEMBL3240836,Antibacterial activity against fluoroquinolone-resistant Staphylococcus aureus 1199B expressing NorA after 24 hrs by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3232989,J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2086162,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,16.0
26191,,14589854,CHEMBL3242234,Antibacterial activity against Escherichia coli ATCC 25922 after 18 hrs by microdilution broth method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3232716,J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2085423,<,1,1,<,MIC,nM,125.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,uM,UO_0000065,0.125
26192,,14589870,CHEMBL3242235,Antibacterial activity against extended-spectrum beta-lactamase producing multidrug-resistant and colistin-susceptible Escherichia coli CTX-M-15 clinical isolate Aar 11 after 18 hrs by microdilution broth method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3232716,J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2085423,=,1,1,=,MIC,nM,64000.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,uM,UO_0000065,64.0
26193,,14589886,CHEMBL3242236,Antibacterial activity against NDM-1 producing Escherichia coli clinical isolate 74859898 after 18 hrs by microdilution broth method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3232716,J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2085423,=,1,1,=,MIC,nM,64000.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,uM,UO_0000065,64.0
26194,,14589902,CHEMBL3241157,Antibacterial activity against multidrug-resistant Acinetobacter baumannii clinical isolate E2-1228625 after 18 hrs by microdilution broth method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3232716,J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2085423,=,1,1,=,MIC,nM,128000.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,uM,UO_0000065,128.0
26195,,14589918,CHEMBL3241158,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33591 after 18 hrs by microdilution broth method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3232716,J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2085423,=,1,1,=,MIC,nM,250.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,uM,UO_0000065,0.25
26196,,14589934,CHEMBL3241159,Antibacterial activity against vancomycin-resistant Enterococcus faecalis ATCC 700221 after 18 hrs by microdilution broth method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3232716,J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2085423,=,1,1,=,MIC,nM,128000.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,uM,UO_0000065,128.0
26197,,14590654,CHEMBL3241922,Antibacterial activity against Escherichia coli DH5alpha assessed as growth inhibition at 0.5 ug/ml after 16 hrs by spectrophotometric method,F,BAO_0000096,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3232791,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,2087166,=,1,0,=,GI,%,76.95,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,GI,%,UO_0000187,76.95
26198,,14590692,CHEMBL3241925,Antibacterial activity against Escherichia coli DH5alpha assessed as growth inhibition at 0.125 ug/ml after 16 hrs by spectrophotometric method,F,BAO_0000096,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3232791,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,2087166,=,1,0,=,GI,%,52.27,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,GI,%,UO_0000187,52.27
26199,,14590698,CHEMBL3241919,Antibacterial activity against Bacillus subtilis 168 assessed as growth inhibition at 0.1 ug/ml after 16 hrs by spectrophotometric analysis,F,BAO_0000096,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3232791,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,2087166,=,1,0,=,GI,%,30.43,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,GI,%,UO_0000187,30.43
26200,,14590711,CHEMBL3241926,Antibacterial activity against Escherichia coli DH5alpha assessed as growth inhibition at 0.0635 ug/ml after 16 hrs by spectrophotometric method,F,BAO_0000096,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3232791,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,2087166,=,1,0,=,GI,%,32.55,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,GI,%,UO_0000187,32.55
26201,,14590781,CHEMBL3241915,Antibacterial activity against Bacillus subtilis 168 assessed as growth inhibition at 0.4 ug/ml after 16 hrs by spectrophotometric analysis,F,BAO_0000096,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3232791,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,2087166,=,1,0,=,GI,%,94.32,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,GI,%,UO_0000187,94.32
26202,,14590783,CHEMBL3241912,Antibacterial activity against Pseudomonas aeruginosa PAO1 assessed as growth inhibition at 10 ug/ml after 16 hrs by spectrophotometric analysis,F,BAO_0000096,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3232791,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,2087166,=,1,0,=,GI,%,91.79,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,GI,%,UO_0000187,91.79104
26203,,14591602,CHEMBL3240964,Antibacterial activity against Salmonella assessed as growth inhibition after 7 days by microtiter plate assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3232938,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2087694,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL614446,Salmonella,Salmonella,590.0,,MIC,ug ml-1,UO_0000274,16.0
26204,,14591603,CHEMBL3240965,Antibacterial activity against Pseudomonas aeruginosa assessed as growth inhibition after 7 days by microtiter plate assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3232938,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2087694,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,2.0
26205,,14591604,CHEMBL3240966,Antibacterial activity against Staphylococcus aureus assessed as growth inhibition after 7 days by microtiter plate assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3232938,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2087694,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,8.0
26206,,14591605,CHEMBL3240967,Antibacterial activity against Escherichia coli assessed as growth inhibition after 7 days by microtiter plate assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3232938,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2087694,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.5
26207,,14591606,CHEMBL3240968,Antibacterial activity against duck Escherichia coli assessed as growth inhibition after 7 days by microtiter plate assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3232938,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2087694,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,4.0
26208,,14591607,CHEMBL3240969,Antibacterial activity against Salmonella assessed as zone of inhibition at 2 ug/ml,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3232938,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,2087694,=,1,1,=,IZ,mm,24.0,CHEMBL614446,Salmonella,Salmonella,590.0,,DIZ,mm,UO_0000016,24.0
26209,,14591608,CHEMBL3240970,Antibacterial activity against Pseudomonas aeruginosa assessed as zone of inhibition at 2 ug/ml,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3232938,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,2087694,=,1,1,=,IZ,mm,18.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,DIZ,mm,UO_0000016,18.0
26210,,14591609,CHEMBL3240971,Antibacterial activity against Staphylococcus aureus assessed as zone of inhibition at 2 ug/ml,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3232938,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,2087694,=,1,1,=,IZ,mm,9.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,DIZ,mm,UO_0000016,9.0
26211,,14591610,CHEMBL3241104,Antibacterial activity against Escherichia coli assessed as zone of inhibition at 2 ug/ml,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3232938,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,2087694,=,1,1,=,IZ,mm,21.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,DIZ,mm,UO_0000016,21.0
26212,,14591611,CHEMBL3241105,Antibacterial activity against duck Escherichia coli assessed as zone of inhibition at 2 ug/ml,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3232938,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,2087694,=,1,1,=,IZ,mm,42.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,DIZ,mm,UO_0000016,42.0
26213,,14591612,CHEMBL3241106,Antibacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 assessed as growth inhibition after 7 days by microtiter plate assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3232938,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2087694,=,1,1,=,MIC,nM,750.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,uM,UO_0000065,0.75
26214,,14591613,CHEMBL3241107,Antibacterial activity against drug-sensitive 1 ug/ml Mycobacterium tuberculosis clinical isolate 741 assessed as growth inhibition after 7 days by microtiter plate assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3232938,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2087694,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,ug ml-1,UO_0000274,2.0
26215,,14591614,CHEMBL3241108,Antibacterial activity against drug-sensitive 1 ug/ml Mycobacterium tuberculosis clinical isolate 753 assessed as growth inhibition after 7 days by microtiter plate assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3232938,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2087694,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,ug ml-1,UO_0000274,2.0
26216,,14591615,CHEMBL3241109,Antibacterial activity against drug-sensitive 1 ug/ml Mycobacterium tuberculosis clinical isolate 758 assessed as growth inhibition after 7 days by microtiter plate assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3232938,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2087694,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,ug ml-1,UO_0000274,1.0
26217,,14591616,CHEMBL3241110,Antibacterial activity against drug-sensitive 1 ug/ml Mycobacterium tuberculosis clinical isolate 760 assessed as growth inhibition after 7 days by microtiter plate assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3232938,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2087694,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,ug ml-1,UO_0000274,1.0
26218,,14591617,CHEMBL3241111,Antibacterial activity against drug-sensitive 1 ug/ml Mycobacterium tuberculosis clinical isolate 821 assessed as growth inhibition after 7 days by microtiter plate assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3232938,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2087694,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,ug ml-1,UO_0000274,2.0
26219,,14591618,CHEMBL3241112,Antibacterial activity against multidrug-resistant 1 ug/ml Mycobacterium tuberculosis clinical isolate 930 assessed as growth inhibition after 7 days by microtiter plate assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3232938,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2087694,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,ug ml-1,UO_0000274,16.0
26220,,14591619,CHEMBL3241113,Antibacterial activity against multidrug-resistant 1 ug/ml Mycobacterium tuberculosis clinical isolate 1237 assessed as growth inhibition after 7 days by microtiter plate assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3232938,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2087694,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,ug ml-1,UO_0000274,8.0
26221,,14591620,CHEMBL3240134,Antibacterial activity against multidrug-resistant 1 ug/ml Mycobacterium tuberculosis clinical isolate 1256 assessed as growth inhibition after 7 days by microtiter plate assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3232938,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2087694,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,ug ml-1,UO_0000274,4.0
26222,,14591621,CHEMBL3240135,Antibacterial activity against multidrug-resistant 1 ug/ml Mycobacterium tuberculosis clinical isolate 1259 assessed as growth inhibition after 7 days by microtiter plate assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3232938,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2087694,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,ug ml-1,UO_0000274,0.5
26223,,14591622,CHEMBL3240136,Antibacterial activity against multidrug-resistant 1 ug/ml Mycobacterium tuberculosis clinical isolate 1288 assessed as growth inhibition after 7 days by microtiter plate assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3232938,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2087694,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,ug ml-1,UO_0000274,8.0
26224,,14595120,CHEMBL3240840,Toxicity in Staphylococcus aureus ATCC 25923 after 24 hrs by microdilution method,A,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3232989,J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2086162,>=,1,1,>=,MIC,ug.mL-1,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,64.0
26225,,14595126,CHEMBL3240835,Antibacterial activity against Staphylococcus aureus ATCC 25923 after 24 hrs by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3232989,J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2086162,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
26226,,14595975,CHEMBL3239076,Antimicrobial activity against methicillin-resistant Staphylococcus aureus SG 511 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3232807,J Nat Prod,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2082219,=,1,1,=,MIC,ug.mL-1,12.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,12.5
26227,,14595980,CHEMBL3239077,Antimicrobial activity against Mycobacterium fortuitum IMET 10667 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3232807,J Nat Prod,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2082219,=,1,1,=,MIC,ug.mL-1,0.1,CHEMBL614983,Mycolicibacterium fortuitum,Mycolicibacterium fortuitum,1766.0,,MIC,ug ml-1,UO_0000274,0.1
26228,,14595985,CHEMBL3239078,Antimicrobial activity against Mycobacterium aurum SB 66 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3232807,J Nat Prod,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2082219,=,1,1,=,MIC,ug.mL-1,0.1,CHEMBL612952,Mycolicibacterium aurum,Mycolicibacterium aurum,1791.0,,MIC,ug ml-1,UO_0000274,0.1
26229,,14595990,CHEMBL3239079,Antimicrobial activity against Mycobacterium vaccae IMET 10670 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3232807,J Nat Prod,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2082219,=,1,1,=,MIC,ug.mL-1,0.1,CHEMBL613224,Mycolicibacterium vaccae,Mycolicibacterium vaccae,1810.0,,MIC,ug ml-1,UO_0000274,0.1
26230,,14595995,CHEMBL3239080,Antimicrobial activity against Mycobacterium smegmatis SG 987 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3232807,J Nat Prod,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2082219,=,1,1,=,MIC,ug.mL-1,0.78,CHEMBL613088,Mycolicibacterium smegmatis,Mycolicibacterium smegmatis,1772.0,,MIC,ug ml-1,UO_0000274,0.78
26231,,14599614,CHEMBL3242157,Antimalarial activity against chloroquine-sensitive Plasmodium falciparum 3D7 infected in human erythrocytes assessed as parasite growth inhibition after 50 hrs by SYBR Green1 dye-based fluorescence assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3232776,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2081450,=,1,1,=,IC50,nM,23100.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,IC50,uM,UO_0000065,23.1
26232,,14599621,CHEMBL3242158,Antimalarial activity against chloroquine-resistant Plasmodium falciparum Dd2 infected in human erythrocytes assessed as parasite growth inhibition after 50 hrs by SYBR Green1 dye-based fluorescence assay,F,BAO_0000190,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3232776,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2081450,=,1,1,=,IC50,nM,33900.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,IC50,uM,UO_0000065,33.9
26233,,14599669,CHEMBL3242165,"Selectivity index, ratio of IC50 for human THP1 cells to IC50 for chloroquine-sensitive Plasmodium falciparum 3D7",T,BAO_0000179,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3232776,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,2081450,=,1,0,=,Ratio IC50,,2.61,CHEMBL612545,,Unchecked,,,Ratio IC50,,,2.61
26234,,14599670,CHEMBL3242166,Antimalarial activity against blood stage form of Plasmodium falciparum assessed as incorporation of [3H]hypoxanthine after 72 hrs by liquid scintillation counting,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3232776,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2081450,=,1,1,=,IC50,nM,20000.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,IC50,uM,UO_0000065,20.0
26235,,14600522,CHEMBL3242631,Antibacterial activity against Staphylococcus aureus NCTC 4163 assessed as growth inhibition after 18 hrs by two-fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3232994,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2081590,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
26236,,14600533,CHEMBL3242632,Antibacterial activity against Staphylococcus aureus ATCC 25923 assessed as growth inhibition after 18 hrs by two-fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3232994,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2081590,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
26237,,14600544,CHEMBL3242633,Antibacterial activity against Staphylococcus aureus ATCC 6538 assessed as growth inhibition after 18 hrs by two-fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3232994,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2081590,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
26238,,14600555,CHEMBL3242634,Antibacterial activity against Staphylococcus aureus ATCC 29213 assessed as growth inhibition after 18 hrs by two-fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3232994,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2081590,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
26239,,14600566,CHEMBL3242635,Antibacterial activity against Staphylococcus epidermidis ATCC 12228 assessed as growth inhibition after 18 hrs by two-fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3232994,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2081590,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.25
26240,,14600577,CHEMBL3242636,Antibacterial activity against Bacillus subtilis ATCC 6633 assessed as growth inhibition after 18 hrs by two-fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3232994,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2081590,<,1,1,<,MIC,ug.mL-1,0.125,CHEMBL613907,Bacillus spizizenii,Bacillus spizizenii,96241.0,,MIC,ug ml-1,UO_0000274,0.125
26241,,14600588,CHEMBL3241378,Antibacterial activity against Bacillus cereus ATCC 11778 assessed as growth inhibition after 18 hrs by two-fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3232994,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2081590,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL613070,Bacillus cereus,Bacillus cereus,1396.0,,MIC,ug ml-1,UO_0000274,1.0
26242,,14600599,CHEMBL3241379,Antibacterial activity against Enterococcus hirae ATCC 10541 assessed as growth inhibition after 18 hrs by two-fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3232994,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2081590,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL614623,Enterococcus hirae,Enterococcus hirae,1354.0,,MIC,ug ml-1,UO_0000274,4.0
26243,,14600610,CHEMBL3241380,Antibacterial activity against Micrococcus luteus ATCC 9341 assessed as growth inhibition after 18 hrs by two-fold serial dilution method,F,BAO_0002146,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3232994,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2081590,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL1075349,Kocuria rhizophila,Kocuria rhizophila,72000.0,,MIC,ug ml-1,UO_0000274,2.0
26244,,14600621,CHEMBL3241381,Antibacterial activity against Micrococcus luteus ATCC 10240 assessed as growth inhibition after 18 hrs by two-fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3232994,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2081590,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL614421,Micrococcus luteus,Micrococcus luteus,1270.0,,MIC,ug ml-1,UO_0000274,1.0
26245,,14642842,CHEMBL3268945,Antibacterial activity against Staphylococcus aureus ATCC 29213 by CLSI method,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3259662,ACS Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2098465,=,1,1,=,IC50,ug.mL-1,0.08,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,IC50,ug ml-1,UO_0000274,0.08
26246,,14642843,CHEMBL3268945,Antibacterial activity against Staphylococcus aureus ATCC 29213 by CLSI method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3259662,ACS Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2098465,=,1,1,=,MIC,ug.mL-1,0.025,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.025
26247,,14642845,CHEMBL3268946,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33591 after 16 to 20 hrs by CLSI method,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3259662,ACS Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2098465,=,1,1,=,IC50,ug.mL-1,0.09,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,IC50,ug ml-1,UO_0000274,0.09
26248,,14642846,CHEMBL3268946,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33591 after 16 to 20 hrs by CLSI method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3259662,ACS Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2098465,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
26249,,14662725,CHEMBL3270016,Antibacterial activity against multidrug resistant Escherichia coli ATCC 35218 assessed as growth inhibition by MTT assay,F,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3259566,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2102392,=,1,1,=,MIC50,ug.mL-1,5.65,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC50,ug ml-1,UO_0000274,5.65
26250,,14662747,CHEMBL3270017,Antibacterial activity against tetracycline-resistant Bacillus subtilis ATCC 6633 assessed as growth inhibition by MTT assay,F,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3259566,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2102392,=,1,1,=,MIC50,ug.mL-1,2.7,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MIC50,ug ml-1,UO_0000274,2.7
26251,,14662769,CHEMBL3270018,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 25923 assessed as growth inhibition by MTT assay,F,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3259566,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2102392,=,1,1,=,MIC50,ug.mL-1,6.82,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC50,ug ml-1,UO_0000274,6.82
26252,,14662791,CHEMBL3270019,Antibacterial activity against amphotericin B-resistant Candida albicans ATCC 90873 assessed as growth inhibition by MTT assay,F,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3259566,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2102392,=,1,1,=,MIC50,ug.mL-1,32.4,CHEMBL366,Candida albicans,Candida albicans,5476.0,,MIC50,ug ml-1,UO_0000274,32.4
26253,,14662819,CHEMBL3270024,Drug uptake in Staphylococcus aureus at 10 ug/ml after 5 mins measured per mg of bacteria by spectrofluorometer analysis,A,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3259566,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,2102392,=,1,0,=,Drug uptake,ng,31.56,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Drug uptake,ng,UO_0000024,31.56
26254,,14662822,CHEMBL3270025,Drug uptake in Staphylococcus aureus at 10 ug/ml after 5 mins measured per mg of bacteria by spectrofluorometer analysis in presence of carbonyl cyanide m-chlorophenylhydrazone,A,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3259566,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,2102392,=,1,0,=,Drug uptake,ng,59.21,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Drug uptake,ng,UO_0000024,59.21
26255,,14662825,CHEMBL3271235,Inhibition of DNA gyrase activity in Escherichia coli using using relaxed pBR322 DNA as substrate assessed as DNA supercoiling activity after 40 mins by agarose gel electrophoresis,B,BAO_0000190,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3259566,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2102392,=,1,1,=,IC50,nM,5230.0,CHEMBL612545,,Unchecked,,,IC50,uM,UO_0000065,5.23
26256,,14662829,CHEMBL3271237,Drug efflux assessed as Staphylococcus aureus multidrug resistance efflux pump-mediated efflux rate at 10 ug/ml after 5 mins,A,BAO_0001103,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3259566,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,2102392,=,1,0,=,Activity,%,46.7,CHEMBL612558,,ADMET,,,Activity,%,UO_0000187,46.7
26257,,14716400,CHEMBL3295828,Antimicrobial activity against Escherichia coli MTCC-443 after 24 hrs by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3286187,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2119678,=,1,1,=,MIC,ug.mL-1,25.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,25.0
26258,,14716422,CHEMBL3295829,Antimicrobial activity against Pseudomonas aeruginosa MTCC-1688 after 24 hrs by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3286187,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2119678,=,1,1,=,MIC,ug.mL-1,25.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,25.0
26259,,14716444,CHEMBL3295830,Antimicrobial activity against Staphylococcus aureus MTCC-96 after 24 hrs by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3286187,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2119678,=,1,1,=,MIC,ug.mL-1,50.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,50.0
26260,,14716466,CHEMBL3295831,Antimicrobial activity against Streptococcus pyogenes MTCC-442 after 24 hrs by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3286187,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2119678,=,1,1,=,MIC,ug.mL-1,50.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC,ug ml-1,UO_0000274,50.0
26261,,14716471,CHEMBL3295832,Antimicrobial activity against methicillin-resistant Staphylococcus aureus ATCC 43300 after 24 hrs by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3286187,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2119678,=,1,1,=,MIC,ug.mL-1,25.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,25.0
26262,,14716597,CHEMBL3295726,Antibacterial activity against Escherichia coli MTCC 723 assessed as growth inhibition after 18 hrs by CLSI microdilution broth assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3286351,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2116500,=,1,1,=,MIC,ug.mL-1,0.7,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.7
26263,,14716628,CHEMBL3295727,Antibacterial activity against Pseudomonas aeruginosa MTCC 2295 assessed as growth inhibition after 18 hrs by CLSI microdilution broth assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3286351,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2116500,=,1,1,=,MIC,ug.mL-1,0.3,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.3
26264,,14716659,CHEMBL3295728,Antibacterial activity against Staphylococcus aureus MTCC 3160 assessed as growth inhibition after 18 hrs by CLSI microdilution broth assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3286351,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2116500,=,1,1,=,MIC,ug.mL-1,0.15,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.15
26265,,14716690,CHEMBL3295729,Antibacterial activity against Bacillus subtilis MTCC 2763 assessed as growth inhibition after 18 hrs by CLSI microdilution broth assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3286351,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2116500,=,1,1,=,MIC,ug.mL-1,0.7,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MIC,ug ml-1,UO_0000274,0.7
26266,,14739047,CHEMBL3296049,Antimicrobial activity against Micrococcus luteus assessed as zone of inhibition by agar diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3286206,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,2115167,=,1,1,=,IZ,mm,25.0,CHEMBL614421,Micrococcus luteus,Micrococcus luteus,1270.0,,DIZ,mm,UO_0000016,25.0
26267,,14739048,CHEMBL3296050,Antimicrobial activity against Micrococcus luteus assessed as growth inhibition by agar diffusion method,F,BAO_0000096,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3286206,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,2115167,=,1,0,=,GI,%,100.0,CHEMBL614421,Micrococcus luteus,Micrococcus luteus,1270.0,,GI,%,UO_0000187,100.0
26268,,14739049,CHEMBL3296051,Antimicrobial activity against Micrococcus luteus assessed as zone of inhibition >8 mm by twofold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3286206,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,2115167,=,1,0,=,MIC,10'-3uM/ml,0.59,CHEMBL614421,Micrococcus luteus,Micrococcus luteus,1270.0,,MIC,10'-3uM/ml,,0.59
26269,,14739050,CHEMBL3296052,Antimicrobial activity against Staphylococcus aureus assessed as zone of inhibition by agar diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3286206,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,2115167,=,1,1,=,IZ,mm,24.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,DIZ,mm,UO_0000016,24.0
26270,,14739051,CHEMBL3296053,Antimicrobial activity against Staphylococcus aureus assessed as growth inhibition by agar diffusion method,F,BAO_0000096,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3286206,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,2115167,=,1,0,=,GI,%,100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,GI,%,UO_0000187,100.0
26271,,14739052,CHEMBL3296054,Antimicrobial activity against Staphylococcus aureus assessed as zone of inhibition >8 mm by twofold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3286206,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,2115167,=,1,0,=,MIC,10'-3uM/ml,9.43,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,10'-3uM/ml,,9.43
26272,,14739053,CHEMBL3296055,Antimicrobial activity against Escherichia coli assessed as zone of inhibition by agar diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3286206,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,2115167,=,1,1,=,IZ,mm,17.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,DIZ,mm,UO_0000016,17.0
26273,,14739054,CHEMBL3296056,Antimicrobial activity against Escherichia coli assessed as growth inhibition by agar diffusion method,F,BAO_0000096,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3286206,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,2115167,=,1,0,=,GI,%,100.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,GI,%,UO_0000187,100.0
26274,,14739055,CHEMBL3296057,Antimicrobial activity against Escherichia coli assessed as zone of inhibition >8 mm by twofold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3286206,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,2115167,=,1,0,=,MIC,10'-3uM/ml,4.72,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,10'-3uM/ml,,4.72
26275,,14739056,CHEMBL3296058,Antimicrobial activity against Klebsiella pneumoniae assessed as zone of inhibition by agar diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3286206,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,2115167,=,1,1,=,IZ,mm,17.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,DIZ,mm,UO_0000016,17.0
26276,,14739057,CHEMBL3296059,Antimicrobial activity against Klebsiella pneumoniae assessed as growth inhibition by agar diffusion method,F,BAO_0000096,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3286206,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,2115167,=,1,0,=,GI,%,100.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,GI,%,UO_0000187,100.0
26277,,14739058,CHEMBL3296060,Antimicrobial activity against Klebsiella pneumoniae assessed as zone of inhibition >8 mm by twofold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3286206,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,2115167,=,1,0,=,MIC,10'-3uM/ml,0.59,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,10'-3uM/ml,,0.59
26278,,14739100,CHEMBL3296162,Bactericidal activity against Micrococcus luteus MTCC 2470 after 24 hrs by agar plating method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3286384,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2115206,=,1,0,=,MBC,ug ml-1,0.58,CHEMBL614421,Micrococcus luteus,Micrococcus luteus,1270.0,,MBC,ug ml-1,UO_0000274,0.58
26279,,14739101,CHEMBL3297048,Bactericidal activity against Staphylococcus aureus MTCC 96 after 24 hrs by agar plating method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3286384,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2115206,=,1,0,=,MBC,ug ml-1,0.58,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MBC,ug ml-1,UO_0000274,0.58
26280,,14739102,CHEMBL3297051,Bactericidal activity against Escherichia coli MTCC 739 after 24 hrs by agar plating method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3286384,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2115206,=,1,0,=,MBC,ug ml-1,0.58,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MBC,ug ml-1,UO_0000274,0.58
26281,,14739103,CHEMBL3297052,Bactericidal activity against Pseudomonas aeruginosa MTCC 2453 after 24 hrs by agar plating method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3286384,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2115206,=,1,0,=,MBC,ug ml-1,0.58,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MBC,ug ml-1,UO_0000274,0.58
26282,,14739104,CHEMBL3296070,Antimicrobial activity against Micrococcus luteus MTCC 2470 after 24 hrs by well diffusion method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3286384,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2115206,=,1,1,=,MIC,ug.mL-1,0.9,CHEMBL614421,Micrococcus luteus,Micrococcus luteus,1270.0,,MIC,ug ml-1,UO_0000274,0.9
26283,,14739105,CHEMBL3296071,Antimicrobial activity against Staphylococcus aureus MTCC 96 after 24 hrs by well diffusion method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3286384,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2115206,=,1,1,=,MIC,ug.mL-1,0.9,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.9
26284,,14739106,CHEMBL3296151,Antimicrobial activity against Staphylococcus aureus MLS-16 MTCC 2940 after 24 hrs by well diffusion method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3286384,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2115206,=,1,1,=,MIC,ug.mL-1,0.9,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.9
26285,,14739107,CHEMBL3296152,Antimicrobial activity against Bacillus subtilis MTCC 121 after 24 hrs by well diffusion method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3286384,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2115206,=,1,1,=,MIC,ug.mL-1,0.9,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MIC,ug ml-1,UO_0000274,0.9
26286,,14739108,CHEMBL3296153,Antimicrobial activity against Escherichia coli MTCC 739 after 24 hrs by well diffusion method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3286384,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2115206,=,1,1,=,MIC,ug.mL-1,0.9,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.9
26287,,14739109,CHEMBL3296154,Antimicrobial activity against Pseudomonas aeruginosa MTCC 2453 after 24 hrs by well diffusion method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3286384,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2115206,=,1,1,=,MIC,ug.mL-1,0.9,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.9
26288,,14739110,CHEMBL3296155,Antimicrobial activity against Klebsiella planticola MTCC 530 after 24 hrs by well diffusion method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3286384,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2115206,=,1,1,=,MIC,ug.mL-1,0.9,CHEMBL613271,Raoultella planticola,Raoultella planticola,575.0,,MIC,ug ml-1,UO_0000274,0.9
26289,,14739111,CHEMBL3297049,Bactericidal activity against Staphylococcus aureus MLS-16 MTCC 2940 after 24 hrs by agar plating method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3286384,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2115206,=,1,0,=,MBC,ug ml-1,1.17,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MBC,ug ml-1,UO_0000274,1.17
26290,,14739112,CHEMBL3297050,Bactericidal activity against Bacillus subtilis MTCC 121 after 24 hrs by agar plating method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3286384,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2115206,=,1,0,=,MBC,ug ml-1,1.17,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MBC,ug ml-1,UO_0000274,1.17
26291,,14739113,CHEMBL3297053,Bactericidal activity against Klebsiella planticola MTCC 530 after 24 hrs by agar plating method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3286384,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2115206,=,1,0,=,MBC,ug ml-1,1.17,CHEMBL613271,Raoultella planticola,Raoultella planticola,575.0,,MBC,ug ml-1,UO_0000274,1.17
26292,,14740588,CHEMBL3294765,Antimicrobial activity against Staphylococcus aureus ATCC 25923 after 24 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3286335,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2118205,=,1,1,=,MIC,ug.mL-1,0.09,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.09
26293,,14740617,CHEMBL3294766,Antimicrobial activity against methicillin-resistant Staphylococcus aureus after 24 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3286335,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2118205,=,1,1,=,MIC,ug.mL-1,0.38,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.38
26294,,14740644,CHEMBL3294767,Antimicrobial activity against Klebsiella pneumoniae ATCC 27736 after 24 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3286335,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2118205,=,1,1,=,MIC,ug.mL-1,0.01,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.01
26295,,14740673,CHEMBL3294768,Antimicrobial activity against Escherichia coli ATCC 9637 after 24 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3286335,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2118205,=,1,1,=,MIC,ug.mL-1,0.01,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.01
26296,,14740702,CHEMBL3294769,Antimicrobial activity against Pseudomonas aeruginosa ATCC BAA-427 after 24 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3286335,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2118205,=,1,1,=,MIC,ug.mL-1,0.09,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.09
26297,Not Active,14741410,CHEMBL3296156,Antimicrobial activity against Candida albicans MTCC 3017 after 24 hrs by well diffusion method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3286384,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,2115206,,1,0,,MIC,,,CHEMBL366,Candida albicans,Candida albicans,5476.0,,MIC,,,
26298,,14742863,CHEMBL3294770,Antimicrobial activity against vancomycin-resistant Staphylococcus aureus after 24 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3286335,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2118205,=,1,1,=,MIC,ug.mL-1,0.38,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.38
26299,,14743733,CHEMBL3294029,Antimycobacterial activity against wild-type Mycobacterium tuberculosis H37Rv ATCC 27294 after 16 to 18 days by BACTEC 7H12B microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3286091,J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2118301,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,ug ml-1,UO_0000274,0.25
26300,Not Active,14745992,CHEMBL3294045,Antimycobacterial activity against spontaneously resistant mutant of Mycobacterium tuberculosis H37Rv at 8 times MIC up to 6 to 8 weeks,F,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3286091,J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,2118301,,1,0,,Activity,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,Activity,,,
26301,,14746002,CHEMBL3291881,"Ratio of MIC for 5-(((3S,4R)-3-Fluoro-1-(2-(7-methoxy-2-oxo-1,5-naphthyridin-1(2H)-yl)ethyl)piperidin-4-ylamino)methyl)-2-methylnicotinonitrile-resistant Mycobacterium tuberculosis harboring DNA gyraseA D89N mutant to MIC for wild-type Mycobacterium tuberculosis H37Rv ATCC 27294",F,BAO_0000193,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3286091,J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,2118301,=,1,0,=,Ratio,,16.0,CHEMBL612545,,Unchecked,,,Ratio,,,16.0
26302,,14746040,CHEMBL3291876,"Antimycobacterial activity against 2-oxo-1-(2-(4-((3-oxo-3,4-dihydro-2H-pyrido[3,2-b][1,4]oxazin-6-yl)methylamino)piperidin-1-yl)ethyl)-1,2-dihydroquinoline-7-carbonitrile-resistant Mycobacterium tuberculosis harboring DNA gyraseA A74V mutant",F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3286091,J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2118301,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,ug ml-1,UO_0000274,0.25
26303,,14746049,CHEMBL3291877,"Antimycobacterial activity against 5-(((3S,4R)-3-Fluoro-1-(2-(7-methoxy-2-oxo-1,5-naphthyridin-1(2H)-yl)ethyl)piperidin-4-ylamino)methyl)-2-methylnicotinonitrile-resistant Mycobacterium tuberculosis harboring DNA gyraseA D89N mutant",F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3286091,J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2118301,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,ug ml-1,UO_0000274,4.0
26304,,14746058,CHEMBL3291878,Antimycobacterial activity against moxifloxacin-resistant Mycobacterium tuberculosis harboring DNA gyraseA G88N mutant,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3286091,J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2118301,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,ug ml-1,UO_0000274,8.0
26305,,14751006,CHEMBL3300228,Antibacterial activity against Pseudomonas aeruginosa by resazurin-based assay,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3297675,J Nat Prod,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2119840,=,1,1,=,MIC80,ug.mL-1,1.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC80,ug ml-1,UO_0000274,1.5
26306,,14757618,CHEMBL3299900,Antibacterial activity against Staphylococcus aureus MTCC 96 by conventional broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3297679,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2121446,=,1,1,=,MIC,ug.mL-1,50.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,50.0
26307,,14757634,CHEMBL3299901,Antibacterial activity against Streptococcus pyogenes MTCC 442 by conventional broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3297679,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2121446,=,1,1,=,MIC,ug.mL-1,50.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC,ug ml-1,UO_0000274,50.0
26308,,14757650,CHEMBL3299902,Antibacterial activity against Escherichia coli MTCC 443 by conventional broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3297679,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2121446,=,1,1,=,MIC,ug.mL-1,25.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,25.0
26309,,14757666,CHEMBL3299903,Antibacterial activity against Pseudomonas aeruginosa MTCC 1688 by conventional broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3297679,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2121446,=,1,1,=,MIC,ug.mL-1,25.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,25.0
26310,,14758996,CHEMBL3301372,"ASTRAZENECA: Intrinsic clearance measured in human hepatocytes following incubation at 37C. Experimental range <3 to >150 microL/min/1E6 cells. Rapid Commun. Mass Spectrom. 2010, 24, 1730-1736.",A,BAO_0002759,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3301361,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,2128778,,27,1,,CL,uL.min-1.(10^6cells)-1,4.17,CHEMBL612558,,ADMET,,,CLint,microL/min/1E6 cells,,4.17
26311,,14973689,CHEMBL3388283,Antibacterial activity against ciprofloxacin-susceptible Streptococcus pneumoniae ATCC49619 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3351768,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2249931,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
26312,,14973709,CHEMBL3388282,Antibacterial activity against ciprofloxacin-susceptible Staphylococcus aureus OC4172 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3351768,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2249931,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.12
26313,,14973721,CHEMBL3388924,Antibacterial activity against ciprofloxacin-resistant Streptococcus pneumoniae OC6608 clinical isolate by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3351768,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2249931,>,1,1,>,MIC,ug.mL-1,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,16.0
26314,,14973741,CHEMBL3388925,Antibacterial activity against ciprofloxacin-resistant Streptococcus pneumoniae OC6578 clinical isolate by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3351768,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2249931,>,1,1,>,MIC,ug.mL-1,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,16.0
26315,,14973761,CHEMBL3388926,Antibacterial activity against ciprofloxacin-resistant Streptococcus pneumoniae OC5465 clinical isolate by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3351768,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2249931,>,1,1,>,MIC,ug.mL-1,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,16.0
26316,,14973781,CHEMBL3388927,Antibacterial activity against methicillin-resistant Staphylococcus aureus OC2805 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3351768,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2249931,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,16.0
26317,,14973785,CHEMBL3389495,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis OC5340 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3351768,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2249931,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,8.0
26318,,14973789,CHEMBL3389496,Antibacterial activity against Escherichia coli ATCC 25922 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3351768,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2249931,=,1,1,=,MIC,ug.mL-1,0.015,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.015
26319,,14973793,CHEMBL3389497,Antibacterial activity against methicillin-susceptible Staphylococcus aureus OC4172 infected in po dosed Swiss Webster mouse assessed as mortality after 3 days,F,BAO_0003036,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3351768,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,2249931,=,1,1,=,ED50,mg.kg-1,11.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,ED50,mg kg-1,UO_0000308,11.0
26320,,14981362,CHEMBL3386673,Antibacterial activity against Staphylococcus aureus SH1000,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3352500,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2266971,=,1,1,=,MIC,ug.mL-1,6.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,6.25
26321,,14981365,CHEMBL3386674,Antibacterial activity against Staphylococcus epidermidis RP62A,F,BAO_0002146,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3352500,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2266971,=,1,1,=,MIC,ug.mL-1,1.56,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,1.56
26322,,14982387,CHEMBL3372906,Antimicrobial activity against Staphylococcus aureus CECT 86 ATCC 12600 incubated for 18 hrs by microplate reader based assay,F,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3352083,Bioorg Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2260923,=,1,1,=,MIC50,nM,300.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC50,uM,UO_0000065,0.3
26323,,14982388,CHEMBL3372907,Antimicrobial activity against Pseudomonas aeruginosa PAO1 CECT 4122 ATCC 15692 incubated for 18 hrs by microplate reader based assay,F,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3352083,Bioorg Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2260923,=,1,1,=,MIC50,nM,1200.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC50,uM,UO_0000065,1.2
26324,Active,15009489,CHEMBL3363724,Inhibition of DNA gyrase (unknown origin) assessed as reduction in supercoiled form of DNA at 5 to 20 uM using ethidium bromide staining by gel electrophoresis,B,BAO_0000201,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3351986,Bioorg Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,2258974,,1,0,,Inhibition,%,,CHEMBL612545,,Unchecked,,,INH,,UO_0000187,
26325,,15009490,CHEMBL3363723,Antimicrobial activity against Stenotrophomonas maltophilia N1119 after 18 hrs by micro dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3351986,Bioorg Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2258974,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,MIC,ug ml-1,UO_0000274,1.0
26326,,15009491,CHEMBL3363722,Antimicrobial activity against Stenotrophomonas maltophilia N1124 after 18 hrs by micro dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3351986,Bioorg Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2258974,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,MIC,ug ml-1,UO_0000274,4.0
26327,,15009492,CHEMBL3363721,Antimicrobial activity against Stenotrophomonas maltophilia N1127 after 18 hrs by micro dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3351986,Bioorg Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2258974,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,MIC,ug ml-1,UO_0000274,2.0
26328,,15009493,CHEMBL3363720,Antimicrobial activity against Burkholderia cepacia BIG 121 after 18 hrs by micro dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3351986,Bioorg Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2258974,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL612499,Burkholderia cepacia,Burkholderia cepacia,292.0,,MIC,ug ml-1,UO_0000274,8.0
26329,,15009494,CHEMBL3363719,Antimicrobial activity against Burkholderia cepacia BIG 120 after 18 hrs by micro dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3351986,Bioorg Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2258974,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL612499,Burkholderia cepacia,Burkholderia cepacia,292.0,,MIC,ug ml-1,UO_0000274,2.0
26330,,15009495,CHEMBL3363718,Antimicrobial activity against Burkholderia cepacia BIG 119 after 18 hrs by micro dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3351986,Bioorg Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2258974,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL612499,Burkholderia cepacia,Burkholderia cepacia,292.0,,MIC,ug ml-1,UO_0000274,4.0
26331,,15009496,CHEMBL3363717,Antimicrobial activity against Burkholderia cepacia BIG 118 after 18 hrs by micro dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3351986,Bioorg Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2258974,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL612499,Burkholderia cepacia,Burkholderia cepacia,292.0,,MIC,ug ml-1,UO_0000274,0.25
26332,,15009497,CHEMBL3363716,Antimicrobial activity against Burkholderia cepacia BIG 117 after 18 hrs by micro dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3351986,Bioorg Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2258974,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL612499,Burkholderia cepacia,Burkholderia cepacia,292.0,,MIC,ug ml-1,UO_0000274,1.0
26333,,15009498,CHEMBL3363715,Antimicrobial activity against Burkholderia cepacia BIG 9 NCTC 10744 after 18 hrs by micro dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3351986,Bioorg Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2258974,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL612499,Burkholderia cepacia,Burkholderia cepacia,292.0,,MIC,ug ml-1,UO_0000274,0.5
26334,,15009499,CHEMBL3363714,Antimicrobial activity against Serratia marcescens BIG 11 NCTC 1377 after 18 hrs by micro dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3351986,Bioorg Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2258974,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,MIC,ug ml-1,UO_0000274,0.06
26335,,15009500,CHEMBL3363713,Antimicrobial activity against Pseudomonas aeruginosa BIG 63 after 18 hrs by micro dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3351986,Bioorg Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2258974,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.25
26336,,15009501,CHEMBL3363712,Antimicrobial activity against Pseudomonas aeruginosa NCTC 10662 after 18 hrs by micro dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3351986,Bioorg Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2258974,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.25
26337,,15009502,CHEMBL3363711,Antimicrobial activity against Pseudomonas aeruginosa BIG 37 clinical isolate after 18 hrs by micro dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3351986,Bioorg Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2258974,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,2.0
26338,,15009503,CHEMBL3363452,Antimicrobial activity against Pseudomonas aeruginosa environmental isolate BIG 39 after 18 hrs by micro dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3351986,Bioorg Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2258974,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.25
26339,,15009504,CHEMBL3363451,Antimicrobial activity against Escherichia coli BIG 0046 after 18 hrs by micro dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3351986,Bioorg Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2258974,>,1,1,>,MIC,ug.mL-1,36.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,36.0
26340,,15009505,CHEMBL3363450,Antimicrobial activity against Escherichia coli NCTC 10418 after 18 hrs by micro dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3351986,Bioorg Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2258974,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.06
26341,,15009506,CHEMBL3363449,Antimicrobial activity against Staphylococcus haemolyticus NCTC 11042 after 18 hrs by micro dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3351986,Bioorg Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2258974,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,MIC,ug ml-1,UO_0000274,0.125
26342,,15009507,CHEMBL3363448,Antimicrobial activity against Staphylococcus epidermidis NCTC 2749 after 18 hrs by micro dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3351986,Bioorg Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2258974,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.25
26343,,15009508,CHEMBL3363447,Antimicrobial activity against Staphylococcus epidermidis NCTC 11047 after 18 hrs by micro dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3351986,Bioorg Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2258974,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.125
26344,,15009509,CHEMBL3363446,Antimicrobial activity against Staphylococcus aureus BIG 52 after 18 hrs by micro dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3351986,Bioorg Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2258974,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
26345,,15009510,CHEMBL3363445,Antimicrobial activity against Staphylococcus aureus NCTC 13143 after 18 hrs by micro dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3351986,Bioorg Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2258974,>,1,1,>,MIC,ug.mL-1,36.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,36.0
26346,,15009511,CHEMBL3363442,Antimicrobial activity against Staphylococcus aureus NCTC 13142 after 18 hrs by micro dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3351986,Bioorg Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2258974,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
26347,,15009512,CHEMBL3363443,Antimicrobial activity against Staphylococcus aureus HG-1 after 18 hrs by micro dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3351986,Bioorg Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2258974,>,1,1,>,MIC,ug.mL-1,36.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,36.0
26348,,15009513,CHEMBL3363444,Antimicrobial activity against Staphylococcus aureus (Oxford) NCTC 6571 after 18 hrs by micro dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3351986,Bioorg Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2258974,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
26349,Not Active,15014315,CHEMBL3363748,Antimicrobial activity against Pseudomonas aeruginosa ATCC 27853 after 70 to 74 hrs by CLSI method,F,BAO_0000201,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3351734,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,2248293,,1,0,,Inhibition,%,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,INH,,UO_0000187,
26350,Not Active,15014341,CHEMBL3363747,Antimicrobial activity against Mycobacterium intracellulare ATCC 23068 after 70 to 74 hrs by Alamar Blue method,F,BAO_0000201,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3351734,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,2248293,,1,0,,Inhibition,%,,CHEMBL612640,Mycobacterium intracellulare,Mycobacterium intracellulare,1767.0,,INH,,UO_0000187,
26351,Not Active,15014367,CHEMBL3363746,Antimicrobial activity against Escherichia coli ATCC 35218 after 70 to 74 hrs by CLSI method,F,BAO_0000201,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3351734,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,2248293,,1,0,,Inhibition,%,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,INH,,UO_0000187,
26352,Not Active,15014393,CHEMBL3363745,Antimicrobial activity against Aspergillus fumigatus after 70 to 74 hrs by CLSI method,F,BAO_0000201,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3351734,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,2248293,,1,0,,Inhibition,%,,CHEMBL363,Aspergillus fumigatus,Aspergillus fumigatus,746128.0,,INH,,UO_0000187,
26353,Not Active,15014419,CHEMBL3363744,Antimicrobial activity against Candida albicans after 70 to 74 hrs by CLSI method,F,BAO_0000201,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3351734,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,2248293,,1,0,,Inhibition,%,,CHEMBL366,Candida albicans,Candida albicans,5476.0,,INH,,UO_0000187,
26354,,15015282,CHEMBL3372082,Antimicrobial activity against Bacillus subtilis NCIM-2063 after 20 hrs by two fold serial macrodilution technique,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3352499,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2269620,=,1,1,=,MIC,ug.mL-1,6.25,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MIC,ug ml-1,UO_0000274,6.25
26355,,15015298,CHEMBL3372083,Bactericidal activity against Bacillus subtilis NCIM-2063 after 72 hrs by two fold serial macrodilution technique,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3352499,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2269620,=,1,0,=,MBC,ug ml-1,13.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MBC,ug ml-1,UO_0000274,13.0
26356,,15015314,CHEMBL3372084,Antimicrobial activity against Staphylococcus aureus NCIM-2901 after 20 hrs by two fold serial macrodilution technique,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3352499,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2269620,=,1,1,=,MIC,ug.mL-1,6.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,6.25
26357,,15015330,CHEMBL3372085,Bactericidal activity against Staphylococcus aureus NCIM-2901 after 72 hrs by two fold serial macrodilution technique,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3352499,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2269620,=,1,0,=,MBC,ug ml-1,13.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MBC,ug ml-1,UO_0000274,13.0
26358,,15016257,CHEMBL3363232,Antimicrobial activity against Streptococcus pneumoniae MTCC 1936 assessed as absence of visible growth after 24 to 48 hrs by broth micro dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3351702,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2271804,=,1,1,=,MIC,ug.mL-1,25.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,25.0
26359,,15016271,CHEMBL3363231,Antimicrobial activity against Bacillus subtilis MTCC 441 assessed as absence of visible growth after 24 to 48 hrs by broth micro dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3351702,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2271804,=,1,1,=,MIC,ug.mL-1,50.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MIC,ug ml-1,UO_0000274,50.0
26360,,15016287,CHEMBL3363230,Antimicrobial activity against Clostridium tetani MTCC 449 assessed as absence of visible growth after 24 to 48 hrs by broth micro dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3351702,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2271804,=,1,1,=,MIC,ug.mL-1,100.0,CHEMBL613073,Clostridium tetani,Clostridium tetani,1513.0,,MIC,ug ml-1,UO_0000274,100.0
26361,,15016303,CHEMBL3363233,Antimicrobial activity against Escherichia coli MTCC 443 assessed as absence of visible growth after 24 to 48 hrs by broth micro dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3351702,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2271804,=,1,1,=,MIC,ug.mL-1,25.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,25.0
26362,,15016319,CHEMBL3363234,Antimicrobial activity against Salmonella typhi MTCC 98 assessed as absence of visible growth after 24 to 48 hrs by broth micro dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3351702,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2271804,=,1,1,=,MIC,ug.mL-1,25.0,CHEMBL614448,Salmonella enterica subsp. enterica serovar Typhi,Salmonella typhi,90370.0,,MIC,ug ml-1,UO_0000274,25.0
26363,,15016335,CHEMBL3363235,Antimicrobial activity against Vibrio cholerae MTCC 3906 assessed as absence of visible growth after 24 to 48 hrs by broth micro dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3351702,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2271804,=,1,1,=,MIC,ug.mL-1,25.0,CHEMBL614402,Vibrio cholerae,Vibrio cholerae,666.0,,MIC,ug ml-1,UO_0000274,25.0
26364,,15018400,CHEMBL3363434,Antimicrobial activity against vancomycin-resistant Enterococcus faecalis after 18 hrs by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3351437,J Nat Prod,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2242137,=,1,1,=,MIC,ug.mL-1,1.56,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,1.56
26365,,15018402,CHEMBL3363433,Antimicrobial activity against Mycobacterium vaccae after 18 hrs by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3351437,J Nat Prod,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2242137,=,1,1,=,MIC,ug.mL-1,0.2,CHEMBL613224,Mycolicibacterium vaccae,Mycolicibacterium vaccae,1810.0,,MIC,ug ml-1,UO_0000274,0.2
26366,,15018404,CHEMBL3363432,Antimicrobial activity against methicillin-resistant Staphylococcus aureus after 18 hrs by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3351437,J Nat Prod,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2242137,=,1,1,=,MIC,ug.mL-1,12.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,12.5
26367,,15018406,CHEMBL3363431,Antimicrobial activity against Staphylococcus aureus after 18 hrs by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3351437,J Nat Prod,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2242137,=,1,1,=,MIC,ug.mL-1,0.4,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.4
26368,,15018408,CHEMBL3363430,Antimicrobial activity against Bacillus subtilis after 18 hrs by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3351437,J Nat Prod,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2242137,<,1,1,<,MIC,ug.mL-1,0.05,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MIC,ug ml-1,UO_0000274,0.05
26369,,15018810,CHEMBL3364043,Antibacterial activity against Staphylococcus aureus ATCC 29213 assessed as growth inhibition,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3351734,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2248293,=,1,1,=,IC50,ug.mL-1,0.08,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,IC50,ug ml-1,UO_0000274,0.08
26370,,15018815,CHEMBL3364044,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33591 assessed as growth inhibition,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3351734,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2248293,=,1,1,=,IC50,ug.mL-1,0.09,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,IC50,ug ml-1,UO_0000274,0.09
26371,,15018820,CHEMBL3364045,Antibacterial activity against Staphylococcus aureus ATCC 29213 assessed as absence of detectable growth,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3351734,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2248293,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
26372,,15018825,CHEMBL3364046,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33591 assessed as absence of detectable growth,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3351734,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2248293,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
26373,,15018830,CHEMBL3364047,Antibacterial activity against Staphylococcus aureus ATCC 29213 assessed as 100% killing,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3351734,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2248293,=,1,0,=,MBC,ug ml-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MBC,ug ml-1,UO_0000274,0.5
26374,,15018835,CHEMBL3364048,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33591 assessed as 100% killing,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3351734,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2248293,=,1,0,=,MBC,ug ml-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MBC,ug ml-1,UO_0000274,0.5
26375,Not Active,15018861,CHEMBL3364049,Antimicrobial activity against Candida glabrata after 70 to 74 hrs by CLSI method,F,BAO_0000201,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3351734,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,2248293,,1,0,,Inhibition,%,,CHEMBL612647,Nakaseomyces glabratus,Nakaseomyces glabratus,5478.0,,INH,,UO_0000187,
26376,Not Active,15018887,CHEMBL3364050,Antimicrobial activity against Candida krusei after 70 to 74 hrs by CLSI method,F,BAO_0000201,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3351734,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,2248293,,1,0,,Inhibition,%,,CHEMBL612841,Pichia kudriavzevii,Pichia kudriavzevii,4909.0,,INH,,UO_0000187,
26377,Not Determined,15018916,CHEMBL3364057,Cytotoxicity against African green monkey Vero cells assessed as reduction in cell viability after 72 hrs by MTT assay,A,BAO_0000190,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3351318,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,2250409,,1,0,,IC50,,,CHEMBL391,Chlorocebus sabaeus,Vero,60711.0,,IC50,,,
26378,Not Determined,15018973,CHEMBL3364056,Antitubercular activity against Mycobacterium tuberculosis H37Rv after 7 days by Resazurin micro titer assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3351318,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,2250409,,1,0,,MIC,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,,,
26379,,15019636,CHEMBL3372086,Antimicrobial activity against Escherichia coli NCIM-2256 after 20 hrs by two fold serial macrodilution technique,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3352499,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2269620,=,1,1,=,MIC,ug.mL-1,7.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,7.5
26380,,15019652,CHEMBL3372087,Bactericidal activity against Escherichia coli NCIM-2256 after 72 hrs by two fold serial macrodilution technique,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3352499,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2269620,=,1,0,=,MBC,ug ml-1,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MBC,ug ml-1,UO_0000274,8.0
26381,,15019668,CHEMBL3372088,Antimicrobial activity against Salmonella typhimurium NCIM-3471 after 20 hrs by two fold serial macrodilution technique,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3352499,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2269620,=,1,1,=,MIC,ug.mL-1,7.5,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,MIC,ug ml-1,UO_0000274,7.5
26382,,15019684,CHEMBL3372089,Bactericidal activity against Salmonella typhimurium NCIM-3471 after 72 hrs by two fold serial macrodilution technique,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3352499,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2269620,=,1,0,=,MBC,ug ml-1,8.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,MBC,ug ml-1,UO_0000274,8.0
26383,Not Active,15020044,CHEMBL3380342,Antibacterial activity against clinical isolates of Escherichia coli PGI/DML02250 after 16 passages by resistance developement assay,F,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3352151,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,2248532,,1,0,,Activity,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,,,
26384,Not Active,15020045,CHEMBL3380343,Antibacterial activity against clinical isolates of imipenem-resistant Escherichia coli PGI/DML02292 after 16 passages by resistance developement assay,F,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3352151,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,2248532,,1,0,,Activity,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,,,
26385,Not Active,15020046,CHEMBL3380344,Antibacterial activity against clinical isolates of Staphylococcus aureus PGI/DML03054 after 16 passages by resistance developement assay,F,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3352151,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,2248532,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
26386,Not Active,15020047,CHEMBL3380345,Antibacterial activity against clinical isolates of methicillin-resistant Staphylococcus aureus PGI/DML03149 after 16 passages by resistance developement assay,F,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3352151,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,2248532,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
26387,Not Determined,15023138,CHEMBL3364055,Antimicrobial activity against Candida albicans after 48 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3351318,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,2250409,,1,0,,MIC,,,CHEMBL366,Candida albicans,Candida albicans,5476.0,,MIC,,,
26388,,15023181,CHEMBL3364054,Antimicrobial activity against methicillin-resistant Staphylococcus aureus ATCC 43866 after 48 hrs by broth dilution technique,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3351318,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2250409,=,1,1,=,MIC,ug.mL-1,3.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,3.125
26389,,15023224,CHEMBL3364053,Antimicrobial activity against methicillin-sensitive Staphylococcus aureus ATCC 35556 after 48 hrs by broth dilution technique,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3351318,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2250409,=,1,1,=,MIC,ug.mL-1,1.56,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.56
26390,,15023267,CHEMBL3364052,Antimicrobial activity against Klebsiella pneumoniae after 48 hrs by broth dilution technique,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3351318,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2250409,=,1,1,=,MIC,ug.mL-1,1.56,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,1.56
26391,,15023310,CHEMBL3364051,Antimicrobial activity against Escherichia coli ATCC 25922 after 48 hrs by broth dilution technique,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3351318,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2250409,=,1,1,=,MIC,ug.mL-1,1.56,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,1.56
26392,,15024893,CHEMBL3365303,Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 after 28 days by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3352807,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2274076,=,1,1,=,MIC,nM,14210.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,uM,UO_0000065,14.21
26393,Not Determined,15038088,CHEMBL3366298,Inhibition of Mycobacterium tuberculosis H37Rv DNA gyrase A2B2 holoenzyme supercoiling activity using relaxed pBR322 substrate incubated for 90 mins by ethidium bromide staining based gel electrophoresis method,B,BAO_0000190,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3352071,ACS Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,2255305,,1,0,,IC50,,,CHEMBL612545,,Unchecked,,,IC50,,,
26394,,15038127,CHEMBL3366299,Antimicrobial activity against Mycobacterium tuberculosis H37Rv ATCC 27294,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3352071,ACS Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2255305,=,1,1,=,MIC,nM,500.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,uM,UO_0000065,0.5
26395,,15038190,CHEMBL3366647,"Antimicrobial activity against 2-oxo-1-(2-(4-((3-oxo-3,4-dihydro-2H-pyrido[3,2-b][1,4]oxazin-6-yl)methylamino)piperidin-1-yl)ethyl)-1,2-dihydroquinoline-7-carbonitrile resistant Mycobacterium tuberculosis H37Rv ATCC 27294 containing DNA gyrase A74V mutant",F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3352071,ACS Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2255305,=,1,1,=,MIC,nM,500.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,uM,UO_0000065,0.5
26396,,15038201,CHEMBL3366648,"Antimicrobial activity against 5-(((3S,4R)-3-fluoro-1-(2-(7-methoxy-2-oxo-1,5-naphthyridin-1(2H)-yl)ethyl)piperidin-4-ylamino)methyl)-2-methylnicotinonitrile resistant Mycobacterium tuberculosis H37Rv ATCC 27294 containing DNA gyrase D89N mutant",F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3352071,ACS Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2255305,=,1,1,=,MIC,nM,16000.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,uM,UO_0000065,16.0
26397,,15038212,CHEMBL3366649,Antimicrobial activity against moxicillin resistant Mycobacterium tuberculosis H37Rv ATCC 27294 containing DNA gyrase G88N mutant,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3352071,ACS Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2255305,=,1,1,=,MIC,nM,8000.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,uM,UO_0000065,8.0
26398,,15044797,CHEMBL3367416,Antimicrobial activity against multiple drug-resistant Escherichia coli ATCC 35218 after 8 to 10 hrs by MTT proliferation assay,F,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3297693,Bioorg Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2256963,=,1,1,=,MIC50,ug.mL-1,5.65,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC50,ug ml-1,UO_0000274,5.65
26399,,15049234,CHEMBL3367417,Antimicrobial activity against tetracycline-resistant Bacillus subtilis ATCC 6633 after 8 to 10 hrs by MTT proliferation assay,F,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3297693,Bioorg Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2256963,=,1,1,=,MIC50,ug.mL-1,2.7,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MIC50,ug ml-1,UO_0000274,2.7
26400,,15049262,CHEMBL3367418,Antimicrobial activity against methicillin-resistant Staphylococcus aureus ATCC 25923 after 8 to 10 hrs by MTT proliferation assay,F,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3297693,Bioorg Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2256963,=,1,1,=,MIC50,ug.mL-1,6.82,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC50,ug ml-1,UO_0000274,6.82
26401,,15049274,CHEMBL3367420,Inhibition of Escherichia coli DNA gyrase assessed as reduction in enzyme-mediated DNA supercoiling using relaxed pBR322 substrate incubated for 60 mins by electrophoresis method,B,BAO_0000190,BAO_0000223,protein complex format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3297693,Bioorg Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2256963,=,1,1,=,IC50,nM,5230.0,CHEMBL2094139,Escherichia coli,DNA gyrase,562.0,,IC50,uM,UO_0000065,5.23
26402,,15052385,CHEMBL3371122,Antimicrobial activity against methicillin-resistant Staphylococcus aureus ATCC 33591,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3351471,J Nat Prod,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2261698,=,1,1,=,IC50,ug.mL-1,0.1,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,IC50,ug ml-1,UO_0000274,0.1
26403,,15052386,CHEMBL3371123,Antimicrobial activity against Staphylococcus aureus ATCC 29213,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3351471,J Nat Prod,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2261698,=,1,1,=,IC50,ug.mL-1,0.1,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,IC50,ug ml-1,UO_0000274,0.1
26404,,15059656,CHEMBL3367896,Antibacterial activity against Staphylococcus aureus ATCC 29213 at 50 mg/mL after 24 hrs by agar well diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3351505,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,2274200,=,1,1,=,IZ,mm,20.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,DIZ,mm,UO_0000016,20.0
26405,,15059658,CHEMBL3367897,Antibacterial activity against Bacillus subtilis ATCC 6633 at 50 mg/mL after 24 hrs by agar well diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3351505,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,2274200,=,1,1,=,IZ,mm,22.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,DIZ,mm,UO_0000016,22.0
26406,,15059660,CHEMBL3367898,Antibacterial activity against Bacillus megaterium ATCC 9885 at 50 mg/mL after 24 hrs by agar well diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3351505,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,2274200,=,1,1,=,IZ,mm,24.0,CHEMBL613071,Priestia megaterium,Priestia megaterium,1404.0,,DIZ,mm,UO_0000016,24.0
26407,,15059662,CHEMBL3367899,Antibacterial activity against Sarcina lutea at 50 mg/mL after 24 hrs by agar well diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3351505,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,2274200,=,1,1,=,IZ,mm,20.0,CHEMBL614421,Micrococcus luteus,Micrococcus luteus,1270.0,,DIZ,mm,UO_0000016,20.0
26408,,15059664,CHEMBL3367900,Antibacterial activity against Klebsiella pneumoniae ATCC 13883 at 50 mg/mL after 24 hrs by agar well diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3351505,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,2274200,=,1,1,=,IZ,mm,25.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,DIZ,mm,UO_0000016,25.0
26409,,15059666,CHEMBL3367901,Antibacterial activity against Pseudomonas aeruginosa ATCC 27953 at 50 mg/mL after 24 hrs by agar well diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3351505,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,2274200,=,1,1,=,IZ,mm,24.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,DIZ,mm,UO_0000016,24.0
26410,,15059668,CHEMBL3368153,Antibacterial activity against Escherichia coli ATCC 25922 at 50 mg/mL after 24 hrs by agar well diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3351505,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,2274200,=,1,1,=,IZ,mm,23.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,DIZ,mm,UO_0000016,23.0
26411,Not Active,15059670,CHEMBL3368154,Antifungal activity against Candida albicans NRRL Y-477 at 50 mg/mL after 48 hrs by agar well diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3351505,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,2274200,,1,0,,DIZ,,,CHEMBL366,Candida albicans,Candida albicans,5476.0,,DIZ,,,
26412,Not Active,15059672,CHEMBL3368155,Antifungal activity against Saccharomyces cerevisiae at 50 mg/mL after 48 hrs by agar well diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3351505,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,2274200,,1,0,,DIZ,,,CHEMBL361,Saccharomyces cerevisiae,Saccharomyces cerevisiae,4932.0,,DIZ,,,
26413,Not Active,15059674,CHEMBL3368156,Antifungal activity against Aspergillus niger at 50 mg/mL after 48 hrs by agar well diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3351505,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,2274200,,1,0,,DIZ,,,CHEMBL358,Aspergillus niger,Aspergillus niger,5061.0,,DIZ,,,
26414,,15059696,CHEMBL3368157,Antibacterial activity against Staphylococcus aureus ATCC 29213 after 24 hrs by two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3351505,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2274200,=,1,1,=,MIC,ug.mL-1,25.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,25.0
26415,,15059718,CHEMBL3368158,Antibacterial activity against Bacillus subtilis ATCC 6633 after 24 hrs by two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3351505,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2274200,=,1,1,=,MIC,ug.mL-1,25.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MIC,ug ml-1,UO_0000274,25.0
26416,,15063053,CHEMBL3364457,Antimicrobial activity against ciprofloxacin-sensitive Pseudomonas aeruginosa DSM 1117 grown under Mueller-Hinton medium by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3351518,Bioorg Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2261243,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.25
26417,,15063054,CHEMBL3364458,Antimicrobial activity against ciprofloxacin-sensitive Pseudomonas aeruginosa DSM 1117 grown under succinate minimum medium by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3351518,Bioorg Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2261243,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.25
26418,,15063055,CHEMBL3364459,Antimicrobial activity against ciprofloxacin-sensitive Pseudomonas aeruginosa DSM 1117 grown under succinate minimum medium in presence of 1 uM FeCl3 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3351518,Bioorg Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2261243,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.25
26419,,15063056,CHEMBL3364460,Antimicrobial activity against ciprofloxacin-resistant Pseudomonas aeruginosa AM 85 grown under Mueller-Hinton medium by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3351518,Bioorg Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2261243,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,16.0
26420,,15063057,CHEMBL3364461,Antimicrobial activity against ciprofloxacin-resistant Pseudomonas aeruginosa AM 85 grown under succinate minimum medium by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3351518,Bioorg Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2261243,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,16.0
26421,,15063058,CHEMBL3364462,Antimicrobial activity against ciprofloxacin-resistant Pseudomonas aeruginosa AM 85 grown under succinate minimum medium in presence of 1 uM FeCl3 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3351518,Bioorg Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2261243,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,32.0
26422,,15063059,CHEMBL3364463,Toxicity in human RBC assessed as induction of hemolysis after 1 hr relative to saponin,T,BAO_0001103,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3351518,Bioorg Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,2261243,<,1,0,<,Activity,%,10.0,CHEMBL612558,,ADMET,,,Activity,%,UO_0000187,10.0
26423,Active,15063060,CHEMBL3364466,Induction of iron complexation in mixed H2O/DMSO solvent mixture (0.2 mole fraction of DMSO) at 1:3 mixture of compound/iron at 25 degC at 3.3 <pH <6.8 by UV-visible spectrophotometry,P,BAO_0000375,BAO_0000100,small-molecule physicochemical format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3351518,Bioorg Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,2261243,,1,0,,Activity,,,CHEMBL2362975,,No relevant target,,,Activity,,,
26424,,15064055,CHEMBL3368159,Antibacterial activity against Bacillus megaterium ATCC 9885 after 24 hrs by two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3351505,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2274200,=,1,1,=,MIC,ug.mL-1,25.0,CHEMBL613071,Priestia megaterium,Priestia megaterium,1404.0,,MIC,ug ml-1,UO_0000274,25.0
26425,,15064077,CHEMBL3368160,Antibacterial activity against Sarcina lutea after 24 hrs by two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3351505,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2274200,=,1,1,=,MIC,ug.mL-1,25.0,CHEMBL614421,Micrococcus luteus,Micrococcus luteus,1270.0,,MIC,ug ml-1,UO_0000274,25.0
26426,,15064099,CHEMBL3368161,Antibacterial activity against Klebsiella pneumoniae ATCC 13883 after 24 hrs by two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3351505,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2274200,=,1,1,=,MIC,ug.mL-1,25.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,25.0
26427,,15064121,CHEMBL3368162,Antibacterial activity against Pseudomonas aeruginosa ATCC 27953 after 24 hrs by two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3351505,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2274200,=,1,1,=,MIC,ug.mL-1,25.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,25.0
26428,,15064143,CHEMBL3368163,Antibacterial activity against Escherichia coli ATCC 25922 after 24 hrs by two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3351505,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2274200,=,1,1,=,MIC,ug.mL-1,25.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,25.0
26429,Not Active,15064165,CHEMBL3368164,Antifungal activity against Candida albicans NRRL Y-477 after 48 hrs by two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3351505,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,2274200,,1,0,,MIC,,,CHEMBL366,Candida albicans,Candida albicans,5476.0,,MIC,,,
26430,Not Active,15064187,CHEMBL3368165,Antifungal activity against Saccharomyces cerevisiae after 48 hrs by two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3351505,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,2274200,,1,0,,MIC,,,CHEMBL361,Saccharomyces cerevisiae,Saccharomyces cerevisiae,4932.0,,MIC,,,
26431,Not Active,15064209,CHEMBL3368166,Antifungal activity against Aspergillus niger after 48 hrs by two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3351505,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,2274200,,1,0,,MIC,,,CHEMBL358,Aspergillus niger,Aspergillus niger,5061.0,,MIC,,,
26432,,15067055,CHEMBL3385760,Antibacterial activity against extended-spectrum beta-lactamase producing Escherichia coli 12-15 after 18 to 24 hrs by standard twofold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3352227,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2272602,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,64.0
26433,,15067086,CHEMBL3385761,Antibacterial activity against Klebsiella pneumoniae 12-1 after 18 to 24 hrs by standard twofold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3352227,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2272602,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.125
26434,,15067117,CHEMBL3385762,Antibacterial activity against Klebsiella pneumoniae 12-2 after 18 to 24 hrs by standard twofold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3352227,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2272602,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.03
26435,,15067148,CHEMBL3385763,Antibacterial activity against Klebsiella pneumoniae 12-4 after 18 to 24 hrs by standard twofold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3352227,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2272602,<,1,1,<,MIC,ug.mL-1,0.008,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.008
26436,,15067179,CHEMBL3385764,Antibacterial activity against extended-spectrum beta-lactamase producin Klebsiella pneumoniae 12-3 after 18 to 24 hrs by standard twofold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3352227,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2272602,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,32.0
26437,,15067210,CHEMBL3385765,Antibacterial activity against extended-spectrum beta-lactamase producin Klebsiella pneumoniae 12-4 after 18 to 24 hrs by standard twofold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3352227,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2272602,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,4.0
26438,,15067241,CHEMBL3385766,Antibacterial activity against extended-spectrum beta-lactamase producin Klebsiella pneumoniae 12-7 after 18 to 24 hrs by standard twofold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3352227,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2272602,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.5
26439,,15067272,CHEMBL3385767,Antibacterial activity against extended-spectrum beta-lactamase producin Klebsiella pneumoniae 12-14 after 18 to 24 hrs by standard twofold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3352227,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2272602,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,64.0
26440,,15067303,CHEMBL3385768,Antibacterial activity against Pseudomonas aeruginosa 12-12 after 18 to 24 hrs by standard twofold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3352227,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2272602,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.125
26441,,15071832,CHEMBL3385769,Antibacterial activity against Pseudomonas aeruginosa 12-14 after 18 to 24 hrs by standard twofold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3352227,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2272602,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,32.0
26442,,15071863,CHEMBL3385770,Antibacterial activity against Staphylococcus aureus ATCC 25923 after 18 to 24 hrs by standard twofold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3352227,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2272602,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
26443,,15071894,CHEMBL3385771,Antibacterial activity against methicillin-sensitive Staphylococcus aureus 12-1 after 18 to 24 hrs by standard twofold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3352227,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2272602,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
26444,,15071925,CHEMBL3385772,Antibacterial activity against methicillin-sensitive Staphylococcus aureus 12-2 after 18 to 24 hrs by standard twofold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3352227,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2272602,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
26445,,15071956,CHEMBL3385773,Antibacterial activity against methicillin-sensitive Staphylococcus aureus 12-4 after 18 to 24 hrs by standard twofold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3352227,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2272602,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
26446,,15071987,CHEMBL3385774,Antibacterial activity against methicillin-sensitive Staphylococcus aureus 12-5 after 18 to 24 hrs by standard twofold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3352227,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2272602,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
26447,,15072018,CHEMBL3385775,Antibacterial activity against methicillin-resistant Staphylococcus aureus 12-2 after 18 to 24 hrs by standard twofold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3352227,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2272602,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,64.0
26448,,15072049,CHEMBL3385776,Antibacterial activity against methicillin-resistant Staphylococcus aureus 12-4 after 18 to 24 hrs by standard twofold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3352227,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2272602,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,64.0
26449,,15072080,CHEMBL3385777,Antibacterial activity against methicillin-resistant Staphylococcus aureus 12-5 after 18 to 24 hrs by standard twofold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3352227,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2272602,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,32.0
26450,,15073370,CHEMBL3389960,Inhibition of Escherichia coli DNA gyrase using fluorescence-tagged DNA by fluorescenct polarization assay,B,BAO_0000190,BAO_0000223,protein complex format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3352584,J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2262345,=,1,1,=,IC50,nM,270.0,CHEMBL2094139,Escherichia coli,DNA gyrase,562.0,,IC50,uM,UO_0000065,0.27
26451,,15073373,CHEMBL3389963,Antimicrobial activity against Streptococcus pneumoniae by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3352584,J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2262345,=,1,1,=,MIC,nM,1500.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,uM,UO_0000065,1.5
26452,,15073374,CHEMBL3389964,Antimicrobial activity against Streptococcus pyogenes by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3352584,J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2262345,=,1,1,=,MIC,nM,1500.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC,uM,UO_0000065,1.5
26453,,15073375,CHEMBL3389965,Antimicrobial activity against methicillin-sensitive Staphylococcus aureus by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3352584,J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2262345,=,1,1,=,MIC,nM,910.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,uM,UO_0000065,0.91
26454,,15073376,CHEMBL3389966,Antimicrobial activity against methicillin-resistant and quinolone-resistant Staphylococcus aureus by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3352584,J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2262345,=,1,1,=,MIC,nM,96000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,uM,UO_0000065,96.0
26455,,15073377,CHEMBL3389967,Antimicrobial activity against Haemophilus influenzae by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3352584,J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2262345,<,1,1,<,MIC,nM,100.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC,uM,UO_0000065,0.1
26456,,15073378,CHEMBL3389968,Antimicrobial activity against Escherichia coli by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3352584,J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2262345,=,1,1,=,MIC,nM,60.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,uM,UO_0000065,0.06
26457,,15073379,CHEMBL3389969,Antimicrobial activity against tolC-deficient Escherichia coli by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3352584,J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2262345,<,1,1,<,MIC,nM,100.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,uM,UO_0000065,0.1
26458,Not Determined,15073380,CHEMBL3389970,Antimicrobial activity against methicillin-sensitive Staphylococcus aureus by broth microdilution method in presence of 50% human serum,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3352584,J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,2262345,,1,0,,MIC,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,,,
26459,,15076600,CHEMBL3386333,Antibacterial activity against methicillin-sensitive Staphylococcus epidermidis 12-1 after 18 to 24 hrs by standard twofold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3352227,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2272602,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.25
26460,,15076631,CHEMBL3386334,Antibacterial activity against methicillin-sensitive Staphylococcus epidermidis 12-3 after 18 to 24 hrs by standard twofold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3352227,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2272602,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,2.0
26461,,15076662,CHEMBL3386335,Antibacterial activity against methicillin-sensitive Staphylococcus epidermidis 12-6 after 18 to 24 hrs by standard twofold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3352227,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2272602,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.25
26462,,15076693,CHEMBL3386336,Antibacterial activity against methicillin-sensitive Staphylococcus epidermidis 12-8 after 18 to 24 hrs by standard twofold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3352227,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2272602,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,4.0
26463,,15076724,CHEMBL3386337,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis 12-1 after 18 to 24 hrs by standard twofold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3352227,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2272602,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,8.0
26464,,15076755,CHEMBL3386338,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis 12-6 after 18 to 24 hrs by standard twofold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3352227,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2272602,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,16.0
26465,,15076786,CHEMBL3386339,Antibacterial activity against Streptococcus pneumoniae ATCC 49619 after 18 to 24 hrs by standard twofold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3352227,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2272602,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.25
26466,,15076817,CHEMBL3386340,Antibacterial activity against Streptococcus pneumoniae 12-18 after 18 to 24 hrs by standard twofold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3352227,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2272602,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
26467,,15081648,CHEMBL3389994,Inhibition of Escherichia coli DNA gyrase assessed as supercoiled plasmid DNA formation after 30 mins by electrophoretic analysis,B,BAO_0000190,BAO_0000223,protein complex format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3351381,J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,1,http://www.openphacts.org/units/Nanomolar,2260162,=,1,1,=,IC50,nM,200.0,CHEMBL2094139,Escherichia coli,DNA gyrase,562.0,,IC50,uM,UO_0000065,0.2
26468,,15087794,CHEMBL3388394,Inhibition of biofilm formation in methicillin-resistant Staphylococcus aureus MTCC 96 after 36 hr incubation by tissue culture plate method,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3352166,Bioorg Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2266660,=,1,1,=,IC50,nM,16890.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,IC50,uM,UO_0000065,16.89
26469,,15091210,CHEMBL3389995,Inhibition of Escherichia coli topoisomerase 4 assessed as inhibition of decatenation of catenated kinetoplast DNA after 30 mins by electrophoretic analysis,B,BAO_0000190,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3351381,J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2260162,=,1,1,=,IC50,nM,2100.0,CHEMBL612545,,Unchecked,,,IC50,uM,UO_0000065,2.1
26470,,15091290,CHEMBL3389997,Antimicrobial activity against Staphylococcus aureus UAMS1 incubated for 16 hrs by CLSI based method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3351553,J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2262164,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
26471,,15091344,CHEMBL3389998,Inhibition of Staphylococcus aureus DNA gyrase assessed as reduction in enzyme-catalyzed supercoiling of relaxed circular pBR322 DNA by agarose gel electrophoresis,B,BAO_0000190,BAO_0000223,protein complex format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3351553,J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2262164,=,1,1,=,IC50,nM,110000.0,CHEMBL3038482,Staphylococcus aureus,DNA gyrase,1280.0,,IC50(app),uM,UO_0000065,110.0
26472,,15091392,CHEMBL3389999,Inhibition of Staphylococcus aureus topoisomerase 4 assessed as reduction in decatenation of kDNA at 100 to 500 uM by gel electrophoresis method,B,BAO_0000190,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3351553,J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2262164,=,1,1,=,IC50,nM,4000.0,CHEMBL612545,,Unchecked,,,IC50(app),uM,UO_0000065,4.0
26473,Active,15091397,CHEMBL3390002,Inhibition of Staphylococcus aureus DNA gyrase assessed as reduction in enzyme-catalyzed supercoiling of relaxed circular pBR322 DNA at 100 uM by agarose gel electrophoresis,B,BAO_0000201,BAO_0000223,protein complex format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3351553,J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,2262164,,1,0,,Inhibition,%,,CHEMBL3038482,Staphylococcus aureus,DNA gyrase,1280.0,,INH,,UO_0000187,
26474,,15120896,CHEMBL3381371,Antimicrobial activity against Micrococcus luteus MTCC 2470 incubated for 24 hrs by well diffusion method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3351415,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2272912,=,1,1,=,MIC,nM,2700.0,CHEMBL614421,Micrococcus luteus,Micrococcus luteus,1270.0,,MIC,uM,UO_0000065,2.7
26475,,15120930,CHEMBL3381372,Antimicrobial activity against Staphylococcus aureus MTCC 96 incubated for 24 hrs by well diffusion method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3351415,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2272912,=,1,1,=,MIC,nM,2700.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,uM,UO_0000065,2.7
26476,,15120948,CHEMBL3381373,Antimicrobial activity against Staphylococcus aureus MLS-16 MTCC 2940 incubated for 24 hrs by well diffusion method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3351415,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2272912,=,1,1,=,MIC,nM,2700.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,uM,UO_0000065,2.7
26477,,15120966,CHEMBL3381374,Antimicrobial activity against Bacillus subtilis MTCC 121 incubated for 24 hrs by well diffusion method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3351415,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2272912,=,1,1,=,MIC,nM,2700.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MIC,uM,UO_0000065,2.7
26478,,15120984,CHEMBL3381375,Antimicrobial activity against Escherichia coli MTCC 739 incubated for 24 hrs by well diffusion method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3351415,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2272912,=,1,1,=,MIC,nM,2700.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,uM,UO_0000065,2.7
26479,,15121002,CHEMBL3381376,Antimicrobial activity against Pseudomonas aeruginosa MTCC 2453 incubated for 24 hrs by well diffusion method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3351415,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2272912,=,1,1,=,MIC,nM,2700.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,uM,UO_0000065,2.7
26480,,15122288,CHEMBL3370029,Antibacterial activity against Escherichia coli MTCC 0723 after 18 hrs by micro dilution broth assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3351820,Bioorg Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2249113,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.5
26481,,15122299,CHEMBL3370030,Antibacterial activity against imipenem-resistant Escherichia coli PGI/ DML02292 clinical isolate after 18 hrs by micro dilution broth assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3351820,Bioorg Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2249113,=,1,1,=,MIC,ug.mL-1,0.75,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.75
26482,,15122310,CHEMBL3370031,Antibacterial activity against Pseudomonas aeruginosa MTCC 2295 after 18 hrs by micro dilution broth assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3351820,Bioorg Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2249113,=,1,1,=,MIC,ug.mL-1,0.3,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.3
26483,,15122321,CHEMBL3370032,Antibacterial activity against Staphylococcus aureus MTCC 3160 after 18 hrs by micro dilution broth assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3351820,Bioorg Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2249113,=,1,1,=,MIC,ug.mL-1,0.2,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.2
26484,,15122332,CHEMBL3370033,Antibacterial activity against methicillin-resistant Staphylococcus aureus PGI/ DML03149 clinical isolate after 18 hrs by micro dilution broth assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3351820,Bioorg Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2249113,=,1,1,=,MIC,ug.mL-1,0.9,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.9
26485,,15122343,CHEMBL3370034,Antibacterial activity against Bacillus subtilis MTCC 2763 after 18 hrs by micro dilution broth assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3351820,Bioorg Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2249113,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MIC,ug ml-1,UO_0000274,0.5
26486,,15125466,CHEMBL3381377,Antimicrobial activity against Klebsiella planticola MTCC 2453 incubated for 24 hrs by well diffusion method,F,BAO_0002146,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3351415,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2272912,=,1,1,=,MIC,nM,2700.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,uM,UO_0000065,2.7
26487,,15125476,CHEMBL3381378,Bactericidal activity against Staphylococcus aureus MTCC 96 incubated for 24 hrs,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3351415,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Micromolar,2272912,=,1,0,=,MBC,uM,2.7,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MBC,uM,UO_0000064,2.7
26488,,15125486,CHEMBL3381379,Bactericidal activity against Staphylococcus aureus MLS-16 MTCC 2940 incubated for 24 hrs,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3351415,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Micromolar,2272912,=,1,0,=,MBC,uM,5.7,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MBC,uM,UO_0000064,5.7
26489,,15125496,CHEMBL3381380,Bactericidal activity against Bacillus subtilis MTCC 121 incubated for 24 hrs,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3351415,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Micromolar,2272912,=,1,0,=,MBC,uM,5.7,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MBC,uM,UO_0000064,5.7
26490,,15125506,CHEMBL3381381,Anti-biofilm activity against Staphylococcus aureus MTCC 96 assessed as inhibition of biofilm formation incubated for 24 hrs by crystal violet staining based modified biofilm inhibition assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3351415,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2272912,=,1,1,=,IC50,nM,990.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,IC50,uM,UO_0000065,0.99
26491,,15125516,CHEMBL3381972,Anti-biofilm activity against Staphylococcus aureus MLS-16 MTCC 2940 assessed as inhibition of biofilm formation incubated for 24 hrs by crystal violet staining based modified biofilm inhibition assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3351415,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2272912,=,1,1,=,IC50,nM,1170.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,IC50,uM,UO_0000065,1.17
26492,,15125526,CHEMBL3381973,Anti-biofilm activity against Bacillus subtilis MTCC 121 assessed as inhibition of biofilm formation incubated for 24 hrs by crystal violet staining based modified biofilm inhibition assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3351415,Bioorg Med Chem Lett,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2272912,=,1,1,=,IC50,nM,1530.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,IC50,uM,UO_0000065,1.53
26493,,15131636,CHEMBL3369624,Antimicrobial activity against Bacillus cereus ATCC 14579 by broth dilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3352307,J Nat Prod,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2251217,=,1,1,=,MIC,nM,600.0,CHEMBL613070,Bacillus cereus,Bacillus cereus,1396.0,,MIC,uM,UO_0000065,0.6
26494,,15131644,CHEMBL3369622,Antimicrobial activity against Escherichia coli ATCC 25922 by broth dilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3352307,J Nat Prod,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2251217,=,1,1,=,MIC,nM,300.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,uM,UO_0000065,0.3
26495,,15131682,CHEMBL3369621,Antimicrobial activity against Micrococcus tetragenus ATCC 13623 by broth dilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3352307,J Nat Prod,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2251217,=,1,1,=,MIC,nM,300.0,CHEMBL612937,Micrococcus,Micrococcus,1269.0,,MIC,uM,UO_0000065,0.3
26496,,15131717,CHEMBL3369623,Antimicrobial activity against Staphylococcus albus ATCC 8799 by broth dilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3352307,J Nat Prod,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2251217,=,1,1,=,MIC,nM,600.0,CHEMBL612624,Staphylococcus,Staphylococcus,1279.0,,MIC,uM,UO_0000065,0.6
26497,,15131737,CHEMBL3369625,Antimicrobial activity against Staphylococcus aureus ATCC 6538 by broth dilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3352307,J Nat Prod,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2251217,=,1,1,=,MIC,nM,160.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,uM,UO_0000065,0.16
26498,,15131751,CHEMBL3369626,Antimicrobial activity against Kocuria rhizophila ATCC 9341 by broth dilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3352307,J Nat Prod,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2251217,=,1,1,=,MIC,nM,300.0,CHEMBL1075349,Kocuria rhizophila,Kocuria rhizophila,72000.0,,MIC,uM,UO_0000065,0.3
26499,,15131765,CHEMBL3369627,Antimicrobial activity against Bacillus subtilis ATCC 6633 by broth dilution assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3352307,J Nat Prod,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2251217,=,1,1,=,MIC,nM,600.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MIC,uM,UO_0000065,0.6
26500,,15132236,CHEMBL3373804,Antimicrobial activity against Staphylococcus aureus after 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3352487,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2247104,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
26501,,15132237,CHEMBL3373805,Antimicrobial activity against methicillin-susceptible Staphylococcus aureus after 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3352487,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2247104,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
26502,,15132238,CHEMBL3373806,Antimicrobial activity against methicillin-resistant Staphylococcus aureus after 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3352487,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2247104,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
26503,,15132239,CHEMBL3373807,Antimicrobial activity against Staphylococcus epidermidis after 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3352487,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2247104,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.25
26504,,15132240,CHEMBL3373808,Antimicrobial activity against Escherichia coli isolate 1 after 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3352487,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2247104,<,1,1,<,MIC,ug.mL-1,0.0312,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.0312
26505,,15132241,CHEMBL3373809,Antimicrobial activity against Escherichia coli isolate 2 after 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3352487,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2247104,<,1,1,<,MIC,ug.mL-1,0.0312,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.0312
26506,,15137897,CHEMBL3385754,Antimycobacterial activity against isoniazid and rifampicin resistant Mycobacterium tuberculosis 11277 by MABA method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3352227,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2272602,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,ug ml-1,UO_0000274,0.125
26507,,15137910,CHEMBL3385753,Antimycobacterial activity against isoniazid and rifampicin resistant Mycobacterium tuberculosis 6133 by MABA method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3352227,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2272602,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,ug ml-1,UO_0000274,0.125
26508,,15137923,CHEMBL3385752,Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 by MABA method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3352227,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2272602,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,ug ml-1,UO_0000274,0.25
26509,,15137967,CHEMBL3385755,Antibacterial activity against Escherichia coli ATCC 25922 after 18 to 24 hrs by standard twofold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3352227,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2272602,<,1,1,<,MIC,ug.mL-1,0.008,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.008
26510,,15137998,CHEMBL3385756,Antibacterial activity against Escherichia coli 12-1 after 18 to 24 hrs by standard twofold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3352227,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2272602,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.125
26511,,15138029,CHEMBL3385757,Antibacterial activity against extended-spectrum beta-lactamase producing Escherichia coli 12-2 after 18 to 24 hrs by standard twofold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3352227,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2272602,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,32.0
26512,,15138060,CHEMBL3385758,Antibacterial activity against extended-spectrum beta-lactamase producing Escherichia coli 12-3 after 18 to 24 hrs by standard twofold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3352227,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2272602,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,32.0
26513,,15138091,CHEMBL3385759,Antibacterial activity against extended-spectrum beta-lactamase producing Escherichia coli 12-14 after 18 to 24 hrs by standard twofold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3352227,Eur J Med Chem,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2272602,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,32.0
26514,,15141243,CHEMBL3392941,"DNDI: HAT in Vitro, 72 hour",F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3392926,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2276401,=,14,1,=,IC50,nM,35910.0,CHEMBL612348,Trypanosoma brucei rhodesiense,Trypanosoma brucei rhodesiense,31286.0,,IC50,uM,UO_0000065,35.91
26515,,15141244,CHEMBL3392937,"DNDI: Chagas in Vitro, 96 hour",F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3392926,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2276401,=,14,1,=,IC50,nM,92050.0,CHEMBL368,Trypanosoma cruzi,Trypanosoma cruzi,5693.0,,IC50,uM,UO_0000065,92.05
26516,,15141245,CHEMBL3392942,"DNDI: Leish (axenic) in Vitro, 72 hour",F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3392926,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2276401,>,14,1,>,IC50,nM,301800.0,CHEMBL367,Leishmania donovani,Leishmania donovani,5661.0,,IC50,uM,UO_0000065,301.8
26517,,15141246,CHEMBL3392943,"DNDI: Leish (macro) in Vitro, 96 hour",F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3392926,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2276401,>,14,1,>,IC50,nM,90540.0,CHEMBL367,Leishmania donovani,Leishmania donovani,5661.0,,IC50,uM,UO_0000065,90.54
26518,,15141247,CHEMBL3392944,"DNDI: Malaria in Vitro, 72 hour",F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3392926,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2276401,=,14,1,=,IC50,nM,13190.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,IC50,uM,UO_0000065,13.19
26519,,15141248,CHEMBL3392938,"DNDI: Cytotoxicity in Vitro, 72 hour, in rat skeletal myoblast cells",F,BAO_0000190,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3392926,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2276401,=,14,1,=,IC50,nM,118010.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,IC50,uM,UO_0000065,118.01
26520,,15141249,CHEMBL3392939,"DNDI: Cytotoxicity in Vitro, 96 hour, in mouse macrophages (infected-amastigotes)",F,BAO_0000190,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3392926,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2276401,>,14,1,>,IC50,nM,90540.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,IC50,uM,UO_0000065,90.54
26521,,15146913,CHEMBL3396096,Antimycobacterial activity against Mycobacterium vaccae IMET10670 assessed as reduction in bacterial growth incubated for 18 to 20 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3393049,ACS Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2277815,=,1,1,=,MIC,nM,320.0,CHEMBL613224,Mycolicibacterium vaccae,Mycolicibacterium vaccae,1810.0,,MIC,uM,UO_0000065,0.32
26522,,15146917,CHEMBL3396095,Antimycobacterial activity against Mycobacterium smegmatis str. MC2 155 assessed as reduction in bacterial growth incubated for 18 to 20 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3393049,ACS Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2277815,=,1,1,=,MIC,nM,320.0,CHEMBL613088,Mycolicibacterium smegmatis,Mycolicibacterium smegmatis,1772.0,,MIC,uM,UO_0000065,0.32
26523,,15146923,CHEMBL3396101,Antibacterial activity against Acinetobacter baumannii ATCC 17961 assessed as reduction in bacterial growth incubated for 18 to 20 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3393049,ACS Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2277815,=,1,1,=,MIC,nM,156.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,uM,UO_0000065,0.156
26524,,15146927,CHEMBL3396100,Antibacterial activity against Pseudomonas aeruginosa KW799/61 assessed as reduction in bacterial growth incubated for 18 to 20 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3393049,ACS Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2277815,=,1,1,=,MIC,nM,156.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,uM,UO_0000065,0.156
26525,,15146931,CHEMBL3396099,Antibacterial activity against Micrococcus luteus ATCC 10240 assessed as reduction in bacterial growth incubated for 18 to 20 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3393049,ACS Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2277815,=,1,1,=,MIC,nM,1250.0,CHEMBL614421,Micrococcus luteus,Micrococcus luteus,1270.0,,MIC,uM,UO_0000065,1.25
26526,,15146935,CHEMBL3396098,Antibacterial activity against Staphylococcus aureus SG511 assessed as reduction in bacterial growth incubated for 18 to 20 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3393049,ACS Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2277815,=,1,1,=,MIC,nM,320.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,uM,UO_0000065,0.32
26527,,15146939,CHEMBL3396097,Antimycobacterial activity against Mycobacterium aurum SB66 assessed as reduction in bacterial growth incubated for 18 to 20 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3393049,ACS Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2277815,=,1,1,=,MIC,nM,20.0,CHEMBL612952,Mycolicibacterium aurum,Mycolicibacterium aurum,1791.0,,MIC,uM,UO_0000065,0.02
26528,Not Determined,15152951,CHEMBL3395476,Inhibition of biofilm formation of Pseudomonas aeruginosa PAO1 incubated for 18 hrs by crystal violet staining based spectroscopy,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3393020,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,2276861,,1,0,,IC50,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,IC50,,,
26529,,15152962,CHEMBL3395477,Antibacterial activity against Bacillus subtilis NCIM-2063 incubated for 24 hrs by two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3393020,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2276861,=,1,1,=,MIC,ug.mL-1,50.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MIC,ug ml-1,UO_0000274,50.0
26530,,15152973,CHEMBL3395478,Antibacterial activity against Escherichia coli NCIM-2256 incubated for 24 hrs by two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3393020,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2276861,=,1,1,=,MIC,ug.mL-1,25.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,25.0
26531,,15152984,CHEMBL3395479,Antibacterial activity against Pseudomonas aeruginosa NCIM-2036 incubated for 24 hrs by two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3393020,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2276861,=,1,1,=,MIC,ug.mL-1,25.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,25.0
26532,,15153908,CHEMBL3399829,Antimicrobial activity against Staphylococcus aureus MTCC 96 assessed as growth inhibition at 4 mg/ml after 24 hrs by agar well diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3396992,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,2280635,=,1,1,=,IZ,mm,24.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,DIZ,mm,UO_0000016,24.0
26533,,15153941,CHEMBL3399830,Antimicrobial activity against Staphylococcus aureus MTCC 96 assessed as growth inhibition after 24 hrs by agar well diffusion method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3396992,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2280635,=,1,1,=,MIC,ug.mL-1,6.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,6.25
26534,,15153974,CHEMBL3399831,Antimicrobial activity against Bacillus subtilis MTCC 121 assessed as growth inhibition at 4 mg/ml after 24 hrs by agar well diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3396992,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,2280635,=,1,1,=,IZ,mm,24.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,DIZ,mm,UO_0000016,24.0
26535,,15154565,CHEMBL3399832,Antimicrobial activity against Bacillus subtilis MTCC 121 assessed as growth inhibition after 24 hrs by agar well diffusion method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3396992,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2280635,=,1,1,=,MIC,ug.mL-1,6.25,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MIC,ug ml-1,UO_0000274,6.25
26536,,15154598,CHEMBL3399833,Antimicrobial activity against Escherichia coli MTCC 1652 assessed as growth inhibition at 4 mg/ml after 24 hrs by agar well diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3396992,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,2280635,=,1,1,=,IZ,mm,25.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,DIZ,mm,UO_0000016,25.0
26537,,15154631,CHEMBL3399834,Antimicrobial activity against Pseudomonas aeruginosa MTCC 741 assessed as growth inhibition at 4 mg/ml after 24 hrs by agar well diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3396992,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,2280635,=,1,1,=,IZ,mm,22.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,DIZ,mm,UO_0000016,22.0
26538,Not Determined,15167479,CHEMBL3404739,Inhibition of recombinant Bacillus anthracis PurE assessed as inhibition of 4-carboxy-amino-imidazole ribonucleotide to N5-carboxy-amino-imidazole ribonucleotide conversion preincubated for 1.5 mins at 10 uM by mass spectrometry analysis,B,BAO_0000201,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3399984,Bioorg Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,2284155,,1,0,,Inhibition,%,,CHEMBL612545,,Unchecked,,,INH,,UO_0000187,
26539,,15167498,CHEMBL3404740,Antimicrobial activity against Bacillus anthracis deltaANR measured after overnight incubation,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3399984,Bioorg Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2284155,=,1,1,=,MIC,ug.mL-1,0.11,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,MIC,ug ml-1,UO_0000274,0.11
26540,,15167513,CHEMBL3405320,Antimicrobial activity against Francisella tularensis BEI/ATCC UTAH 112 measured after overnight incubation,F,BAO_0002146,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3399984,Bioorg Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2284155,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.03
26541,,15167529,CHEMBL3405322,Antimicrobial activity against Yersinia pestis BEI/ATCC A1122 measured after overnight incubation,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3399984,Bioorg Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2284155,=,1,1,=,MIC,ug.mL-1,0.04,CHEMBL614597,Yersinia pestis,Yersinia pestis,632.0,,MIC,ug ml-1,UO_0000274,0.04
26542,,15167545,CHEMBL3405493,Antimicrobial activity against methicillin-sensitive Staphylococcus aureus ATCC 29213 measured after overnight incubation,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3399984,Bioorg Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2284155,=,1,1,=,MIC,ug.mL-1,0.35,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.35
26543,,15167552,CHEMBL3405321,Antimicrobial activity against methicillin-resistant Staphylococcus aureus ATCC 43300 measured after overnight incubation,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3399984,Bioorg Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2284155,=,1,1,=,MIC,ug.mL-1,0.34,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.34
26544,,15167643,CHEMBL3405494,Antimicrobial activity against TolC-deficient Escherichia coli BW25113 measured after overnight incubation,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3399984,Bioorg Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2284155,=,1,1,=,MIC,ug.mL-1,0.01,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.01
26545,,15178427,CHEMBL3405132,Antimicrobial activity against Bacillus subtilis MTCC 121 after 24 hrs by well diffusion method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3400018,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2283231,=,1,1,=,MIC,ug.mL-1,0.9,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MIC,ug ml-1,UO_0000274,0.9
26546,,15178444,CHEMBL3405131,Antimicrobial activity against Staphylococcus aureus MLS-16 MTCC 2940 after 24 hrs by well diffusion method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3400018,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2283231,=,1,1,=,MIC,ug.mL-1,0.9,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.9
26547,,15178461,CHEMBL3405130,Antimicrobial activity against Micrococcus luteus MTCC 2470 after 24 hrs by well diffusion method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3400018,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2283231,=,1,1,=,MIC,ug.mL-1,0.9,CHEMBL614421,Micrococcus luteus,Micrococcus luteus,1270.0,,MIC,ug ml-1,UO_0000274,0.9
26548,,15178493,CHEMBL3405133,Antimicrobial activity against Escherichia coli MTCC 739 after 24 hrs by well diffusion method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3400018,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2283231,=,1,1,=,MIC,ug.mL-1,0.9,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.9
26549,,15178510,CHEMBL3405134,Antimicrobial activity against Pseudomonas aeruginosa MTCC 2453 after 24 hrs by well diffusion method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3400018,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2283231,=,1,1,=,MIC,ug.mL-1,0.9,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.9
26550,,15178527,CHEMBL3405135,Antimicrobial activity against Klebsiella planticola MTCC 530 after 24 hrs by well diffusion method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3400018,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2283231,=,1,1,=,MIC,ug.mL-1,0.9,CHEMBL613271,Raoultella planticola,Raoultella planticola,575.0,,MIC,ug ml-1,UO_0000274,0.9
26551,Not Active,15178544,CHEMBL3405136,Antimicrobial activity against Candida albicans MTCC 3017 after 24 hrs by well diffusion method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3400018,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,2283231,,1,0,,MIC,,,CHEMBL366,Candida albicans,Candida albicans,5476.0,,MIC,,,
26552,,15178587,CHEMBL3405137,Bactericidal activity against Staphylococcus aureus MLS-16 MTCC 2940 after 24 hrs by Mueller Hinton agar plate assay,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3400018,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2283231,=,1,0,=,MBC,ug ml-1,1.9,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MBC,ug ml-1,UO_0000274,1.9
26553,,15178588,CHEMBL3405138,Bactericidal activity against Bacillus subtilis MTCC 121 after 24 hrs by Mueller Hinton agar plate assay,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3400018,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2283231,=,1,0,=,MBC,ug ml-1,0.9,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MBC,ug ml-1,UO_0000274,0.9
26554,,15178589,CHEMBL3405139,Bactericidal activity against Escherichia coli MTCC 739 after 24 hrs by Mueller Hinton agar plate assay,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3400018,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2283231,=,1,0,=,MBC,ug ml-1,1.9,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MBC,ug ml-1,UO_0000274,1.9
26555,,15184200,CHEMBL3406236,Antimicrobial activity against Klebsiella pneumoniae,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3400054,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2283385,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,mg/L,UO_0000274,0.5
26556,,15184215,CHEMBL3406231,Antimicrobial activity against Klebsiella pneumoniae ATCC 13883 incubated at 37 degC for 24 hrs by broth macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3400054,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2283385,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,mg/L,UO_0000274,0.125
26557,,15184613,CHEMBL3405973,Antimicrobial activity against Staphylococcus aureus NCTC 4163 after 18 hrs by twofold serial broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3400015,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2281549,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
26558,,15184614,CHEMBL3405974,Antimicrobial activity against Staphylococcus aureus ATCC 25923 after 18 hrs by twofold serial broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3400015,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2281549,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
26559,,15184615,CHEMBL3405975,Antimicrobial activity against Staphylococcus aureus ATCC 6538 after 18 hrs by twofold serial broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3400015,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2281549,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
26560,,15184616,CHEMBL3405976,Antimicrobial activity against Staphylococcus aureus ATCC 29212 after 18 hrs by twofold serial broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3400015,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2281549,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
26561,,15184617,CHEMBL3405977,Antimicrobial activity against Staphylococcus epidermidis ATCC 12228 after 18 hrs by twofold serial broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3400015,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2281549,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.25
26562,,15184618,CHEMBL3405978,Antimicrobial activity against Staphylococcus epidermidis ATCC 35984 after 18 hrs by twofold serial broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3400015,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2281549,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.125
26563,,15184619,CHEMBL3405979,Antimicrobial activity against Escherichia coli ATCC 10538 after 18 hrs by twofold serial broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3400015,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2281549,=,1,1,=,MIC,ug.mL-1,0.008,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.008
26564,,15184620,CHEMBL3405980,Antimicrobial activity against Escherichia coli ATCC 25922 after 18 hrs by twofold serial broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3400015,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2281549,=,1,1,=,MIC,ug.mL-1,0.008,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.008
26565,,15184621,CHEMBL3405981,Antimicrobial activity against Escherichia coli NCTC 8196 after 18 hrs by twofold serial broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3400015,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2281549,=,1,1,=,MIC,ug.mL-1,0.008,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.008
26566,,15184622,CHEMBL3405982,Antimicrobial activity against Pseudomonas aeruginosa ATCC 15442 after 18 hrs by twofold serial broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3400015,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2281549,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.125
26567,,15184623,CHEMBL3405983,Antimicrobial activity against Pseudomonas aeruginosa NCTC 6749 after 18 hrs by twofold serial broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3400015,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2281549,=,1,1,=,MIC,ug.mL-1,0.0625,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.0625
26568,,15184624,CHEMBL3405984,Antimicrobial activity against Pseudomonas aeruginosa ATCC 27853 after 18 hrs by twofold serial broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3400015,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2281549,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.125
26569,,15184637,CHEMBL3406191,Antimicrobial activity against methicillin-resistant Staphylococcus epidermidis isolate 403/10 after 18 hrs by twofold serial broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3400015,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2281549,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,8.0
26570,,15184638,CHEMBL3406192,Antimicrobial activity against methicillin-resistant Staphylococcus epidermidis isolate 404/10 after 18 hrs by twofold serial broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3400015,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2281549,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,32.0
26571,,15184639,CHEMBL3406193,Antimicrobial activity against methicillin-resistant Staphylococcus epidermidis isolate 405/10 after 18 hrs by twofold serial broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3400015,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2281549,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,2.0
26572,,15184640,CHEMBL3406194,Antimicrobial activity against methicillin-resistant Staphylococcus epidermidis isolate 407/10 after 18 hrs by twofold serial broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3400015,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2281549,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,64.0
26573,,15184641,CHEMBL3406195,Antimicrobial activity against methicillin-resistant Staphylococcus epidermidis isolate 409/10 after 18 hrs by twofold serial broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3400015,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2281549,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,2.0
26574,,15184642,CHEMBL3406196,Antimicrobial activity against methicillin-resistant Staphylococcus epidermidis isolate 422/10 after 18 hrs by twofold serial broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3400015,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2281549,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,2.0
26575,,15184643,CHEMBL3406197,Antimicrobial activity against methicillin-resistant Staphylococcus epidermidis isolate 424/10 after 18 hrs by twofold serial broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3400015,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2281549,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,8.0
26576,,15184644,CHEMBL3406198,Antimicrobial activity against methicillin-resistant Staphylococcus epidermidis isolate 454/11 after 18 hrs by twofold serial broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3400015,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2281549,=,1,1,=,MIC,ug.mL-1,0.0625,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.0625
26577,,15184645,CHEMBL3406199,Antimicrobial activity against methicillin-resistant Staphylococcus epidermidis isolate 455/11 after 18 hrs by twofold serial broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3400015,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2281549,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,32.0
26578,,15184646,CHEMBL3406200,Antimicrobial activity against methicillin-resistant Staphylococcus epidermidis isolate 457/11 after 18 hrs by twofold serial broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3400015,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2281549,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,32.0
26579,,15184647,CHEMBL3406201,Antimicrobial activity against methicillin-resistant Staphylococcus epidermidis isolate 458/11 after 18 hrs by twofold serial broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3400015,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2281549,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,32.0
26580,,15184648,CHEMBL3406202,Antimicrobial activity against methicillin-resistant Staphylococcus epidermidis isolate 459/11 after 18 hrs by twofold serial broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3400015,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2281549,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,32.0
26581,,15184649,CHEMBL3406203,Antimicrobial activity against methicillin-resistant Staphylococcus epidermidis isolate 460/11 after 18 hrs by twofold serial broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3400015,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2281549,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.125
26582,,15184650,CHEMBL3406204,Antimicrobial activity against methicillin-resistant Staphylococcus epidermidis isolate 461/11 after 18 hrs by twofold serial broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3400015,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2281549,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.25
26583,,15184651,CHEMBL3406205,Antimicrobial activity against methicillin-resistant Staphylococcus epidermidis isolate 469/11 after 18 hrs by twofold serial broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3400015,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2281549,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,8.0
26584,,15184652,CHEMBL3406206,Antimicrobial activity against methicillin-resistant Staphylococcus epidermidis isolate 470/11 after 18 hrs by twofold serial broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3400015,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2281549,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.125
26585,Active,15184669,CHEMBL3406408,Inhibition of Staphylococcus epidermidis ATCC 35984 biofilm formation at 1 to 32 ug/ml after 24 hrs by MTT assay,F,BAO_0000201,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3400015,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,2281549,,1,0,,Inhibition,%,,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,INH,,UO_0000187,
26586,Active,15184670,CHEMBL3406409,Inhibition of Staphylococcus epidermidis ATCC 12228 biofilm formation at 1 to 32 ug/ml after 24 hrs by MTT assay,F,BAO_0000201,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3400015,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,2281549,,1,0,,Inhibition,%,,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,INH,,UO_0000187,
26587,Active,15184671,CHEMBL3406410,Inhibition of Staphylococcus epidermidis isolate 407/10 biofilm formation at 1 to 32 ug/ml after 24 hrs by MTT assay,F,BAO_0000201,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3400015,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,2281549,,1,0,,Inhibition,%,,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,INH,,UO_0000187,
26588,Active,15184672,CHEMBL3406411,Inhibition of Staphylococcus epidermidis isolate 409/10 biofilm formation at 1 to 32 ug/ml after 24 hrs by MTT assay,F,BAO_0000201,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3400015,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,2281549,,1,0,,Inhibition,%,,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,INH,,UO_0000187,
26589,Active,15184673,CHEMBL3406412,Inhibition of Staphylococcus epidermidis isolate 461/11 biofilm formation at 1 to 32 ug/ml after 24 hrs by MTT assay,F,BAO_0000201,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3400015,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,2281549,,1,0,,Inhibition,%,,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,INH,,UO_0000187,
26590,Active,15184674,CHEMBL3406413,Inhibition of Staphylococcus epidermidis isolate 469/11 biofilm formation at 1 to 32 ug/ml after 24 hrs by MTT assay,F,BAO_0000201,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3400015,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,2281549,,1,0,,Inhibition,%,,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,INH,,UO_0000187,
26591,,15184691,CHEMBL3406416,Ratio of ciprofloxacin MIC to compound MIC for methicillin-resistant Staphylococcus epidermidis clinical isolate after 18 hrs by twofold serial broth dilution method,F,BAO_0000193,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3400015,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,2281549,=,1,0,=,Ratio,,40.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,Ratio,,,40.0
26592,,15203496,CHEMBL3413349,Antimicrobial activity against Bacillus subtilis ATCC 6633 at 1 ug/ml after 24 hrs by agar diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3407338,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,2289162,=,1,1,=,IZ,mm,30.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,DIZ,mm,UO_0000016,30.0
26593,,15203497,CHEMBL3413350,Antimicrobial activity against Staphylococcus aureus ATCC 25923 at 1 ug/ml after 24 hrs by agar diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3407338,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,2289162,=,1,1,=,IZ,mm,25.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,DIZ,mm,UO_0000016,25.0
26594,,15203498,CHEMBL3413351,Antimicrobial activity against Pseudomonas aeruginosa ATCC 9027 at 1 ug/ml after 24 hrs by agar diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3407338,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,2289162,=,1,1,=,IZ,mm,20.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,DIZ,mm,UO_0000016,20.0
26595,,15203499,CHEMBL3413352,Antimicrobial activity against Salmonella enterica ATCC 14028 at 1 ug/ml after 24 hrs by agar diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3407338,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,2289162,=,1,1,=,IZ,mm,35.0,CHEMBL613762,Salmonella enterica,Salmonella enterica,28901.0,,DIZ,mm,UO_0000016,35.0
26596,,15203500,CHEMBL3413353,Antimicrobial activity against Escherichia coli ATCC 25922 at 1 ug/ml after 24 hrs by agar diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3407338,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,2289162,=,1,1,=,IZ,mm,30.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,DIZ,mm,UO_0000016,30.0
26597,,15203501,CHEMBL3413354,Antimicrobial activity against Candida albicans ATCC 32354 at 1 ug/ml after 24 hrs by agar diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3407338,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,2289162,=,1,1,=,IZ,mm,0.0,CHEMBL366,Candida albicans,Candida albicans,5476.0,,DIZ,mm,UO_0000016,0.0
26598,,15203526,CHEMBL3413361,Antimicrobial activity against 10'4 CFU/ml Bacillus subtilis ATCC 6633 after 22 hrs by serial microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3407338,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2289162,<,1,1,<,MIC,ug.mL-1,0.8,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MIC,ug ml-1,UO_0000274,0.8
26599,,15203527,CHEMBL3413362,Antimicrobial activity against 10'7 CFU/ml Bacillus subtilis ATCC 6633 after 22 hrs by serial microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3407338,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2289162,<,1,1,<,MIC,ug.mL-1,0.8,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MIC,ug ml-1,UO_0000274,0.8
26600,,15203528,CHEMBL3413363,Antimicrobial activity against 10'4 CFU/ml Pseudomonas aeruginosa ATCC 9027 after 22 hrs by serial microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3407338,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2289162,=,1,1,=,MIC,ug.mL-1,1.6,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,1.6
26601,,15203529,CHEMBL3413364,Antimicrobial activity against 10'7 CFU/ml Pseudomonas aeruginosa ATCC 9027 after 22 hrs by serial microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3407338,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2289162,=,1,1,=,MIC,ug.mL-1,1.6,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,1.6
26602,,15203530,CHEMBL3413365,Antimicrobial activity against 10'4 CFU/ml Staphylococcus aureus ATCC 25923 after 22 hrs by serial microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3407338,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2289162,<,1,1,<,MIC,ug.mL-1,0.8,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.8
26603,,15203531,CHEMBL3413366,Antimicrobial activity against 10'7 CFU/ml Staphylococcus aureus ATCC 25923 after 22 hrs by serial microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3407338,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2289162,<,1,1,<,MIC,ug.mL-1,0.8,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.8
26604,,15203532,CHEMBL3413367,Antimicrobial activity against 10'4 CFU/ml Escherichia coli ATCC 25922 after 22 hrs by serial microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3407338,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2289162,<,1,1,<,MIC,ug.mL-1,0.8,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.8
26605,,15203533,CHEMBL3413368,Antimicrobial activity against 10'7 CFU/ml Escherichia coli ATCC 25922 after 22 hrs by serial microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3407338,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2289162,<,1,1,<,MIC,ug.mL-1,0.8,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.8
26606,,15203534,CHEMBL3414188,Antimicrobial activity against 10'4 CFU/ml Salmonella enterica ATCC 14028 after 22 hrs by serial microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3407338,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2289162,<,1,1,<,MIC,ug.mL-1,0.8,CHEMBL613762,Salmonella enterica,Salmonella enterica,28901.0,,MIC,ug ml-1,UO_0000274,0.8
26607,,15203535,CHEMBL3414189,Antimicrobial activity against 10'7 CFU/ml Salmonella enterica ATCC 14028 after 22 hrs by serial microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3407338,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2289162,<,1,1,<,MIC,ug.mL-1,0.8,CHEMBL613762,Salmonella enterica,Salmonella enterica,28901.0,,MIC,ug ml-1,UO_0000274,0.8
26608,,15203536,CHEMBL3414190,Antimicrobial activity against 10'4 CFU/ml Candida albicans ATCC 32354 after 22 hrs by serial microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3407338,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2289162,>,1,1,>,MIC,ug.mL-1,100.0,CHEMBL366,Candida albicans,Candida albicans,5476.0,,MIC,ug ml-1,UO_0000274,100.0
26609,,15203537,CHEMBL3414191,Antimicrobial activity against 10'7 CFU/ml Candida albicans ATCC 32354 after 22 hrs by serial microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3407338,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2289162,=,1,1,=,MIC,ug.mL-1,100.0,CHEMBL366,Candida albicans,Candida albicans,5476.0,,MIC,ug ml-1,UO_0000274,100.0
26610,,15203562,CHEMBL3413361,Antimicrobial activity against 10'4 CFU/ml Bacillus subtilis ATCC 6633 after 22 hrs by serial microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3407338,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2289162,<,1,0,<,MBC,ug ml-1,0.8,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MBC,ug ml-1,UO_0000274,0.8
26611,,15203563,CHEMBL3413362,Antimicrobial activity against 10'7 CFU/ml Bacillus subtilis ATCC 6633 after 22 hrs by serial microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3407338,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2289162,<,1,0,<,MBC,ug ml-1,0.8,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MBC,ug ml-1,UO_0000274,0.8
26612,,15203564,CHEMBL3413363,Antimicrobial activity against 10'4 CFU/ml Pseudomonas aeruginosa ATCC 9027 after 22 hrs by serial microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3407338,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2289162,=,1,0,=,MBC,ug ml-1,3.1,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MBC,ug ml-1,UO_0000274,3.1
26613,,15203565,CHEMBL3413364,Antimicrobial activity against 10'7 CFU/ml Pseudomonas aeruginosa ATCC 9027 after 22 hrs by serial microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3407338,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2289162,=,1,0,=,MBC,ug ml-1,3.1,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MBC,ug ml-1,UO_0000274,3.1
26614,,15203566,CHEMBL3413365,Antimicrobial activity against 10'4 CFU/ml Staphylococcus aureus ATCC 25923 after 22 hrs by serial microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3407338,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2289162,<,1,0,<,MBC,ug ml-1,0.8,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MBC,ug ml-1,UO_0000274,0.8
26615,,15203567,CHEMBL3413366,Antimicrobial activity against 10'7 CFU/ml Staphylococcus aureus ATCC 25923 after 22 hrs by serial microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3407338,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2289162,<,1,0,<,MBC,ug ml-1,0.8,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MBC,ug ml-1,UO_0000274,0.8
26616,,15203568,CHEMBL3413367,Antimicrobial activity against 10'4 CFU/ml Escherichia coli ATCC 25922 after 22 hrs by serial microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3407338,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2289162,<,1,0,<,MBC,ug ml-1,0.8,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MBC,ug ml-1,UO_0000274,0.8
26617,,15203569,CHEMBL3413368,Antimicrobial activity against 10'7 CFU/ml Escherichia coli ATCC 25922 after 22 hrs by serial microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3407338,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2289162,<,1,0,<,MBC,ug ml-1,0.8,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MBC,ug ml-1,UO_0000274,0.8
26618,,15203570,CHEMBL3414188,Antimicrobial activity against 10'4 CFU/ml Salmonella enterica ATCC 14028 after 22 hrs by serial microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3407338,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2289162,<,1,0,<,MBC,ug ml-1,0.8,CHEMBL613762,Salmonella enterica,Salmonella enterica,28901.0,,MBC,ug ml-1,UO_0000274,0.8
26619,,15203571,CHEMBL3414189,Antimicrobial activity against 10'7 CFU/ml Salmonella enterica ATCC 14028 after 22 hrs by serial microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3407338,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2289162,<,1,0,<,MBC,ug ml-1,0.8,CHEMBL613762,Salmonella enterica,Salmonella enterica,28901.0,,MBC,ug ml-1,UO_0000274,0.8
26620,,15203572,CHEMBL3414190,Antimicrobial activity against 10'4 CFU/ml Candida albicans ATCC 32354 after 22 hrs by serial microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3407338,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2289162,>,1,0,>,MBC,ug ml-1,100.0,CHEMBL366,Candida albicans,Candida albicans,5476.0,,MBC,ug ml-1,UO_0000274,100.0
26621,,15203573,CHEMBL3414191,Antimicrobial activity against 10'7 CFU/ml Candida albicans ATCC 32354 after 22 hrs by serial microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3407338,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2289162,=,1,0,=,MBC,ug ml-1,100.0,CHEMBL366,Candida albicans,Candida albicans,5476.0,,MBC,ug ml-1,UO_0000274,100.0
26622,,15214024,CHEMBL3420369,Antimicrobial activity against Staphylococcus aureus ATCC 6538 after 18 hrs by two-fold serial microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3414487,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2292817,=,1,1,=,MIC,nM,760.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,uM,UO_0000065,0.76
26623,,15215459,CHEMBL3420368,Antimicrobial activity against Staphylococcus aureus ATCC 25923 after 18 hrs by two-fold serial microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3414487,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2292817,=,1,1,=,MIC,nM,1510.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,uM,UO_0000065,1.51
26624,,15215460,CHEMBL3420176,Antimicrobial activity against Staphylococcus aureus ACTC 4163 after 18 hrs by two-fold serial microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3414487,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2292817,=,1,1,=,MIC,nM,760.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,uM,UO_0000065,0.76
26625,,15215461,CHEMBL3420370,Antimicrobial activity against Staphylococcus aureus ATCC 29213 after 18 hrs by two-fold serial microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3414487,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2292817,=,1,1,=,MIC,nM,1510.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,uM,UO_0000065,1.51
26626,,15215462,CHEMBL3420371,Antimicrobial activity against Staphylococcus epidermidis ATCC 12228 after 18 hrs by two-fold serial microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3414487,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2292817,=,1,1,=,MIC,nM,760.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,uM,UO_0000065,0.76
26627,,15215463,CHEMBL3420372,Antimicrobial activity against Staphylococcus epidermidis ATCC 35984 after 18 hrs by two-fold serial microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3414487,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2292817,=,1,1,=,MIC,nM,380.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,uM,UO_0000065,0.38
26628,,15215464,CHEMBL3420373,Antimicrobial activity against methicillin-resistant Staphylococcus aureus 452/11 after 18 hrs by two-fold serial microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3414487,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2292817,=,1,1,=,MIC,nM,96680.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,uM,UO_0000065,96.68
26629,,15215465,CHEMBL3420374,Antimicrobial activity against methicillin-resistant Staphylococcus aureus 456/11 after 18 hrs by two-fold serial microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3414487,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2292817,=,1,1,=,MIC,nM,96680.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,uM,UO_0000065,96.68
26630,,15215466,CHEMBL3420375,Antimicrobial activity against methicillin-resistant Staphylococcus aureus 462/11 after 18 hrs by two-fold serial microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3414487,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2292817,=,1,1,=,MIC,nM,193350.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,uM,UO_0000065,193.35
26631,,15215467,CHEMBL3420376,Antimicrobial activity against methicillin-resistant Staphylococcus aureus 514/11 after 18 hrs by two-fold serial microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3414487,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2292817,=,1,1,=,MIC,nM,96680.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,uM,UO_0000065,96.68
26632,,15215468,CHEMBL3420377,Antimicrobial activity against methicillin-resistant Staphylococcus aureus 522/12 after 18 hrs by two-fold serial microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3414487,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2292817,=,1,1,=,MIC,nM,96680.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,uM,UO_0000065,96.68
26633,,15215469,CHEMBL3420378,Antimicrobial activity against methicillin-resistant Staphylococcus aureus 537/12 after 18 hrs by two-fold serial microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3414487,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2292817,=,1,1,=,MIC,nM,193350.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,uM,UO_0000065,193.35
26634,,15215470,CHEMBL3420379,Antimicrobial activity against methicillin-resistant Staphylococcus aureus 572/12 after 18 hrs by two-fold serial microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3414487,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2292817,=,1,1,=,MIC,nM,193350.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,uM,UO_0000065,193.35
26635,,15215471,CHEMBL3420380,Antimicrobial activity against methicillin-resistant Staphylococcus aureus 573/12 after 18 hrs by two-fold serial microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3414487,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2292817,=,1,1,=,MIC,nM,96680.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,uM,UO_0000065,96.68
26636,,15215472,CHEMBL3420381,Antimicrobial activity against methicillin-resistant Staphylococcus aureus 585/12 after 18 hrs by two-fold serial microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3414487,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2292817,=,1,1,=,MIC,nM,193350.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,uM,UO_0000065,193.35
26637,,15215473,CHEMBL3420382,Antimicrobial activity against methicillin-resistant Staphylococcus aureus 586/12 after 18 hrs by two-fold serial microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3414487,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2292817,=,1,1,=,MIC,nM,193350.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,uM,UO_0000065,193.35
26638,,15215474,CHEMBL3420383,Antimicrobial activity against methicillin-resistant Staphylococcus epidermidis 459/11 after 18 hrs by two-fold serial microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3414487,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2292817,=,1,1,=,MIC,nM,48340.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,uM,UO_0000065,48.34
26639,,15215475,CHEMBL3420384,Antimicrobial activity against methicillin-resistant Staphylococcus epidermidis 460/11 after 18 hrs by two-fold serial microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3414487,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2292817,=,1,1,=,MIC,nM,380.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,uM,UO_0000065,0.38
26640,,15215476,CHEMBL3420385,Antimicrobial activity against methicillin-resistant Staphylococcus epidermidis 461/11 after 18 hrs by two-fold serial microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3414487,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2292817,=,1,1,=,MIC,nM,760.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,uM,UO_0000065,0.76
26641,,15215477,CHEMBL3420386,Antimicrobial activity against methicillin-resistant Staphylococcus epidermidis 466/11 after 18 hrs by two-fold serial microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3414487,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2292817,=,1,1,=,MIC,nM,6040.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,uM,UO_0000065,6.04
26642,,15215478,CHEMBL3420387,Antimicrobial activity against methicillin-resistant Staphylococcus epidermidis 467/11 after 18 hrs by two-fold serial microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3414487,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2292817,=,1,1,=,MIC,nM,48340.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,uM,UO_0000065,48.34
26643,,15215479,CHEMBL3420388,Antimicrobial activity against methicillin-resistant Staphylococcus epidermidis 468/11 after 18 hrs by two-fold serial microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3414487,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2292817,=,1,1,=,MIC,nM,48340.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,uM,UO_0000065,48.34
26644,,15215480,CHEMBL3420389,Antimicrobial activity against methicillin-resistant Staphylococcus epidermidis 469/11 after 18 hrs by two-fold serial microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3414487,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2292817,=,1,1,=,MIC,nM,24170.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,uM,UO_0000065,24.17
26645,,15215481,CHEMBL3420390,Antimicrobial activity against methicillin-resistant Staphylococcus epidermidis 470/11 after 18 hrs by two-fold serial microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3414487,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2292817,=,1,1,=,MIC,nM,380.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,uM,UO_0000065,0.38
26646,,15215482,CHEMBL3420392,Antimicrobial activity against methicillin-resistant Staphylococcus epidermidis 488/11 after 18 hrs by two-fold serial microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3414487,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2292817,=,1,1,=,MIC,nM,48340.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,uM,UO_0000065,48.34
26647,,15215483,CHEMBL3420393,Antimicrobial activity against methicillin-resistant Staphylococcus epidermidis 489/11 after 18 hrs by two-fold serial microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3414487,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2292817,=,1,1,=,MIC,nM,760.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,uM,UO_0000065,0.76
26648,,15216199,CHEMBL3419617,Antimicrobial activity against Staphylococcus aureus ATCC 25923 assessed as diameter of zone of inhibition at 25 microg/disc after 24 hrs by agar well diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3414431,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,2293206,=,1,1,=,IZ,mm,24.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,DIZ,mm,UO_0000016,24.0
26649,,15216221,CHEMBL3419619,Antimicrobial activity against Escherichia coli ATCC 25922 assessed as diameter of zone of inhibition at 25 microg/disc after 24 hrs by agar well diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3414431,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,2293206,=,1,1,=,IZ,mm,24.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,DIZ,mm,UO_0000016,24.0
26650,,15218561,CHEMBL3419720,"Antimicrobial activity against Escherichia coli UTI89 infected in C3H/HeN mouse urinary tract infection model assessed as bacterial load reduction in bladder at 8 mg/kg, sc administered 10 mins prior to infection measured after 3 hrs (Rvb = 6.6 log10 CFU)",F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3414523,J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,2293116,=,1,0,=,log10cfu,,2.44,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,log10cfu,,,2.44
26651,,15218562,CHEMBL3419721,"Antimicrobial activity against Escherichia coli UTI89 infected in C3H/HeN mouse urinary tract infection model assessed as bacterial load reduction in kidney at 8 mg/kg, sc administered 10 mins prior to infection measured after 3 hrs (Rvb = 6 log10 CFU)",F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3414523,J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,2293116,=,1,0,=,log10cfu,,2.47,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,log10cfu,,,2.47
26652,,15220536,CHEMBL3418790,Antibacterial activity against fluoroquinolone-resistant Staphylococcus aureus 1199B overexpressing NorA after 24 hrs by two fold microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3414455,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2293421,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,8.0
26653,,15221815,CHEMBL3419439,Antibacterial activity against fluoroquinolone-susceptible Staphylococcus aureus 1199B after 24 hrs by two fold microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3414455,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2293421,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
26654,,15230240,CHEMBL3424276,Inhibition of cell division in penicillin-susceptible Bacillus subtilis ATCC 9372 assessed as filamentation after 5 hrs by phase contrast microscopy,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3421607,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2296076,>,1,1,>,MIC,ug.mL-1,128.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MIC,ug ml-1,UO_0000274,128.0
26655,,15230280,CHEMBL3424277,Inhibition of cell division in penicillin-susceptible Escherichia coli ATCC 25922 assessed as filamentation after 5 hrs by phase contrast microscopy,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3421607,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2296076,>,1,1,>,MIC,ug.mL-1,128.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,128.0
26656,,15230320,CHEMBL3424278,Inhibition of cell division in penicillin-susceptible Pseudomonas aeruginosa ATCC 27853 assessed as filamentation after 5 hrs by phase contrast microscopy,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3421607,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2296076,>,1,1,>,MIC,ug.mL-1,128.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,128.0
26657,,15230360,CHEMBL3424279,Inhibition of cell division in penicillin-susceptible Staphylococcus aureus ATCC 25923 assessed as ballooning after 5 hrs by phase contrast microscopy,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3421607,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2296076,>,1,1,>,MIC,ug.mL-1,128.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,128.0
26658,,15230378,CHEMBL3424343,Inhibition of Escherichia coli DNA topoisomerase 4 using kDNA as substrate after 1 hr by agarose gel electrophoresis,B,BAO_0000190,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3421560,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2296100,=,1,1,=,IC50,nM,80000.0,CHEMBL612545,,Unchecked,,,IC50,uM,UO_0000065,80.0
26659,,15230379,CHEMBL3424342,Inhibition of Escherichia coli DNA gyrase after 1 hr by agarose gel electrophoresis,B,BAO_0000190,BAO_0000223,protein complex format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3421560,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2296100,=,1,1,=,IC50,nM,150.0,CHEMBL2094139,Escherichia coli,DNA gyrase,562.0,,IC50,uM,UO_0000065,0.15
26660,,15230418,CHEMBL3424329,Antimicrobial activity against Micrococcus luteus ATCC 10240 after 18 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3421560,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2296100,=,1,1,=,MIC,nM,5880.0,CHEMBL614421,Micrococcus luteus,Micrococcus luteus,1270.0,,MIC,uM,UO_0000065,5.88
26661,,15230441,CHEMBL3424328,Antimicrobial activity against Bacillus cereus ATCC 10876 after 18 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3421560,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2296100,=,1,1,=,MIC,nM,360.0,CHEMBL613070,Bacillus cereus,Bacillus cereus,1396.0,,MIC,uM,UO_0000065,0.36
26662,,15230464,CHEMBL3424327,Antimicrobial activity against Bacillus subtilis ATCC 6638 after 18 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3421560,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2296100,=,1,1,=,MIC,nM,90.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MIC,uM,UO_0000065,0.09
26663,,15230487,CHEMBL3424326,Antimicrobial activity against Staphylococcus epidermidis ATCC 12228 after 18 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3421560,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2296100,=,1,1,=,MIC,nM,1480.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,uM,UO_0000065,1.48
26664,,15231395,CHEMBL3424324,Antimicrobial activity against methicillin-susceptible Staphylococcus aureus ATCC 6538 after 18 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3421560,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2296100,=,1,1,=,MIC,nM,720.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,uM,UO_0000065,0.72
26665,,15231418,CHEMBL3424323,Antimicrobial activity against methicillin-susceptible Staphylococcus aureus ATCC 25923 after 18 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3421560,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2296100,=,1,1,=,MIC,nM,2960.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,uM,UO_0000065,2.96
26666,,15231505,CHEMBL3424336,Antimicrobial activity against Escherichia coli ATCC 25922 after 18 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3421560,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2296100,=,1,1,=,MIC,nM,24.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,uM,UO_0000065,0.024
26667,,15231528,CHEMBL3424337,Antimicrobial activity against Klebsiella pneumoniae ATCC 13883 after 18 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3421560,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2296100,=,1,1,=,MIC,nM,360.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,uM,UO_0000065,0.36
26668,,15231551,CHEMBL3424338,Antimicrobial activity against Proteus mirabilis ATCC 12453 after 18 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3421560,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2296100,=,1,1,=,MIC,nM,45.0,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,MIC,uM,UO_0000065,0.045
26669,,15231574,CHEMBL3424339,Antimicrobial activity against Pseudomonas aeruginosa ATCC 9027 after 18 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3421560,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2296100,=,1,1,=,MIC,nM,720.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,uM,UO_0000065,0.72
26670,,15236237,CHEMBL3424703,Anti-mycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 assessed as inhibition of microbial growth incubated for 5 days by MABA method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3421527,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2295354,=,1,1,=,MIC,nM,12600.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,uM,UO_0000065,12.6
26671,,15241775,CHEMBL3424267,Antibacterial activity against penicillin-susceptible Bacillus subtilis ATCC 9372 after 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3421607,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2296076,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MIC,ug ml-1,UO_0000274,8.0
26672,,15242768,CHEMBL3424268,Antibacterial activity against penicillin-susceptible Escherichia coli ATCC 25922 after 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3421607,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2296076,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,8.0
26673,,15242808,CHEMBL3424269,Antibacterial activity against penicillin-susceptible Pseudomonas aeruginosa ATCC 27853 after 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3421607,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2296076,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,4.0
26674,,15242848,CHEMBL3424270,Antibacterial activity against penicillin-susceptible Staphylococcus aureus ATCC 25923 after 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3421607,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2296076,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,8.0
26675,,15242888,CHEMBL3424271,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 29213 after 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3421607,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2296076,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,4.0
26676,,15242928,CHEMBL3424272,Antibacterial activity against penicillin-resistant Staphylococcus aureus clinical isolates after 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3421607,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2296076,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,8.0
26677,,15242968,CHEMBL3424273,Antibacterial activity against penicillin-resistant Staphylococcus epidermidis clinical isolates after 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3421607,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2296076,>,1,1,>,MIC,ug.mL-1,128.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,128.0
26678,,15243008,CHEMBL3424274,Antibacterial activity against penicillin-susceptible Streptococcus pyogenes clinical isolates after 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3421607,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2296076,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC,ug ml-1,UO_0000274,8.0
26679,,15243048,CHEMBL3424275,Antibacterial activity against penicillin-resistant Streptococcus pyogenes clinical isolates after 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3421607,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2296076,>,1,1,>,MIC,ug.mL-1,128.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC,ug ml-1,UO_0000274,128.0
26680,Active,15257667,CHEMBL3430228,Bactericidal activity against Pseudomonas aeruginosa ATCC 27853 assessed as decrease in log10CFU/ml at 12.5 to 50 ug/ml incubated for 6 hrs followed by plating measured after 24 hrs relative to control,F,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3425490,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,2296539,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
26681,Active,15257692,CHEMBL3430229,Bactericidal activity against methicillin-resistant Staphylococcus epidermidis ATCC 35984 assessed as decrease in log10CFU/ml at 12.5 to 50 ug/ml incubated for 6 hrs followed by plating measured after 24 hrs relative to control,F,BAO_0000375,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3425490,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,2296539,,1,0,,Activity,,,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,Activity,,,
26682,,15257700,CHEMBL3430232,Induction of pre-existing Pseudomonas aeruginosa ATCC 27853 biofilm detachment after 24 hrs by crystal violet staining-based assay relative to control,F,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3425490,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,2296539,=,1,0,=,Activity,%,50.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,%,UO_0000187,50.0
26683,,15257706,CHEMBL3427831,Induction of pre-existing methicillin-resistant Staphylococcus epidermidis ATCC 35984 biofilm detachment after 24 hrs by crystal violet staining-based assay relative to control,F,BAO_0001103,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3425490,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,2296539,=,1,0,=,Activity,%,30.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,Activity,%,UO_0000187,30.0
26684,Active,15257711,CHEMBL3427832,Inhibition of biofilm formation of Pseudomonas aeruginosa ATCC 27853 after 24 hrs by crystal violet staining-based assay,F,BAO_0000201,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3425490,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,2296539,,1,0,,Inhibition,%,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,INH,,UO_0000187,
26685,Active,15257716,CHEMBL3427833,Inhibition of biofilm formation of methicillin-resistant Staphylococcus epidermidis ATCC 35984 after 24 hrs by crystal violet staining-based assay relative to control,F,BAO_0000201,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3425490,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,2296539,,1,0,,Inhibition,%,,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,INH,,UO_0000187,
26686,,15257717,CHEMBL3427834,Antibacterial activity against Pseudomonas aeruginosa 5761 by macrobroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3425490,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2296539,=,1,1,=,MIC,ug.mL-1,0.09,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.09
26687,,15257718,CHEMBL3427835,Antibacterial activity against Pseudomonas aeruginosa 11683 by macrobroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3425490,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2296539,=,1,1,=,MIC,ug.mL-1,0.09,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.09
26688,,15257719,CHEMBL3427836,Antibacterial activity against Pseudomonas aeruginosa 8545 by macrobroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3425490,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2296539,=,1,1,=,MIC,ug.mL-1,0.09,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.09
26689,,15257720,CHEMBL3427837,Antibacterial activity against oxacillin-susceptible Staphylococcus epidermidis ATCC 35984,F,BAO_0002146,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3425490,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2296539,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.12
26690,,15257721,CHEMBL3427838,Antibacterial activity against oxacillin-resistant Staphylococcus epidermidis ATCC 35984,F,BAO_0002146,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3425490,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2296539,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.12
26691,,15446764,CHEMBL3529279,Transporter substrate index ratio of permeability from apical to basolateral side in human Caco2 cells at 10 uM up to 120 mins by HPLC-MC analysis in presence of 1 uM of P-gp inhibitor LY335979,A,BAO_0000193,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3526001,Drug Metab Dispos,2011.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,2470951,=,1,0,=,Ratio,,-15.0,CHEMBL612558,,ADMET,,,Ratio,,,-15.0
26692,,15446824,CHEMBL3529278,Efflux ratio of permeability from apical to basolateral side over basolateral to apical side of human Caco2 cells at 10 uM up to 120 mins by HPLC-MC analysis in presence of 1 uM of P-gp inhibitor LY335979,A,BAO_0000193,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3526001,Drug Metab Dispos,2011.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,2470951,=,1,0,=,Ratio,,2.0,CHEMBL612558,,ADMET,,,Ratio,,,2.0
26693,,15446884,CHEMBL3529277,Apparent permeability from basolateral to apical side of human Caco2 cells at 10 uM up to 120 mins by HPLC-MC analysis in presence of 1 uM of P-gp inhibitor LY335979,A,BAO_0002808,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3526001,Drug Metab Dispos,2011.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,2470951,=,1,0,=,Papp,ucm/s,4.1,CHEMBL612558,,ADMET,,,Papp,ucm/s,,4.1
26694,,15446944,CHEMBL3529276,Apparent permeability from apical to basolateral side of human Caco2 cells at 10 uM up to 120 mins by HPLC-MC analysis in presence of 1 uM of P-gp inhibitor LY335979,A,BAO_0002808,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3526001,Drug Metab Dispos,2011.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,2470951,=,1,0,=,Papp,ucm/s,2.1,CHEMBL612558,,ADMET,,,Papp,ucm/s,,2.1
26695,,15447018,CHEMBL3529274,Efflux ratio of permeability from apical to basolateral side over basolateral to apical side of human Caco2 cells at 10 uM up to 120 mins by HPLC-MC analysis,A,BAO_0000193,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3526001,Drug Metab Dispos,2011.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,2470951,=,1,0,=,Ratio,,2.1,CHEMBL612558,,ADMET,,,Ratio,,,2.1
26696,,15453433,CHEMBL3529296,Transporter substrate index of efflux ratio in human Caco2 cells at 10 uM up to 120 mins by HPLC-MC analysis in presence of 10 uM of MRP2 inhibitor MK571,A,BAO_0000193,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3526001,Drug Metab Dispos,2011.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,2470951,=,1,0,=,Ratio,,6.0,CHEMBL612558,,ADMET,,,Ratio,,,6.0
26697,,15453460,CHEMBL3529295,Transporter substrate index ratio of permeability from basolateral to apical side in human Caco2 cells at 10 uM up to 120 mins by HPLC-MC analysis in presence of 10 uM of MRP2 inhibitor MK571,A,BAO_0000193,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3526001,Drug Metab Dispos,2011.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,2470951,=,1,0,=,Ratio,,2.0,CHEMBL612558,,ADMET,,,Ratio,,,2.0
26698,,15453487,CHEMBL3529294,Transporter substrate index ratio of permeability from apical to basolateral side in human Caco2 cells at 10 uM up to 120 mins by HPLC-MC analysis in presence of 10 uM of MRP2 inhibitor MK571,A,BAO_0000193,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3526001,Drug Metab Dispos,2011.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,2470951,=,1,0,=,Ratio,,4.0,CHEMBL612558,,ADMET,,,Ratio,,,4.0
26699,,15453512,CHEMBL3529293,Transporter substrate index of efflux ratio in human Caco2 cells at 10 uM up to 120 mins by HPLC-MC analysis in presence of 1 uM of BCRP inhibitor Ko143,A,BAO_0000193,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3526001,Drug Metab Dispos,2011.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,2470951,=,1,0,=,Ratio,,34.0,CHEMBL612558,,ADMET,,,Ratio,,,34.0
26700,,15453537,CHEMBL3529292,Transporter substrate index ratio of permeability from basolateral to apical side in human Caco2 cells at 10 uM up to 120 mins by HPLC-MC analysis in presence of 1 uM of BCRP inhibitor Ko143,A,BAO_0000193,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3526001,Drug Metab Dispos,2011.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,2470951,=,1,0,=,Ratio,,26.0,CHEMBL612558,,ADMET,,,Ratio,,,26.0
26701,,15453562,CHEMBL3529291,Transporter substrate index ratio of permeability from apical to basolateral side in human Caco2 cells at 10 uM up to 120 mins by HPLC-MC analysis in presence of 1 uM of BCRP inhibitor Ko143,A,BAO_0000193,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3526001,Drug Metab Dispos,2011.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,2470951,=,1,0,=,Ratio,,12.0,CHEMBL612558,,ADMET,,,Ratio,,,12.0
26702,,15457393,CHEMBL3529273,Apparent permeability from basolateral to apical side of human Caco2 cells at 10 uM up to 120 mins by HPLC-MC analysis,A,BAO_0002808,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3526001,Drug Metab Dispos,2011.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,2470951,=,1,0,=,Papp,ucm/s,5.2,CHEMBL612558,,ADMET,,,Papp,ucm/s,,5.2
26703,,15458916,CHEMBL3529272,Apparent permeability from apical to basolateral side of human Caco2 cells at 10 uM up to 120 mins by HPLC-MC analysis,A,BAO_0002808,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3526001,Drug Metab Dispos,2011.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,2470951,=,1,0,=,Papp,ucm/s,2.0,CHEMBL612558,,ADMET,,,Papp,ucm/s,,2.0
26704,,15463888,CHEMBL3529289,Efflux ratio of permeability from apical to basolateral side over basolateral to apical side of human Caco2 cells at 10 uM up to 120 mins by HPLC-MC analysis in presence of 10 uM of MRP2 inhibitor MK571,A,BAO_0000193,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3526001,Drug Metab Dispos,2011.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,2470951,=,1,0,=,Ratio,,5.3,CHEMBL612558,,ADMET,,,Ratio,,,5.3
26705,,15463915,CHEMBL3529288,Apparent permeability from basolateral to apical side of human Caco2 cells at 10 uM up to 120 mins by HPLC-MC analysis in presence of 10 uM of MRP2 inhibitor MK571,A,BAO_0002808,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3526001,Drug Metab Dispos,2011.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,2470951,=,1,0,=,Papp,ucm/s,11.1,CHEMBL612558,,ADMET,,,Papp,ucm/s,,11.1
26706,,15463942,CHEMBL3529287,Apparent permeability from apical to basolateral side of human Caco2 cells at 10 uM up to 120 mins by HPLC-MC analysis in presence of 10 uM of MRP2 inhibitor MK571,A,BAO_0002808,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3526001,Drug Metab Dispos,2011.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,2470951,=,1,0,=,Papp,ucm/s,2.1,CHEMBL612558,,ADMET,,,Papp,ucm/s,,2.1
26707,,15463967,CHEMBL3529286,Efflux ratio of permeability from apical to basolateral side over basolateral to apical side of human Caco2 cells at 10 uM up to 120 mins by HPLC-MC analysis in presence of 1 uM of BCRP inhibitor Ko143,A,BAO_0000193,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3526001,Drug Metab Dispos,2011.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,2470951,=,1,0,=,Ratio,,1.4,CHEMBL612558,,ADMET,,,Ratio,,,1.4
26708,,15463992,CHEMBL3529285,Apparent permeability from basolateral to apical side of human Caco2 cells at 10 uM up to 120 mins by HPLC-MC analysis in presence of 1 uM of BCRP inhibitor Ko143,A,BAO_0002808,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3526001,Drug Metab Dispos,2011.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,2470951,=,1,0,=,Papp,ucm/s,3.9,CHEMBL612558,,ADMET,,,Papp,ucm/s,,3.9
26709,,15464017,CHEMBL3529284,Apparent permeability from apical to basolateral side of human Caco2 cells at 10 uM up to 120 mins by HPLC-MC analysis in presence of 1 uM of BCRP inhibitor Ko143,A,BAO_0002808,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3526001,Drug Metab Dispos,2011.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,2470951,=,1,0,=,Papp,ucm/s,2.8,CHEMBL612558,,ADMET,,,Papp,ucm/s,,2.8
26710,,15464089,CHEMBL3529281,Transporter substrate index of efflux ratio in human Caco2 cells at 10 uM up to 120 mins by HPLC-MC analysis in presence of 1 uM of P-gp inhibitor LY335979,A,BAO_0000193,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3526001,Drug Metab Dispos,2011.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,2470951,=,1,0,=,Ratio,,42.0,CHEMBL612558,,ADMET,,,Ratio,,,42.0
26711,,15464149,CHEMBL3529280,Transporter substrate index ratio of permeability from basolateral to apical side in human Caco2 cells at 10 uM up to 120 mins by HPLC-MC analysis in presence of 1 uM of P-gp inhibitor LY335979,A,BAO_0000193,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3526001,Drug Metab Dispos,2011.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,2470951,=,1,0,=,Ratio,,51.0,CHEMBL612558,,ADMET,,,Ratio,,,51.0
26712,,15464547,CHEMBL3529958,Unbound biliary clearance in iv dosed Wistar rat,A,BAO_0002759,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3526096,Drug Metab Dispos,2013.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,2468528,=,1,1,=,CL,mL.min-1.kg-1,6.14,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,CL free,ml/min.kg,,6.14
26713,,15464548,CHEMBL3529746,Total biliary clearance in iv dosed Wistar rat,A,BAO_0002759,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3526096,Drug Metab Dispos,2013.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,2468528,=,1,1,=,CL,mL.min-1.kg-1,3.5,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,CL,ml/min.kg,,3.5
26714,,15601072,CHEMBL3578435,Bactericidal activity against methicillin-resistant Staphylococcus aureus ATCC 33591 using fresh sample in DMSO after 24 to 48 hrs by CLSI method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3576782,J Nat Prod,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2479999,=,1,0,=,MBC,ug ml-1,0.8,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MBC,ug ml-1,UO_0000274,0.8
26715,,15601075,CHEMBL3578434,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33591 assessed as growth inhibition using fresh sample in DMSO by CLSI method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3576782,J Nat Prod,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2479999,=,1,1,=,MIC,ug.mL-1,0.4,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.4
26716,,15601078,CHEMBL3578434,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33591 assessed as growth inhibition using fresh sample in DMSO by CLSI method,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3576782,J Nat Prod,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2479999,<,1,1,<,IC50,ug.mL-1,0.1,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,IC50,ug ml-1,UO_0000274,0.1
26717,,15601082,CHEMBL3578433,Bactericidal activity against Staphylococcus aureus ATCC 29213 using fresh sample in DMSO after 24 to 48 hrs by CLSI method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3576782,J Nat Prod,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2479999,=,1,0,=,MBC,ug ml-1,0.4,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MBC,ug ml-1,UO_0000274,0.4
26718,,15601685,CHEMBL3580367,Antibacterial activity against Staphylococcus aureus ATCC 29213 assessed as growth inhibition using fresh sample in DMSO by CLSI method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3576782,J Nat Prod,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2479999,=,1,1,=,MIC,ug.mL-1,0.4,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.4
26719,,15601689,CHEMBL3580367,Antibacterial activity against Staphylococcus aureus ATCC 29213 assessed as growth inhibition using fresh sample in DMSO by CLSI method,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3576782,J Nat Prod,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2479999,<,1,1,<,IC50,ug.mL-1,0.1,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,IC50,ug ml-1,UO_0000274,0.1
26720,,15601692,CHEMBL3578436,Antibacterial activity against methicillin-resistant Staphylococcus aureus EAMC30 assessed as growth inhibition using fresh sample in DMSO by CLSI method,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3576782,J Nat Prod,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2479999,=,1,1,=,IC50,ug.mL-1,29.4,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,IC50,ug ml-1,UO_0000274,29.4
26721,,15601696,CHEMBL3578436,Antibacterial activity against methicillin-resistant Staphylococcus aureus EAMC30 assessed as growth inhibition using fresh sample in DMSO by CLSI method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3576782,J Nat Prod,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2479999,=,1,1,=,MIC,ug.mL-1,100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,100.0
26722,,15601702,CHEMBL3578438,Antibacterial activity against Enterococcus faecalis ATCC 29212 assessed as growth inhibition using fresh sample in DMSO by CLSI method,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3576782,J Nat Prod,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2479999,=,1,1,=,IC50,ug.mL-1,0.2,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,IC50,ug ml-1,UO_0000274,0.2
26723,,15601706,CHEMBL3578438,Antibacterial activity against Enterococcus faecalis ATCC 29212 assessed as growth inhibition using fresh sample in DMSO by CLSI method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3576782,J Nat Prod,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2479999,=,1,1,=,MIC,ug.mL-1,0.8,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,0.8
26724,,15601710,CHEMBL3578439,Bactericidal activity against Enterococcus faecalis ATCC 29212 using fresh sample in DMSO after 24 to 48 hrs by CLSI method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3576782,J Nat Prod,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2479999,=,1,0,=,MBC,ug ml-1,6.2,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MBC,ug ml-1,UO_0000274,6.2
26725,,15601716,CHEMBL3578441,Antibacterial activity against Enterococcus faecalis ATCC 51299 assessed as growth inhibition using fresh sample in DMSO by CLSI method,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3576782,J Nat Prod,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2479999,=,1,1,=,IC50,ug.mL-1,0.2,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,IC50,ug ml-1,UO_0000274,0.2
26726,,15601720,CHEMBL3578441,Antibacterial activity against Enterococcus faecalis ATCC 51299 assessed as growth inhibition using fresh sample in DMSO by CLSI method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3576782,J Nat Prod,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2479999,=,1,1,=,MIC,ug.mL-1,0.4,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,0.4
26727,,15601723,CHEMBL3578442,Bactericidal activity against Enterococcus faecalis ATCC 51299 using fresh sample in DMSO after 24 to 48 hrs by CLSI method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3576782,J Nat Prod,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2479999,=,1,0,=,MBC,ug ml-1,6.2,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MBC,ug ml-1,UO_0000274,6.2
26728,Not Active,15601727,CHEMBL3578445,Bactericidal activity against methicillin-resistant Staphylococcus aureus EAMC30 using fresh sample in DMSO at 100 ug/ml after 24 to 48 hrs by CLSI method,F,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3576782,J Nat Prod,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,2479999,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
26729,Not Active,15601732,CHEMBL3578448,Bactericidal activity against vancomycin-resistant Enterococcus faecium ATCC 700221 using fresh sample in DMSO at 100 ug/ml after 24 to 48 hrs by CLSI method,F,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3576782,J Nat Prod,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,2479999,,1,0,,Activity,,,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,Activity,,,
26730,Not Active,15601735,CHEMBL3578449,Antibacterial activity against vancomycin-resistant Enterococcus faecium ATCC 700221 assessed as growth inhibition using fresh sample in DMSO at 100 ug/ml by CLSI method,F,BAO_0000181,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3576782,J Nat Prod,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,2479999,,1,0,,GI,,,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,GI,,,
26731,,15602752,CHEMBL3578660,Antimicrobial activity against Pseudomonas aeruginosa ATCC 10145 assessed as bacterial growth inhibition after 24 hrs by standard broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3576821,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2479444,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,1.0
26732,,15602755,CHEMBL3578659,Antimicrobial activity against Klebsiella pneumoniae ATCC 13883 assessed as bacterial growth inhibition after 24 hrs by standard broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3576821,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2479444,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,1.0
26733,,15602759,CHEMBL3578658,Antimicrobial activity against Acinetobacter baumannii ATCC 19606 assessed as bacterial growth inhibition after 24 hrs by standard broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3576821,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2479444,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,2.0
26734,,15609295,CHEMBL3578695,Antibacterial activity against Escherichia coli transformed with plasmid carrying MG1655 deltaBC/pXYM by p-iodonitrotetrazolium chloride colorimetric assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3576792,J Nat Prod,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2479620,=,1,1,=,MIC,ug.mL-1,0.02,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.02
26735,,15609304,CHEMBL3580284,Antibacterial activity against Escherichia coli transformed with plasmid carrying MG1655 deltaBC/pABM by p-iodonitrotetrazolium chloride colorimetric assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3576792,J Nat Prod,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2479620,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.03
26736,,15609313,CHEMBL3580283,Antibacterial activity against Escherichia coli AG102 overexpressing AcrAB-TolC by p-iodonitrotetrazolium chloride colorimetric assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3576792,J Nat Prod,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2479620,=,1,1,=,MIC,ug.mL-1,0.13,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.13
26737,,15623545,CHEMBL3587506,Antibacterial activity against Pseudomonas aeruginosa K799/61 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3585272,ACS Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2484992,=,1,1,=,MIC,nM,240.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,uM,UO_0000065,0.24
26738,,15623552,CHEMBL3587505,Antibacterial activity against wild type Pseudomonas aeruginosa K799 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3585272,ACS Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2484992,=,1,1,=,MIC,nM,470.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,uM,UO_0000065,0.47
26739,,15623559,CHEMBL3587504,Antibacterial activity against Acinetobacter baumannii ATCC 17961 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3585272,ACS Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2484992,=,1,1,=,MIC,nM,240.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,uM,UO_0000065,0.24
26740,,15623566,CHEMBL3587503,Antibacterial activity against Mycobacterium vaccae IMET10670 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3585272,ACS Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2484992,=,1,1,=,MIC,nM,470.0,CHEMBL613224,Mycolicibacterium vaccae,Mycolicibacterium vaccae,1810.0,,MIC,uM,UO_0000065,0.47
26741,,15623573,CHEMBL3587502,Antibacterial activity against Micrococcus luteus ATCC 10240 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3585272,ACS Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2484992,=,1,1,=,MIC,nM,8000.0,CHEMBL614421,Micrococcus luteus,Micrococcus luteus,1270.0,,MIC,uM,UO_0000065,8.0
26742,,15623578,CHEMBL3587501,Antibacterial activity against Staphylococcus aureus SG511 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3585272,ACS Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2484992,=,1,1,=,MIC,nM,470.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,uM,UO_0000065,0.47
26743,,15623587,CHEMBL3587424,Antibacterial activity against Bacillus subtilis ATCC 6633 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3585272,ACS Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2484992,=,1,1,=,MIC,nM,30.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MIC,uM,UO_0000065,0.03
26744,,15623604,CHEMBL3587508,Antibacterial activity against Escherichia coli DC2 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3585272,ACS Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2484992,=,1,1,=,MIC,nM,240.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,uM,UO_0000065,0.24
26745,,15623611,CHEMBL3587507,Antibacterial activity against Escherichia coli DC0 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3585272,ACS Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2484992,=,1,1,=,MIC,nM,470.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,uM,UO_0000065,0.47
26746,,15623637,CHEMBL3587405,Antibacterial activity against Bacillus subtilis ATCC 6633 at 1.66 ug/ml incubated for 24 hrs at 37 degC by agar diffusion assay,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3585272,ACS Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,2484992,=,1,1,=,IZ,mm,20.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,DIZ,mm,UO_0000016,20.0
26747,,15623638,CHEMBL3587406,Antibacterial activity against Staphylococcus aureus SG511 at 5 ug/ml incubated for 24 hrs at 37 degC by agar diffusion assay,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3585272,ACS Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,2484992,=,1,1,=,IZ,mm,21.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,DIZ,mm,UO_0000016,21.0
26748,,15623639,CHEMBL3587407,Antibacterial activity against Micrococcus luteus ATCC 10240 at 5 ug/ml incubated for 24 hrs at 37 degC by agar diffusion assay,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3585272,ACS Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,2484992,=,1,1,=,IZ,mm,0.0,CHEMBL614421,Micrococcus luteus,Micrococcus luteus,1270.0,,DIZ,mm,UO_0000016,0.0
26749,,15623640,CHEMBL3587408,Antibacterial activity against Mycobacterium vaccae IMET10670 at 5 ug/ml incubated for 44 hrs at 37 degC by agar diffusion assay,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3585272,ACS Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,2484992,=,1,1,=,IZ,mm,23.0,CHEMBL613224,Mycolicibacterium vaccae,Mycolicibacterium vaccae,1810.0,,DIZ,mm,UO_0000016,23.0
26750,,15623641,CHEMBL3587409,Antibacterial activity against Acinetobacter baumannii ATCC 17961 at 5 ug/ml incubated for 24 hrs at 37 degC by agar diffusion assay,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3585272,ACS Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,2484992,=,1,1,=,IZ,mm,18.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,DIZ,mm,UO_0000016,18.0
26751,,15623642,CHEMBL3587410,Antibacterial activity against wild type Pseudomonas aeruginosa K799 at 1.66 ug/ml incubated for 24 hrs at 37 degC by agar diffusion assay,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3585272,ACS Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,2484992,=,1,1,=,IZ,mm,15.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,DIZ,mm,UO_0000016,15.0
26752,,15623643,CHEMBL3587411,Antibacterial activity against Pseudomonas aeruginosa K799/61 at 1.66 ug/ml incubated for 24 hrs at 37 degC by agar diffusion assay,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3585272,ACS Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,2484992,=,1,1,=,IZ,mm,19.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,DIZ,mm,UO_0000016,19.0
26753,,15623644,CHEMBL3587412,Antibacterial activity against Escherichia coli X580 at 0.33 ug/ml incubated for 24 hrs at 37 degC by agar diffusion assay,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3585272,ACS Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,2484992,=,1,1,=,IZ,mm,23.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,DIZ,mm,UO_0000016,23.0
26754,,15623645,CHEMBL3587413,Antibacterial activity against Escherichia coli DC0 at 5 ug/ml incubated for 24 hrs at 37 degC by agar diffusion assay,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3585272,ACS Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,2484992,=,1,1,=,IZ,mm,18.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,DIZ,mm,UO_0000016,18.0
26755,,15623646,CHEMBL3587414,Antibacterial activity against Escherichia coli DC2 at 5 ug/ml incubated for 24 hrs at 37 degC by agar diffusion assay,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3585272,ACS Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,2484992,=,1,1,=,IZ,mm,22.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,DIZ,mm,UO_0000016,22.0
26756,,15623647,CHEMBL3587415,Antibacterial activity against Bacillus subtilis ATCC 6633 assessed as unclear inhibition zone or inhibition zone with many colonies at 1.66 ug/ml incubated for 24 hrs at 37 degC by agar diffusion assay,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3585272,ACS Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,2484992,=,1,1,=,IZ,mm,24.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,DIZ,mm,UO_0000016,24.0
26757,,15623648,CHEMBL3587416,Antibacterial activity against Acinetobacter baumannii ATCC 17961 assessed as unclear inhibition zone or inhibition zone with many colonies at 5 ug/ml incubated for 24 hrs at 37 degC by agar diffusion assay,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3585272,ACS Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,2484992,=,1,1,=,IZ,mm,21.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,DIZ,mm,UO_0000016,21.0
26758,,15623649,CHEMBL3587417,Antibacterial activity against Pseudomonas aeruginosa K799/61 assessed as unclear inhibition zone or inhibition zone with many colonies at 1.66 ug/ml incubated for 24 hrs at 37 degC by agar diffusion assay,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3585272,ACS Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,2484992,=,1,1,=,IZ,mm,24.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,DIZ,mm,UO_0000016,24.0
26759,,15638309,CHEMBL3592096,Antibacterial activity against Escherichia coli after 18 to 20 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3588802,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2486993,<=,1,1,<=,MIC,ug.mL-1,0.00075,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.00075
26760,,15638320,CHEMBL3592102,Antibacterial activity against patient-derived methicillin-resistant Staphylococcus aureus 7419 after 18 to 20 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3588802,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2486993,>,1,1,>,MIC,ug.mL-1,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,4.0
26761,,15638326,CHEMBL3592103,Antibacterial activity against patient-derived methicillin-resistant Staphylococcus aureus B19506 after 18 to 20 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3588802,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2486993,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,32.0
26762,,15638332,CHEMBL3592104,Antibacterial activity against patient-derived methicillin-resistant Staphylococcus aureus 7425 after 18 to 20 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3588802,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2486993,>,1,1,>,MIC,ug.mL-1,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,4.0
26763,,15638338,CHEMBL3592105,Antibacterial activity against patient-derived methicillin-resistant Staphylococcus aureus 7386 after 18 to 20 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3588802,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2486993,>,1,1,>,MIC,ug.mL-1,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,4.0
26764,,15638344,CHEMBL3592106,Antibacterial activity against patient-derived methicillin-resistant Staphylococcus aureus K1 after 18 to 20 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3588802,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2486993,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
26765,,15638383,CHEMBL3592109,Antibacterial activity against methicillin-resistant Staphylococcus aureus after 18 to 20 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3588802,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2486993,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
26766,,15645881,CHEMBL3591708,Antibacterial activity against Escherichia coli ATCC 25922 assessed as inhibition of bacterial growth incubated at 37 degC for 24 hrs by broth microdilution assay,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3588777,J Nat Prod,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2487335,=,1,0,=,MIC>90,ug ml-1,0.016,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC>90,ug ml-1,UO_0000274,0.016
26767,,15645882,CHEMBL3591709,Antibacterial activity against Enterococcus faecalis ATCC 29212 assessed as inhibition of bacterial growth incubated at 37 degC for 24 hrs by broth microdilution assay,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3588777,J Nat Prod,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2487335,=,1,0,=,MIC>90,ug ml-1,1.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC>90,ug ml-1,UO_0000274,1.0
26768,,15645884,CHEMBL3591710,Antibacterial activity against Staphylococcus aureus ATCC 25923 assessed as inhibition of bacterial growth incubated at 37 degC for 24 hrs by broth microdilution assay,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3588777,J Nat Prod,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2487335,=,1,0,=,MIC>90,ug ml-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC>90,ug ml-1,UO_0000274,0.5
26769,,15646463,CHEMBL3595059,Antimicrobial activity against Mycobacterium smegmatis incubated for 4 days by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3593169,J Nat Prod,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2488802,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL613088,Mycolicibacterium smegmatis,Mycolicibacterium smegmatis,1772.0,,MIC,ug ml-1,UO_0000274,2.0
26770,,15654521,CHEMBL3598492,Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 after 28 days by two-fold serial dilution method,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3596139,Medchemcomm,2014.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2489776,=,1,0,=,MIC99,ug ml-1,1.56,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC99,ug ml-1,UO_0000274,1.56
26771,,15661005,CHEMBL3599608,Antimicrobial activity against Staphylococcus aureus MLS16 MTCC 2940 incubated for 24 hrs at 37 degC by well diffusion method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3596103,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2489870,=,1,1,=,MIC,nM,2700.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,uM,UO_0000065,2.7
26772,,15661021,CHEMBL3599882,Antimicrobial activity against Micrococcus luteus MTCC 2470 incubated for 24 hrs at 37 degC by well diffusion method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3596103,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2489870,=,1,1,=,MIC,nM,2700.0,CHEMBL614421,Micrococcus luteus,Micrococcus luteus,1270.0,,MIC,uM,UO_0000065,2.7
26773,,15661037,CHEMBL3599883,Antimicrobial activity against Bacillus subtilis MTCC 121 incubated for 24 hrs at 37 degC by well diffusion method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3596103,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2489870,=,1,1,=,MIC,nM,2700.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MIC,uM,UO_0000065,2.7
26774,,15661053,CHEMBL3599884,Antimicrobial activity against Escherichia coli MTCC 739 incubated for 24 hrs at 37 degC by well diffusion method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3596103,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2489870,=,1,1,=,MIC,nM,2700.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,uM,UO_0000065,2.7
26775,,15661069,CHEMBL3599885,Antimicrobial activity against Klebsiella planticola MTCC 530 incubated for 24 hrs at 37 degC by well diffusion method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3596103,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2489870,=,1,1,=,MIC,nM,2700.0,CHEMBL613271,Raoultella planticola,Raoultella planticola,575.0,,MIC,uM,UO_0000065,2.7
26776,,15661085,CHEMBL3599886,Antimicrobial activity against Pseudomonas aeruginosa MTCC 2453 incubated for 24 hrs at 37 degC by well diffusion method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3596103,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2489870,=,1,1,=,MIC,nM,2700.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,uM,UO_0000065,2.7
26777,,15661102,CHEMBL3599887,Antimicrobial activity against Candida albicans MTCC 3017 incubated for 24 hrs at 30 degC by well diffusion method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3596103,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2489870,>,1,1,>,MIC,ug.mL-1,125.0,CHEMBL366,Candida albicans,Candida albicans,5476.0,,MIC,ug ml-1,UO_0000274,125.0
26778,,15661111,CHEMBL3599888,Bactericidal activity against Micrococcus luteus MTCC 2470 incubated for 24 hrs at 37 degC,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3596103,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Micromolar,2489870,=,1,0,=,MBC,uM,5.7,CHEMBL614421,Micrococcus luteus,Micrococcus luteus,1270.0,,MBC,uM,UO_0000064,5.7
26779,,15661119,CHEMBL3599889,Bactericidal activity against Staphylococcus aureus MLS16 MTCC 2940 incubated for 24 hrs at 37 degC,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3596103,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Micromolar,2489870,=,1,0,=,MBC,uM,2.7,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MBC,uM,UO_0000064,2.7
26780,,15661127,CHEMBL3599890,Bactericidal activity against Bacillus subtilis MTCC 121 incubated for 24 hrs at 37 degC,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3596103,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Micromolar,2489870,=,1,0,=,MBC,uM,5.7,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MBC,uM,UO_0000064,5.7
26781,,15661135,CHEMBL3599891,Bactericidal activity against Escherichia coli MTCC 739 incubated for 24 hrs at 37 degC,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3596103,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Micromolar,2489870,=,1,0,=,MBC,uM,5.7,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MBC,uM,UO_0000064,5.7
26782,,15661143,CHEMBL3599892,Bactericidal activity against Klebsiella planticola MTCC 530 incubated for 24 hrs at 37 degC,F,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3596103,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Micromolar,2489870,=,1,0,=,MBC,uM,2.7,CHEMBL613271,Raoultella planticola,Raoultella planticola,575.0,,MBC,uM,UO_0000064,2.7
26783,,15669020,CHEMBL3603064,Antitrypanosomal activity against Trypanosoma brucei gambiense FeoITMAP/1893 assessed as inhibition of parasite growth after 72 hrs by resazurin dye based microplate reader analysis,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3600287,Bioorg Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2491867,=,1,1,=,IC50,nM,52000.0,CHEMBL613768,Trypanosoma brucei gambiense,Trypanosoma brucei gambiense,31285.0,,IC50,uM,UO_0000065,52.0
26784,,15677057,CHEMBL3607850,Antibacterial activity against wild type Escherichia coli ATCC 25922 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3603745,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2495611,<=,1,1,<=,MIC,ug.mL-1,0.03,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.03
26785,,15677078,CHEMBL3607728,Inhibition of Escherichia coli recombinant gyrase A2B2 assessed as reduction of pHOT-1 supercoiling after 90 mins,B,BAO_0000190,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3603745,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2495611,=,1,1,=,IC50,nM,460.0,CHEMBL612545,,Unchecked,,,IC50,uM,UO_0000065,0.46
26786,,15677086,CHEMBL3607851,Antibacterial activity against wild type Escherichia coli BW5328/pAH69 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3603745,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2495611,<=,1,1,<=,MIC,ug.mL-1,0.03,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.03
26787,,15677108,CHEMBL3607852,Antibacterial activity against tolC-deficient Escherichia coli JW5503-1 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3603745,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2495611,<=,1,1,<=,MIC,ug.mL-1,0.03,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.03
26788,,15677130,CHEMBL3607853,"Antibacterial activity against tolC-deficient Escherichia coli NB27005-CDY0039 expressing gyrA S83L D83G, parC S80I mutant by broth microdilution method",F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3603745,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2495611,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,2.0
26789,,15677152,CHEMBL3607854,Antibacterial activity against wild type Escherichia coli MC4100 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3603745,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2495611,<=,1,1,<=,MIC,ug.mL-1,0.03,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.03
26790,,15678032,CHEMBL3607855,Antibacterial activity against Escherichia coli imp-4213 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3603745,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2495611,<=,1,1,<=,MIC,ug.mL-1,0.03,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.03
26791,,15678054,CHEMBL3607856,"Antibacterial activity against fluoroquinolone-resistant Escherichia coli CH10 harboring gyrA S83L D87N, parC S80I E84G, AcrA+ by broth microdilution method",F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3603745,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2495611,>,1,1,>,MIC,ug.mL-1,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,32.0
26792,,15678076,CHEMBL3607857,Antibacterial activity against wild type Staphylococcus aureus ATCC 29213 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3603745,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2495611,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
26793,,15678098,CHEMBL3607858,Antibacterial activity against wild type methicillin-susceptible Staphylococcus aureus ATCC 49951 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3603745,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2495611,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
26794,,15678120,CHEMBL3607859,"Antibacterial activity against fluoroquinolone-resistant Staphylococcus aureus NB01006-AVR005 harboring gyrA S84L, parC S80F, parE E471K by broth microdilution method",F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3603745,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2495611,>,1,1,>,MIC,ug.mL-1,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,32.0
26795,,15678142,CHEMBL3607860,Antibacterial activity against wild type Pseudomonas aeruginosa PAO1 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3603745,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2495611,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.125
26796,,15678164,CHEMBL3607861,"Antibacterial activity against Pseudomonas aeruginosa K1542 deficient with mexX, mexB by broth microdilution method",F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3603745,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2495611,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.06
26797,,15678186,CHEMBL3607862,"Antibacterial activity against mexX, mexB deficient Pseudomonas aeruginosa NB52023-CDK005 harboring gyrAT83I by broth microdilution method",F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3603745,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2495611,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.5
26798,,15678208,CHEMBL3607863,"Antibacterial activity against mexX, mexB deficient Pseudomonas aeruginosa NB52023-CDK006 harboring gyrAT83I and parC S87L by broth microdilution method",F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3603745,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2495611,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,4.0
26799,,15678527,CHEMBL3606844,Antimycobacterial activity against isoniazid-resistant Mycobacterium tuberculosis MYC5165 after 6 days by MTT assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3603838,Bioorg Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2494116,=,1,1,=,MIC,nM,2500.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,uM,UO_0000065,2.5
26800,,15678538,CHEMBL3606843,Antimycobacterial activity against Mycobacterium tuberculosis H37Rv after 6 days by MTT assay,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3603838,Bioorg Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2494116,=,1,1,=,MIC,nM,2500.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,uM,UO_0000065,2.5
26801,,15678573,CHEMBL3606843,Antimycobacterial activity against Mycobacterium tuberculosis H37Rv after 6 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3603838,Bioorg Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2494116,=,1,1,=,IC50,nM,600.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,IC50,uM,UO_0000065,0.6
26802,,15678574,CHEMBL3606844,Antimycobacterial activity against isoniazid-resistant Mycobacterium tuberculosis MYC5165 after 6 days by MTT assay,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3603838,Bioorg Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2494116,=,1,1,=,IC50,nM,1800.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,IC50,uM,UO_0000065,1.8
26803,,15682770,CHEMBL3606896,Antibacterial activity against Escherichia coli JM109 after 24 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3603734,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2494995,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,1.0
26804,,15682788,CHEMBL3606897,Antibacterial activity against Bacillus proteus ATCC 13315 after 24 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3603734,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2494995,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL612428,Bacillus,Bacillus,1386.0,,MIC,ug ml-1,UO_0000274,1.0
26805,,15682806,CHEMBL3606898,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 after 24 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3603734,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2494995,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,1.0
26806,,15682824,CHEMBL3606899,Antibacterial activity against Salmonella enterica ATCC 14028 after 24 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3603734,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2494995,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL613762,Salmonella enterica,Salmonella enterica,28901.0,,MIC,ug ml-1,UO_0000274,1.0
26807,,15682842,CHEMBL3606900,Antibacterial activity against methicillin-resistant Staphylococcus aureus N315 after 24 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3603734,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2494995,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
26808,,15682860,CHEMBL3606901,Antibacterial activity against Staphylococcus aureus ATCC 25923 after 24 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3603734,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2494995,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
26809,,15682878,CHEMBL3606902,Antibacterial activity against Bacillus subtilis ATCC 6633 after 24 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3603734,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2494995,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL613907,Bacillus spizizenii,Bacillus spizizenii,96241.0,,MIC,ug ml-1,UO_0000274,1.0
26810,,15682896,CHEMBL3606903,Antibacterial activity against Micrococcus luteus ATCC 4698 after 24 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3603734,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2494995,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL614421,Micrococcus luteus,Micrococcus luteus,1270.0,,MIC,ug ml-1,UO_0000274,1.0
26811,,15690000,CHEMBL3610295,Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 incubated for 7 days by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3608244,ACS Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2496836,=,1,1,=,MIC,nM,500.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,uM,UO_0000065,0.5
26812,Not Determined,15690027,CHEMBL3610297,Inhibition of Mycobacterium tuberculosis H37Rv DNA gyrase assessed as supercoiling of pBR322 DNA after 90 mins by agarose gel electrophoresis method,B,BAO_0000190,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3608244,ACS Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,2496836,,1,0,,IC50,,,CHEMBL3430898,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv),DNA gyrase subunit A/DNA gyrase subunit B,83332.0,,IC50,,,
26813,,15690035,CHEMBL3610298,"Antimycobacterial activity against 6-((1-(2-(7-chloro-2-oxo-1,8-naphthyridin-1(2H)-yl)ethyl)piperidin-4-ylamino)methyl)-2H-pyrido[3,2-b][1,4]oxazin-3(4H)-one resistant Mycobacterium tuberculosis H37Rv harboring DNA gyraseA A74V mutant incubated for 7 days by microdilution method",F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3608244,ACS Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2496836,=,1,1,=,MIC,nM,500.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,uM,UO_0000065,0.5
26814,,15690043,CHEMBL3610299,"Antimycobacterial activity against 1-(2-(4-((5-chloro-6-methylpyridin-3-yl)methylamino)piperidin-1-yl)ethyl)-7-fluoro-1,5-naphthyridin-2(1H)-one resistant Mycobacterium tuberculosis H37Rv harboring DNA gyraseA D89N mutant incubated for 7 days by microdilution method",F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3608244,ACS Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2496836,=,1,1,=,MIC,nM,16000.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,uM,UO_0000065,16.0
26815,,15690051,CHEMBL3610300,Antimycobacterial activity against moxifloxacin resistant Mycobacterium tuberculosis H37Rv harboring DNA gyraseA G88N mutant incubated for 7 days by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3608244,ACS Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2496836,=,1,1,=,MIC,nM,8000.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,uM,UO_0000065,8.0
26816,,15691772,CHEMBL3610235,Antimicrobial activity against methicillin-resistant Staphylococcus aureus clinical isolates by standard broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3608201,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2497973,=,1,1,=,MIC,ug.mL-1,128.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,128.0
26817,,15691791,CHEMBL3610234,Antimicrobial activity against Staphylococcus aureus ATCC 25923 by standard broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3608201,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2497973,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
26818,,15691823,CHEMBL3610236,Antimicrobial activity against levofloxacin-resistant Staphylococcus aureus clinical isolates by standard broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3608201,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2497973,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,32.0
26819,,15691842,CHEMBL3610237,Antimicrobial activity against Streptococcus pneumoniae ATCC 49619 by standard broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3608201,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2497973,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,2.0
26820,,15691861,CHEMBL3610238,Antimicrobial activity against penicillin-resistant Streptococcus pneumoniae clinical isolates by standard broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3608201,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2497973,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.5
26821,,15691880,CHEMBL3610239,Antimicrobial activity against Streptococcus pyogenes ATCC 19615 by standard broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3608201,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2497973,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC,ug ml-1,UO_0000274,0.5
26822,,15691899,CHEMBL3610240,Antimicrobial activity against Staphylococcus epidermidis ATCC 12228 by standard broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3608201,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2497973,=,1,1,=,MIC,ug.mL-1,0.0625,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.0625
26823,,15691918,CHEMBL3610307,Antimicrobial activity against methicillin-resistant Staphylococcus epidermidis clinical isolates by standard broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3608201,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2497973,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,8.0
26824,,15691937,CHEMBL3610308,Antimicrobial activity against Escherichia coli ATCC 25922 by standard broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3608201,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2497973,<=,1,1,<=,MIC,ug.mL-1,0.016,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.016
26825,,15691956,CHEMBL3610309,Antimicrobial activity against ciprofloxacin-resistant Escherichia coli clinical isolates by standard broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3608201,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2497973,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,4.0
26826,,15691975,CHEMBL3610310,Antimicrobial activity against Pseudomonas aeruginosa ATCC 27853 by standard broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3608201,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2497973,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.25
26827,,15693611,CHEMBL3610983,Antimicrobial activity against Streptococcus pyogenes ATCC 19615 incubated for 18 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3608264,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2497755,=,1,1,=,MIC,nM,2392500.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC,uM,UO_0000065,2392.5
26828,,15693639,CHEMBL3610982,Antimicrobial activity against Staphylococcus aureus ATCC 25923 incubated for 18 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3608264,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2497755,=,1,1,=,MIC,nM,74600.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,uM,UO_0000065,74.6
26829,,15693669,CHEMBL3610984,Antimicrobial activity against Salmonella typhimurium ATCC 19430 incubated for 18 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3608264,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2497755,=,1,1,=,MIC,nM,9200.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,MIC,uM,UO_0000065,9.2
26830,,15693697,CHEMBL3610985,Antimicrobial activity against Pseudomonas aeruginosa ATCC 27853 incubated for 18 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3608264,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2497755,=,1,1,=,MIC,nM,74600.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,uM,UO_0000065,74.6
26831,,15694555,CHEMBL3611586,Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 after 28 days by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3608226,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2496451,=,1,1,=,MIC,nM,12600.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,uM,UO_0000065,12.6
26832,,15703588,CHEMBL3615874,Antimycobacterial activity against Mycobacterium abscessus ATCC 19977 after 7 days by serial dilution method,F,BAO_0002146,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3612041,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2499747,=,1,1,=,MIC,nM,3000.0,CHEMBL612951,Mycobacteroides abscessus,Mycobacteroides abscessus,36809.0,,MIC,uM,UO_0000065,3.0
26833,Not Determined,15708667,CHEMBL3614273,Antimicrobial activity against vancomycin-susceptible Enterococcus faecalis after 16 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3611970,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,2498835,,1,0,,MIC,,,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,,,
26834,Not Determined,15708689,CHEMBL3614274,Antimicrobial activity against Enterococcus faecalis VRE-309 after 16 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3611970,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,2498835,,1,0,,MIC,,,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,,,
26835,,15708711,CHEMBL3614275,Antimicrobial activity against Pseudomonas aeruginosa PAO1 after 16 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3611970,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2498835,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,mg/L,UO_0000274,1.0
26836,,15709315,CHEMBL3614276,Antimicrobial activity against Klebsiella pneumoniae KP-249 clinical isolate after 16 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3611970,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2498835,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,mg/L,UO_0000274,2.0
26837,Not Determined,15709337,CHEMBL3614277,Antimicrobial activity against methicillin-resistant Staphylococcus aureus 309-4 clinical isolate after 16 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3611970,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,2498835,,1,0,,MIC,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,,,
26838,Not Determined,15709359,CHEMBL3614278,Antimicrobial activity against methicillin-resistant Staphylococcus aureus 6281 clinical isolate after 16 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3611970,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,2498835,,1,0,,MIC,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,,,
26839,Not Determined,15709381,CHEMBL3614279,Antimicrobial activity against methicillin-resistant Staphylococcus aureus 309-8 clinical isolate after 16 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3611970,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,2498835,,1,0,,MIC,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,,,
26840,Not Determined,15709403,CHEMBL3614280,Antimicrobial activity against methicillin-resistant Staphylococcus aureus 6-42 clinical isolate after 16 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3611970,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,2498835,,1,0,,MIC,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,,,
26841,Not Determined,15709425,CHEMBL3614281,Antimicrobial activity against methicillin-resistant Staphylococcus aureus 8-21 clinical isolate after 16 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3611970,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,2498835,,1,0,,MIC,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,,,
26842,Not Determined,15709447,CHEMBL3614282,Antimicrobial activity against methicillin-resistant Staphylococcus aureus 309-3 clinical isolate after 16 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3611970,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,2498835,,1,0,,MIC,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,,,
26843,Not Determined,15709469,CHEMBL3614283,Antimicrobial activity against methicillin-resistant Staphylococcus aureus 309-1 clinical isolate after 16 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3611970,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,2498835,,1,0,,MIC,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,,,
26844,Not Determined,15709491,CHEMBL3614284,Antimicrobial activity against methicillin-resistant Staphylococcus aureus 309-7 clinical isolate after 16 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3611970,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,2498835,,1,0,,MIC,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,,,
26845,Not Determined,15709513,CHEMBL3614285,Antimicrobial activity against methicillin-resistant Staphylococcus aureus 8-24 clinical isolate after 16 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3611970,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,2498835,,1,0,,MIC,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,,,
26846,Not Determined,15709535,CHEMBL3614286,Antimicrobial activity against methicillin-resistant Staphylococcus aureus 309-6 clinical isolate after 16 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3611970,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,2498835,,1,0,,MIC,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,,,
26847,,15713620,CHEMBL3620745,Antibacterial activity against Staphylococcus aureus at 10 ug/disk after 24 hrs by agar plate disk diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3616412,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,2502108,=,1,1,=,IZ,mm,30.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,DIZ,mm,UO_0000016,30.0
26848,,15713630,CHEMBL3620746,Antibacterial activity against Escherichia coli at 10 ug/disk after 24 hrs by agar plate disk diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3616412,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,2502108,=,1,1,=,IZ,mm,28.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,DIZ,mm,UO_0000016,28.0
26849,,15713640,CHEMBL3620747,Antibacterial activity against Proteus vulgaris at 10 ug/disk after 24 hrs by agar plate disk diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3616412,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,2502108,=,1,1,=,IZ,mm,33.0,CHEMBL614450,Proteus vulgaris,Proteus vulgaris,585.0,,DIZ,mm,UO_0000016,33.0
26850,,15713650,CHEMBL3620748,Antibacterial activity against Pseudomonas aeruginosa at 10 ug/disk after 24 hrs by agar plate disk diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3616412,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,2502108,=,1,1,=,IZ,mm,23.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,DIZ,mm,UO_0000016,23.0
26851,,15713660,CHEMBL3620749,Antibacterial activity against Salmonella typhi at 10 ug/disk after 24 hrs by agar plate disk diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3616412,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,2502108,=,1,1,=,IZ,mm,26.0,CHEMBL614448,Salmonella enterica subsp. enterica serovar Typhi,Salmonella typhi,90370.0,,DIZ,mm,UO_0000016,26.0
26852,,15713670,CHEMBL3620750,Antibacterial activity against Salmonella paratyphi at 10 ug/disk after 24 hrs by agar plate disk diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3616412,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,2502108,=,1,1,=,IZ,mm,25.0,CHEMBL612293,Salmonella enterica subsp. enterica serovar Paratyphi A,Salmonella paratyphi,54388.0,,DIZ,mm,UO_0000016,25.0
26853,,15713690,CHEMBL3620752,Antibacterial activity against Staphylococcus aureus after 24 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3616412,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2502108,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.12
26854,,15713700,CHEMBL3620753,Antibacterial activity against Staphylococcus aureus after 5 days by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3616412,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2502108,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.12
26855,,15713710,CHEMBL3620754,Antibacterial activity against Escherichia coli after 24 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3616412,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2502108,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.25
26856,,15713720,CHEMBL3620755,Antibacterial activity against Escherichia coli after 5 days by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3616412,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2502108,=,1,1,=,MIC,ug.mL-1,0.15,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.15
26857,,15713730,CHEMBL3620756,Antibacterial activity against Proteus vulgaris after 24 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3616412,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2502108,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL614450,Proteus vulgaris,Proteus vulgaris,585.0,,MIC,ug ml-1,UO_0000274,0.25
26858,,15713740,CHEMBL3620899,Antibacterial activity against Proteus vulgaris after 5 days by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3616412,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2502108,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL614450,Proteus vulgaris,Proteus vulgaris,585.0,,MIC,ug ml-1,UO_0000274,0.25
26859,,15713750,CHEMBL3620900,Antibacterial activity against Pseudomonas aeruginosa after 24 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3616412,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2502108,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,2.0
26860,,15713760,CHEMBL3620901,Antibacterial activity against Pseudomonas aeruginosa after 5 days by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3616412,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2502108,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,2.0
26861,,15713770,CHEMBL3620902,Antibacterial activity against Salmonella typhi after 24 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3616412,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2502108,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL614448,Salmonella enterica subsp. enterica serovar Typhi,Salmonella typhi,90370.0,,MIC,ug ml-1,UO_0000274,0.12
26862,,15713780,CHEMBL3620903,Antibacterial activity against Salmonella typhi after 5 days by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3616412,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2502108,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL614448,Salmonella enterica subsp. enterica serovar Typhi,Salmonella typhi,90370.0,,MIC,ug ml-1,UO_0000274,0.12
26863,,15713790,CHEMBL3620904,Antibacterial activity against Salmonella paratyphi after 24 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3616412,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2502108,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL612293,Salmonella enterica subsp. enterica serovar Paratyphi A,Salmonella paratyphi,54388.0,,MIC,ug ml-1,UO_0000274,0.25
26864,,15714079,CHEMBL3620905,Antibacterial activity against Salmonella paratyphi after 5 days by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3616412,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2502108,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL612293,Salmonella enterica subsp. enterica serovar Paratyphi A,Salmonella paratyphi,54388.0,,MIC,ug ml-1,UO_0000274,0.25
26865,,15715511,CHEMBL3619649,Antimicrobial activity against Staphylococcus aureus NCTC 4163 at 400 ug after 18 hrs by disc-diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3616436,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,2501592,=,1,1,=,IZ,mm,26.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,IZ,mm,UO_0000016,26.0
26866,,15715532,CHEMBL3619650,Antimicrobial activity against Staphylococcus aureus ATCC 25923 at 400 ug after 18 hrs by disc-diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3616436,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,2501592,=,1,1,=,IZ,mm,26.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,IZ,mm,UO_0000016,26.0
26867,,15715553,CHEMBL3619651,Antimicrobial activity against Staphylococcus aureus ATCC 6538 at 400 ug after 18 hrs by disc-diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3616436,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,2501592,=,1,1,=,IZ,mm,28.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,IZ,mm,UO_0000016,28.0
26868,,15715574,CHEMBL3619652,Antimicrobial activity against Staphylococcus aureus ATCC 29213 at 400 ug after 18 hrs by disc-diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3616436,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,2501592,=,1,1,=,IZ,mm,22.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,IZ,mm,UO_0000016,22.0
26869,,15715595,CHEMBL3619653,Antimicrobial activity against Staphylococcus epidermidis ATCC 12228 at 400 ug after 18 hrs by disc-diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3616436,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,2501592,=,1,1,=,IZ,mm,30.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,IZ,mm,UO_0000016,30.0
26870,,15715616,CHEMBL3619654,Antimicrobial activity against Staphylococcus epidermidis ATCC 35984 at 400 ug after 18 hrs by disc-diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3616436,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,2501592,=,1,1,=,IZ,mm,32.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,IZ,mm,UO_0000016,32.0
26871,,15715637,CHEMBL3619760,Antimicrobial activity against Bacillus subtilis ATCC 6633 at 400 ug after 18 hrs by disc-diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3616436,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,2501592,=,1,1,=,IZ,mm,40.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,IZ,mm,UO_0000016,40.0
26872,,15715950,CHEMBL3619761,Antimicrobial activity against Bacillus cereus ATCC 11778 at 400 ug after 18 hrs by disc-diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3616436,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,2501592,=,1,1,=,IZ,mm,30.0,CHEMBL613070,Bacillus cereus,Bacillus cereus,1396.0,,IZ,mm,UO_0000016,30.0
26873,,15715971,CHEMBL3619762,Antimicrobial activity against Enterococcus hirae ATCC 10541 at 400 ug after 18 hrs by disc-diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3616436,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,2501592,=,1,1,=,IZ,mm,18.0,CHEMBL614623,Enterococcus hirae,Enterococcus hirae,1354.0,,IZ,mm,UO_0000016,18.0
26874,,15715992,CHEMBL3619763,Antimicrobial activity against Enterococcus faecalis ATCC 29212 at 400 ug after 18 hrs by disc-diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3616436,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,2501592,=,1,1,=,IZ,mm,15.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,IZ,mm,UO_0000016,15.0
26875,,15716013,CHEMBL3619764,Antimicrobial activity against Micrococcus luteus ATCC 10240 at 400 ug after 18 hrs by disc-diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3616436,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,2501592,=,1,1,=,IZ,mm,22.0,CHEMBL614421,Micrococcus luteus,Micrococcus luteus,1270.0,,IZ,mm,UO_0000016,22.0
26876,,15716034,CHEMBL3619765,Antimicrobial activity against Micrococcus luteus ATCC 9341 at 400 ug after 18 hrs by disc-diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3616436,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,2501592,=,1,1,=,IZ,mm,24.0,CHEMBL614421,Micrococcus luteus,Micrococcus luteus,1270.0,,IZ,mm,UO_0000016,24.0
26877,,15716055,CHEMBL3619766,Antimicrobial activity against Proteus vulgaris NCTC 4635 at 400 ug after 18 hrs by disc-diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3616436,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,2501592,=,1,1,=,IZ,mm,36.0,CHEMBL614450,Proteus vulgaris,Proteus vulgaris,585.0,,IZ,mm,UO_0000016,36.0
26878,,15716076,CHEMBL3619767,Antimicrobial activity against Staphylococcus aureus NCTC 4163 after 18 hrs by twofold serial microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3616436,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2501592,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
26879,,15716097,CHEMBL3619768,Antimicrobial activity against Staphylococcus aureus ATCC 25923 after 18 hrs by twofold serial microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3616436,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2501592,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
26880,,15716118,CHEMBL3619769,Antimicrobial activity against Staphylococcus aureus ATCC 6538 after 18 hrs by twofold serial microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3616436,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2501592,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
26881,,15716139,CHEMBL3619770,Antimicrobial activity against Staphylococcus aureus ATCC 29213 after 18 hrs by twofold serial microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3616436,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2501592,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
26882,,15716160,CHEMBL3619771,Antimicrobial activity against Staphylococcus epidermidis ATCC 12228 after 18 hrs by twofold serial microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3616436,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2501592,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.25
26883,,15716181,CHEMBL3619772,Antimicrobial activity against Staphylococcus epidermidis ATCC 35984 after 18 hrs by twofold serial microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3616436,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2501592,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.25
26884,,15716189,CHEMBL3619773,Antimicrobial activity against hospital methicillin-resistant Staphylococcus aureus 53/05 after 18 hrs by twofold serial microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3616436,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2501592,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,64.0
26885,,15716197,CHEMBL3619774,Antimicrobial activity against hospital methicillin-resistant Staphylococcus aureus 54/05 after 18 hrs by twofold serial microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3616436,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2501592,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,16.0
26886,,15716205,CHEMBL3619775,Antimicrobial activity against hospital methicillin-resistant Staphylococcus aureus 57/05 after 18 hrs by twofold serial microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3616436,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2501592,=,1,1,=,MIC,ug.mL-1,128.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,128.0
26887,,15716213,CHEMBL3619776,Antimicrobial activity against hospital methicillin-resistant Staphylococcus aureus 79/05 after 18 hrs by twofold serial microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3616436,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2501592,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,64.0
26888,,15716221,CHEMBL3619777,Antimicrobial activity against hospital methicillin-resistant Staphylococcus aureus 80/05 after 18 hrs by twofold serial microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3616436,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2501592,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,16.0
26889,,15716229,CHEMBL3619778,Antimicrobial activity against hospital methicillin-resistant Staphylococcus aureus 81/05 after 18 hrs by twofold serial microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3616436,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2501592,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,8.0
26890,,15716237,CHEMBL3619779,Antimicrobial activity against hospital methicillin-resistant Staphylococcus aureus 522/11 after 18 hrs by twofold serial microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3616436,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2501592,=,1,1,=,MIC,ug.mL-1,128.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,128.0
26891,,15716245,CHEMBL3619780,Antimicrobial activity against hospital methicillin-resistant Staphylococcus aureus 573/11 after 18 hrs by twofold serial microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3616436,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2501592,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,64.0
26892,,15716536,CHEMBL3619781,Antimicrobial activity against hospital methicillin-resistant Staphylococcus epidermidis 16/04 after 18 hrs by twofold serial microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3616436,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2501592,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,32.0
26893,,15716544,CHEMBL3619782,Antimicrobial activity against hospital methicillin-resistant Staphylococcus epidermidis 23/04 after 18 hrs by twofold serial microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3616436,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2501592,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,2.0
26894,,15716552,CHEMBL3619783,Antimicrobial activity against hospital methicillin-resistant Staphylococcus epidermidis 24/04 after 18 hrs by twofold serial microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3616436,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2501592,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,64.0
26895,,15716560,CHEMBL3619784,Antimicrobial activity against hospital methicillin-resistant Staphylococcus epidermidis 31/04 after 18 hrs by twofold serial microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3616436,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2501592,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,64.0
26896,,15716568,CHEMBL3619785,Antimicrobial activity against hospital methicillin-resistant Staphylococcus epidermidis 62/04 after 18 hrs by twofold serial microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3616436,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2501592,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.125
26897,,15716576,CHEMBL3619786,Antimicrobial activity against hospital methicillin-resistant Staphylococcus epidermidis 63/04 after 18 hrs by twofold serial microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3616436,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2501592,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,4.0
26898,,15716584,CHEMBL3619787,Antimicrobial activity against hospital methicillin-resistant Staphylococcus epidermidis 76/04 after 18 hrs by twofold serial microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3616436,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2501592,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.125
26899,,15716592,CHEMBL3619788,Antimicrobial activity against hospital methicillin-resistant Staphylococcus epidermidis 151/04 after 18 hrs by twofold serial microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3616436,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2501592,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,4.0
26900,Active,15716782,CHEMBL3620345,Inhibition of decatenation activity of DNA topoisomerase 4 in Staphylococcus aureus NCTC 4163 using kDNA as substrate at 32 ug/ml after 1 hr using ethidium bromide staining by agarose gel electrophoresis,B,BAO_0000201,BAO_0000223,protein complex format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3616436,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,2501592,,1,0,,Inhibition,%,,CHEMBL3038508,Staphylococcus aureus,Topoisomerase IV,1280.0,,INH,,UO_0000187,
26901,Active,15716785,CHEMBL3620346,Inhibition of decatenation activity of DNA topoisomerase 4 in Staphylococcus aureus ATCC 25923 using kDNA as substrate at 32 ug/ml after 1 hr using ethidium bromide staining by agarose gel electrophoresis,B,BAO_0000201,BAO_0000223,protein complex format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3616436,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,2501592,,1,0,,Inhibition,%,,CHEMBL3038508,Staphylococcus aureus,Topoisomerase IV,1280.0,,INH,,UO_0000187,
26902,Active,15716788,CHEMBL3620347,Inhibition of decatenation activity of DNA topoisomerase 4 in Staphylococcus aureus ATCC 6538 using kDNA as substrate at 32 ug/ml after 1 hr using ethidium bromide staining by agarose gel electrophoresis,B,BAO_0000201,BAO_0000223,protein complex format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3616436,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,2501592,,1,0,,Inhibition,%,,CHEMBL3038508,Staphylococcus aureus,Topoisomerase IV,1280.0,,INH,,UO_0000187,
26903,Active,15716791,CHEMBL3620348,Inhibition of decatenation activity of DNA topoisomerase 4 in Staphylococcus aureus ATCC 29213 using kDNA as substrate at 32 ug/ml after 1 hr using ethidium bromide staining by agarose gel electrophoresis,B,BAO_0000201,BAO_0000223,protein complex format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3616436,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,2501592,,1,0,,Inhibition,%,,CHEMBL3038508,Staphylococcus aureus,Topoisomerase IV,1280.0,,INH,,UO_0000187,
26904,Active,15716794,CHEMBL3620349,Inhibition of decatenation activity of DNA topoisomerase 4 in Staphylococcus epidermidis ATCC 12228 using kDNA as substrate at 32 ug/ml after 1 hr using ethidium bromide staining by agarose gel electrophoresis,B,BAO_0000201,BAO_0000224,protein format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3616436,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,2501592,,1,0,,Inhibition,%,,CHEMBL3706563,Staphylococcus epidermidis,DNA topoisomerase 4,176279.0,,INH,,UO_0000187,
26905,Active,15716797,CHEMBL3620350,Inhibition of decatenation activity of DNA topoisomerase 4 in Staphylococcus epidermidis ATCC 35984 using kDNA as substrate at 32 ug/ml after 1 hr using ethidium bromide staining by agarose gel electrophoresis,B,BAO_0000201,BAO_0000224,protein format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3616436,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,2501592,,1,0,,Inhibition,%,,CHEMBL3706563,Staphylococcus epidermidis,DNA topoisomerase 4,176279.0,,INH,,UO_0000187,
26906,Active,15716800,CHEMBL3620351,Inhibition of decatenation activity of DNA topoisomerase 4 in hospital methicillin-resistant Staphylococcus aureus 53/05 using kDNA as substrate at 32 ug/ml after 1 hr using ethidium bromide staining by agarose gel electrophoresis,B,BAO_0000201,BAO_0000223,protein complex format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3616436,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,2501592,,1,0,,Inhibition,%,,CHEMBL3038508,Staphylococcus aureus,Topoisomerase IV,1280.0,,INH,,UO_0000187,
26907,Active,15716803,CHEMBL3620465,Inhibition of decatenation activity of DNA topoisomerase 4 in hospital methicillin-resistant Staphylococcus aureus 54/05 using kDNA as substrate at 32 ug/ml after 1 hr using ethidium bromide staining by agarose gel electrophoresis,B,BAO_0000201,BAO_0000223,protein complex format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3616436,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,2501592,,1,0,,Inhibition,%,,CHEMBL3038508,Staphylococcus aureus,Topoisomerase IV,1280.0,,INH,,UO_0000187,
26908,Active,15716806,CHEMBL3620466,Inhibition of decatenation activity of DNA topoisomerase 4 in hospital methicillin-resistant Staphylococcus aureus 57/05 using kDNA as substrate at 32 ug/ml after 1 hr using ethidium bromide staining by agarose gel electrophoresis,B,BAO_0000201,BAO_0000223,protein complex format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3616436,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,2501592,,1,0,,Inhibition,%,,CHEMBL3038508,Staphylococcus aureus,Topoisomerase IV,1280.0,,INH,,UO_0000187,
26909,Active,15716809,CHEMBL3620467,Inhibition of decatenation activity of DNA topoisomerase 4 in hospital methicillin-resistant Staphylococcus aureus 79/05 using kDNA as substrate at 32 ug/ml after 1 hr using ethidium bromide staining by agarose gel electrophoresis,B,BAO_0000201,BAO_0000223,protein complex format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3616436,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,2501592,,1,0,,Inhibition,%,,CHEMBL3038508,Staphylococcus aureus,Topoisomerase IV,1280.0,,INH,,UO_0000187,
26910,Active,15716812,CHEMBL3620468,Inhibition of decatenation activity of DNA topoisomerase 4 in hospital methicillin-resistant Staphylococcus aureus 80/05 using kDNA as substrate at 32 ug/ml after 1 hr using ethidium bromide staining by agarose gel electrophoresis,B,BAO_0000201,BAO_0000223,protein complex format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3616436,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,2501592,,1,0,,Inhibition,%,,CHEMBL3038508,Staphylococcus aureus,Topoisomerase IV,1280.0,,INH,,UO_0000187,
26911,Active,15716815,CHEMBL3620469,Inhibition of decatenation activity of DNA topoisomerase 4 in hospital methicillin-resistant Staphylococcus aureus 81/05 using kDNA as substrate at 32 ug/ml after 1 hr using ethidium bromide staining by agarose gel electrophoresis,B,BAO_0000201,BAO_0000223,protein complex format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3616436,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,2501592,,1,0,,Inhibition,%,,CHEMBL3038508,Staphylococcus aureus,Topoisomerase IV,1280.0,,INH,,UO_0000187,
26912,Active,15716818,CHEMBL3620470,Inhibition of decatenation activity of DNA topoisomerase 4 in hospital methicillin-resistant Staphylococcus aureus 522/11 using kDNA as substrate at 32 ug/ml after 1 hr using ethidium bromide staining by agarose gel electrophoresis,B,BAO_0000201,BAO_0000223,protein complex format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3616436,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,2501592,,1,0,,Inhibition,%,,CHEMBL3038508,Staphylococcus aureus,Topoisomerase IV,1280.0,,INH,,UO_0000187,
26913,Active,15716821,CHEMBL3620471,Inhibition of decatenation activity of DNA topoisomerase 4 in hospital methicillin-resistant Staphylococcus aureus 573/11 using kDNA as substrate at 32 ug/ml after 1 hr using ethidium bromide staining by agarose gel electrophoresis,B,BAO_0000201,BAO_0000223,protein complex format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3616436,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,2501592,,1,0,,Inhibition,%,,CHEMBL3038508,Staphylococcus aureus,Topoisomerase IV,1280.0,,INH,,UO_0000187,
26914,Active,15716824,CHEMBL3620472,Inhibition of decatenation activity of DNA topoisomerase 4 in hospital methicillin-resistant Staphylococcus epidermidis 16/04 using kDNA as substrate at 32 ug/ml after 1 hr using ethidium bromide staining by agarose gel electrophoresis,B,BAO_0000201,BAO_0000224,protein format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3616436,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,2501592,,1,0,,Inhibition,%,,CHEMBL3706563,Staphylococcus epidermidis,DNA topoisomerase 4,176279.0,,INH,,UO_0000187,
26915,Active,15716827,CHEMBL3620473,Inhibition of decatenation activity of DNA topoisomerase 4 in hospital methicillin-resistant Staphylococcus epidermidis 23/04 using kDNA as substrate at 32 ug/ml after 1 hr using ethidium bromide staining by agarose gel electrophoresis,B,BAO_0000201,BAO_0000224,protein format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3616436,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,2501592,,1,0,,Inhibition,%,,CHEMBL3706563,Staphylococcus epidermidis,DNA topoisomerase 4,176279.0,,INH,,UO_0000187,
26916,Active,15716830,CHEMBL3620474,Inhibition of decatenation activity of DNA topoisomerase 4 in hospital methicillin-resistant Staphylococcus epidermidis 24/04 using kDNA as substrate at 32 ug/ml after 1 hr using ethidium bromide staining by agarose gel electrophoresis,B,BAO_0000201,BAO_0000224,protein format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3616436,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,2501592,,1,0,,Inhibition,%,,CHEMBL3706563,Staphylococcus epidermidis,DNA topoisomerase 4,176279.0,,INH,,UO_0000187,
26917,Active,15717134,CHEMBL3620475,Inhibition of decatenation activity of DNA topoisomerase 4 in hospital methicillin-resistant Staphylococcus epidermidis 31/04 using kDNA as substrate at 32 ug/ml after 1 hr using ethidium bromide staining by agarose gel electrophoresis,B,BAO_0000201,BAO_0000224,protein format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3616436,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,2501592,,1,0,,Inhibition,%,,CHEMBL3706563,Staphylococcus epidermidis,DNA topoisomerase 4,176279.0,,INH,,UO_0000187,
26918,Active,15717137,CHEMBL3620476,Inhibition of decatenation activity of DNA topoisomerase 4 in hospital methicillin-resistant Staphylococcus epidermidis 62/04 using kDNA as substrate at 32 ug/ml after 1 hr using ethidium bromide staining by agarose gel electrophoresis,B,BAO_0000201,BAO_0000224,protein format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3616436,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,2501592,,1,0,,Inhibition,%,,CHEMBL3706563,Staphylococcus epidermidis,DNA topoisomerase 4,176279.0,,INH,,UO_0000187,
26919,Active,15717140,CHEMBL3620477,Inhibition of decatenation activity of DNA topoisomerase 4 in hospital methicillin-resistant Staphylococcus epidermidis 63/04 using kDNA as substrate at 32 ug/ml after 1 hr using ethidium bromide staining by agarose gel electrophoresis,B,BAO_0000201,BAO_0000224,protein format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3616436,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,2501592,,1,0,,Inhibition,%,,CHEMBL3706563,Staphylococcus epidermidis,DNA topoisomerase 4,176279.0,,INH,,UO_0000187,
26920,Active,15717143,CHEMBL3620478,Inhibition of decatenation activity of DNA topoisomerase 4 in hospital methicillin-resistant Staphylococcus epidermidis 76/04 using kDNA as substrate at 32 ug/ml after 1 hr using ethidium bromide staining by agarose gel electrophoresis,B,BAO_0000201,BAO_0000224,protein format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3616436,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,2501592,,1,0,,Inhibition,%,,CHEMBL3706563,Staphylococcus epidermidis,DNA topoisomerase 4,176279.0,,INH,,UO_0000187,
26921,Active,15717146,CHEMBL3620479,Inhibition of decatenation activity of DNA topoisomerase 4 in hospital methicillin-resistant Staphylococcus epidermidis 151/04 using kDNA as substrate at 32 ug/ml after 1 hr using ethidium bromide staining by agarose gel electrophoresis,B,BAO_0000201,BAO_0000224,protein format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3616436,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,2501592,,1,0,,Inhibition,%,,CHEMBL3706563,Staphylococcus epidermidis,DNA topoisomerase 4,176279.0,,INH,,UO_0000187,
26922,Active,15717149,CHEMBL3620480,Inhibition of decatenation activity of DNA topoisomerase 4 in Staphylococcus aureus NCTC 4163 using kDNA as substrate at 1 to 4 ug/ml after 1 hr using ethidium bromide staining by agarose gel electrophoresis,B,BAO_0000201,BAO_0000223,protein complex format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3616436,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,2501592,,1,0,,Inhibition,%,,CHEMBL3038508,Staphylococcus aureus,Topoisomerase IV,1280.0,,INH,,UO_0000187,
26923,Active,15717152,CHEMBL3618626,Inhibition of decatenation activity of DNA topoisomerase 4 in Staphylococcus aureus ATCC 25923 using kDNA as substrate at 1 to 4 ug/ml after 1 hr using ethidium bromide staining by agarose gel electrophoresis,B,BAO_0000201,BAO_0000223,protein complex format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3616436,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,2501592,,1,0,,Inhibition,%,,CHEMBL3038508,Staphylococcus aureus,Topoisomerase IV,1280.0,,INH,,UO_0000187,
26924,Active,15717155,CHEMBL3618627,Inhibition of decatenation activity of DNA topoisomerase 4 in Staphylococcus aureus ATCC 6538 using kDNA as substrate at 1 to 4 ug/ml after 1 hr using ethidium bromide staining by agarose gel electrophoresis,B,BAO_0000201,BAO_0000223,protein complex format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3616436,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,2501592,,1,0,,Inhibition,%,,CHEMBL3038508,Staphylococcus aureus,Topoisomerase IV,1280.0,,INH,,UO_0000187,
26925,Active,15717158,CHEMBL3618628,Inhibition of decatenation activity of DNA topoisomerase 4 in Staphylococcus aureus ATCC 29213 using kDNA as substrate at 1 to 4 ug/ml after 1 hr using ethidium bromide staining by agarose gel electrophoresis,B,BAO_0000201,BAO_0000223,protein complex format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3616436,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,2501592,,1,0,,Inhibition,%,,CHEMBL3038508,Staphylococcus aureus,Topoisomerase IV,1280.0,,INH,,UO_0000187,
26926,Active,15717161,CHEMBL3618629,Inhibition of decatenation activity of DNA topoisomerase 4 in Staphylococcus epidermidis ATCC 12228 using kDNA as substrate at 1 to 4 ug/ml after 1 hr using ethidium bromide staining by agarose gel electrophoresis,B,BAO_0000201,BAO_0000224,protein format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3616436,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,2501592,,1,0,,Inhibition,%,,CHEMBL3706563,Staphylococcus epidermidis,DNA topoisomerase 4,176279.0,,INH,,UO_0000187,
26927,Active,15717164,CHEMBL3618630,Inhibition of decatenation activity of DNA topoisomerase 4 in Staphylococcus epidermidis ATCC 35984 using kDNA as substrate at 1 to 4 ug/ml after 1 hr using ethidium bromide staining by agarose gel electrophoresis,B,BAO_0000201,BAO_0000224,protein format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3616436,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,2501592,,1,0,,Inhibition,%,,CHEMBL3706563,Staphylococcus epidermidis,DNA topoisomerase 4,176279.0,,INH,,UO_0000187,
26928,Active,15717167,CHEMBL3618631,Inhibition of decatenation activity of DNA topoisomerase 4 in hospital methicillin-resistant Staphylococcus aureus 53/05 using kDNA as substrate at 1 to 4 ug/ml after 1 hr using ethidium bromide staining by agarose gel electrophoresis,B,BAO_0000201,BAO_0000223,protein complex format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3616436,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,2501592,,1,0,,Inhibition,%,,CHEMBL3038508,Staphylococcus aureus,Topoisomerase IV,1280.0,,INH,,UO_0000187,
26929,Active,15717170,CHEMBL3618632,Inhibition of decatenation activity of DNA topoisomerase 4 in hospital methicillin-resistant Staphylococcus aureus 54/05 using kDNA as substrate at 1 to 4 ug/ml after 1 hr using ethidium bromide staining by agarose gel electrophoresis,B,BAO_0000201,BAO_0000223,protein complex format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3616436,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,2501592,,1,0,,Inhibition,%,,CHEMBL3038508,Staphylococcus aureus,Topoisomerase IV,1280.0,,INH,,UO_0000187,
26930,Active,15717173,CHEMBL3618633,Inhibition of decatenation activity of DNA topoisomerase 4 in hospital methicillin-resistant Staphylococcus aureus 57/05 using kDNA as substrate at 1 to 4 ug/ml after 1 hr using ethidium bromide staining by agarose gel electrophoresis,B,BAO_0000201,BAO_0000223,protein complex format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3616436,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,2501592,,1,0,,Inhibition,%,,CHEMBL3038508,Staphylococcus aureus,Topoisomerase IV,1280.0,,INH,,UO_0000187,
26931,Active,15717176,CHEMBL3618634,Inhibition of decatenation activity of DNA topoisomerase 4 in hospital methicillin-resistant Staphylococcus aureus 79/05 using kDNA as substrate at 1 to 4 ug/ml after 1 hr using ethidium bromide staining by agarose gel electrophoresis,B,BAO_0000201,BAO_0000223,protein complex format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3616436,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,2501592,,1,0,,Inhibition,%,,CHEMBL3038508,Staphylococcus aureus,Topoisomerase IV,1280.0,,INH,,UO_0000187,
26932,Active,15717179,CHEMBL3618635,Inhibition of decatenation activity of DNA topoisomerase 4 in hospital methicillin-resistant Staphylococcus aureus 80/05 using kDNA as substrate at 1 to 4 ug/ml after 1 hr using ethidium bromide staining by agarose gel electrophoresis,B,BAO_0000201,BAO_0000223,protein complex format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3616436,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,2501592,,1,0,,Inhibition,%,,CHEMBL3038508,Staphylococcus aureus,Topoisomerase IV,1280.0,,INH,,UO_0000187,
26933,Active,15717182,CHEMBL3618636,Inhibition of decatenation activity of DNA topoisomerase 4 in hospital methicillin-resistant Staphylococcus aureus 81/05 using kDNA as substrate at 1 to 4 ug/ml after 1 hr using ethidium bromide staining by agarose gel electrophoresis,B,BAO_0000201,BAO_0000223,protein complex format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3616436,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,2501592,,1,0,,Inhibition,%,,CHEMBL3038508,Staphylococcus aureus,Topoisomerase IV,1280.0,,INH,,UO_0000187,
26934,Active,15717185,CHEMBL3618637,Inhibition of decatenation activity of DNA topoisomerase 4 in hospital methicillin-resistant Staphylococcus aureus 522/11 using kDNA as substrate at 1 to 4 ug/ml after 1 hr using ethidium bromide staining by agarose gel electrophoresis,B,BAO_0000201,BAO_0000223,protein complex format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3616436,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,2501592,,1,0,,Inhibition,%,,CHEMBL3038508,Staphylococcus aureus,Topoisomerase IV,1280.0,,INH,,UO_0000187,
26935,Active,15717188,CHEMBL3618638,Inhibition of decatenation activity of DNA topoisomerase 4 in hospital methicillin-resistant Staphylococcus aureus 573/11 using kDNA as substrate at 1 to 4 ug/ml after 1 hr using ethidium bromide staining by agarose gel electrophoresis,B,BAO_0000201,BAO_0000223,protein complex format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3616436,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,2501592,,1,0,,Inhibition,%,,CHEMBL3038508,Staphylococcus aureus,Topoisomerase IV,1280.0,,INH,,UO_0000187,
26936,Active,15717191,CHEMBL3618639,Inhibition of decatenation activity of DNA topoisomerase 4 in hospital methicillin-resistant Staphylococcus epidermidis 16/04 using kDNA as substrate at 1 to 4 ug/ml after 1 hr using ethidium bromide staining by agarose gel electrophoresis,B,BAO_0000201,BAO_0000224,protein format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3616436,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,2501592,,1,0,,Inhibition,%,,CHEMBL3706563,Staphylococcus epidermidis,DNA topoisomerase 4,176279.0,,INH,,UO_0000187,
26937,Active,15717194,CHEMBL3618640,Inhibition of decatenation activity of DNA topoisomerase 4 in hospital methicillin-resistant Staphylococcus epidermidis 23/04 using kDNA as substrate at 1 to 4 ug/ml after 1 hr using ethidium bromide staining by agarose gel electrophoresis,B,BAO_0000201,BAO_0000224,protein format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3616436,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,2501592,,1,0,,Inhibition,%,,CHEMBL3706563,Staphylococcus epidermidis,DNA topoisomerase 4,176279.0,,INH,,UO_0000187,
26938,Active,15717197,CHEMBL3618641,Inhibition of decatenation activity of DNA topoisomerase 4 in hospital methicillin-resistant Staphylococcus epidermidis 24/04 using kDNA as substrate at 1 to 4 ug/ml after 1 hr using ethidium bromide staining by agarose gel electrophoresis,B,BAO_0000201,BAO_0000224,protein format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3616436,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,2501592,,1,0,,Inhibition,%,,CHEMBL3706563,Staphylococcus epidermidis,DNA topoisomerase 4,176279.0,,INH,,UO_0000187,
26939,Active,15717200,CHEMBL3618642,Inhibition of decatenation activity of DNA topoisomerase 4 in hospital methicillin-resistant Staphylococcus epidermidis 31/04 using kDNA as substrate at 1 to 4 ug/ml after 1 hr using ethidium bromide staining by agarose gel electrophoresis,B,BAO_0000201,BAO_0000224,protein format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3616436,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,2501592,,1,0,,Inhibition,%,,CHEMBL3706563,Staphylococcus epidermidis,DNA topoisomerase 4,176279.0,,INH,,UO_0000187,
26940,Active,15717203,CHEMBL3618643,Inhibition of decatenation activity of DNA topoisomerase 4 in hospital methicillin-resistant Staphylococcus epidermidis 62/04 using kDNA as substrate at 1 to 4 ug/ml after 1 hr using ethidium bromide staining by agarose gel electrophoresis,B,BAO_0000201,BAO_0000224,protein format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3616436,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,2501592,,1,0,,Inhibition,%,,CHEMBL3706563,Staphylococcus epidermidis,DNA topoisomerase 4,176279.0,,INH,,UO_0000187,
26941,Active,15717206,CHEMBL3618644,Inhibition of decatenation activity of DNA topoisomerase 4 in hospital methicillin-resistant Staphylococcus epidermidis 63/04 using kDNA as substrate at 1 to 4 ug/ml after 1 hr using ethidium bromide staining by agarose gel electrophoresis,B,BAO_0000201,BAO_0000224,protein format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3616436,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,2501592,,1,0,,Inhibition,%,,CHEMBL3706563,Staphylococcus epidermidis,DNA topoisomerase 4,176279.0,,INH,,UO_0000187,
26942,Active,15717209,CHEMBL3618645,Inhibition of decatenation activity of DNA topoisomerase 4 in hospital methicillin-resistant Staphylococcus epidermidis 76/04 using kDNA as substrate at 1 to 4 ug/ml after 1 hr using ethidium bromide staining by agarose gel electrophoresis,B,BAO_0000201,BAO_0000224,protein format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3616436,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,2501592,,1,0,,Inhibition,%,,CHEMBL3706563,Staphylococcus epidermidis,DNA topoisomerase 4,176279.0,,INH,,UO_0000187,
26943,Active,15717212,CHEMBL3618646,Inhibition of decatenation activity of DNA topoisomerase 4 in hospital methicillin-resistant Staphylococcus epidermidis 151/04 using kDNA as substrate at 1 to 4 ug/ml after 1 hr using ethidium bromide staining by agarose gel electrophoresis,B,BAO_0000201,BAO_0000224,protein format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3616436,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,2501592,,1,0,,Inhibition,%,,CHEMBL3706563,Staphylococcus epidermidis,DNA topoisomerase 4,176279.0,,INH,,UO_0000187,
26944,,15717215,CHEMBL3618647,Inhibition of biofilm formation in Staphylococcus epidermidis ATCC 12228 after 24 hrs using MTT staining by spectrophotometer analysis,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3616436,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2501592,=,1,1,=,IC50,ug.mL-1,7.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,IC50,ug ml-1,UO_0000274,7.0
26945,,15717218,CHEMBL3618648,Inhibition of biofilm formation in Staphylococcus epidermidis ATCC 35984 after 24 hrs using MTT staining by spectrophotometer analysis,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3616436,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2501592,=,1,1,=,IC50,ug.mL-1,11.59,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,IC50,ug ml-1,UO_0000274,11.59
26946,,15717221,CHEMBL3618807,Inhibition of biofilm formation in Staphylococcus epidermidis 16/04 after 24 hrs using MTT staining by spectrophotometer analysis,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3616436,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2501592,=,1,1,=,IC50,ug.mL-1,6.81,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,IC50,ug ml-1,UO_0000274,6.81
26947,,15717224,CHEMBL3618808,Inhibition of biofilm formation in Staphylococcus epidermidis 23/04 after 24 hrs using MTT staining by spectrophotometer analysis,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3616436,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2501592,=,1,1,=,IC50,ug.mL-1,42.76,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,IC50,ug ml-1,UO_0000274,42.76
26948,,15717227,CHEMBL3618809,Inhibition of biofilm formation in Staphylococcus epidermidis 24/04 after 24 hrs using MTT staining by spectrophotometer analysis,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3616436,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2501592,=,1,1,=,IC50,ug.mL-1,12.95,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,IC50,ug ml-1,UO_0000274,12.95
26949,,15717230,CHEMBL3618810,Inhibition of biofilm formation in Staphylococcus epidermidis 31/04 after 24 hrs using MTT staining by spectrophotometer analysis,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3616436,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2501592,=,1,1,=,IC50,ug.mL-1,22.13,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,IC50,ug ml-1,UO_0000274,22.13
26950,,15717233,CHEMBL3618811,Inhibition of biofilm formation in Staphylococcus epidermidis 62/04 after 24 hrs using MTT staining by spectrophotometer analysis,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3616436,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2501592,=,1,1,=,IC50,ug.mL-1,4.81,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,IC50,ug ml-1,UO_0000274,4.81
26951,,15717236,CHEMBL3618812,Inhibition of biofilm formation in Staphylococcus epidermidis 63/04 after 24 hrs using MTT staining by spectrophotometer analysis,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3616436,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2501592,=,1,1,=,IC50,ug.mL-1,7.14,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,IC50,ug ml-1,UO_0000274,7.14
26952,,15717239,CHEMBL3618813,Inhibition of biofilm formation in Staphylococcus epidermidis 76/04 after 24 hrs using MTT staining by spectrophotometer analysis,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3616436,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2501592,=,1,1,=,IC50,ug.mL-1,7.93,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,IC50,ug ml-1,UO_0000274,7.93
26953,,15717242,CHEMBL3618814,Inhibition of biofilm formation in Staphylococcus epidermidis 151/04 after 24 hrs using MTT staining by spectrophotometer analysis,F,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3616436,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2501592,=,1,1,=,IC50,ug.mL-1,13.1,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,IC50,ug ml-1,UO_0000274,13.1
26954,,15717245,CHEMBL3618815,Inhibition of biofilm formation in Staphylococcus epidermidis ATCC 12228 at 4 ug/ml after 24 hrs using MTT staining by spectrophotometer analysis,F,BAO_0000201,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3616436,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,2501592,=,1,1,=,Inhibition,%,21.3,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,INH,%,UO_0000187,21.3
26955,,15717248,CHEMBL3618816,Inhibition of biofilm formation in Staphylococcus epidermidis ATCC 35984 at 4 ug/ml after 24 hrs using MTT staining by spectrophotometer analysis,F,BAO_0000201,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3616436,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,2501592,=,1,1,=,Inhibition,%,45.43,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,INH,%,UO_0000187,45.43
26956,,15717251,CHEMBL3618817,Inhibition of biofilm formation in Staphylococcus epidermidis 16/04 at 4 ug/ml after 24 hrs using MTT staining by spectrophotometer analysis,F,BAO_0000201,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3616436,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,2501592,=,1,1,=,Inhibition,%,41.96,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,INH,%,UO_0000187,41.96
26957,,15717254,CHEMBL3618818,Inhibition of biofilm formation in Staphylococcus epidermidis 23/04 at 4 ug/ml after 24 hrs using MTT staining by spectrophotometer analysis,F,BAO_0000201,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3616436,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,2501592,=,1,1,=,Inhibition,%,5.71,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,INH,%,UO_0000187,5.71
26958,,15717257,CHEMBL3618819,Inhibition of biofilm formation in Staphylococcus epidermidis 31/04 at 4 ug/ml after 24 hrs using MTT staining by spectrophotometer analysis,F,BAO_0000201,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3616436,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,2501592,=,1,1,=,Inhibition,%,18.66,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,INH,%,UO_0000187,18.66
26959,,15717260,CHEMBL3618820,Inhibition of biofilm formation in Staphylococcus epidermidis 62/04 at 4 ug/ml after 24 hrs using MTT staining by spectrophotometer analysis,F,BAO_0000201,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3616436,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Percent,2501592,=,1,1,=,Inhibition,%,59.89,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,INH,%,UO_0000187,59.89
26960,,15718360,CHEMBL3619522,Antimicrobial activity against methicillin-resistant Staphylococcus aureus HEMSA incubated for 20 hrs by serial dilution broth microplate method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3616416,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2501610,=,1,1,=,MIC,nM,14000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mM,UO_0000065,0.014
26961,,15718377,CHEMBL3619523,Antimicrobial activity against Staphylococcus aureus ATCC 25923 incubated for 20 hrs by serial dilution broth microplate method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3616416,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2501610,=,1,1,=,MIC,nM,380.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mM,UO_0000065,0.00038
26962,,15718473,CHEMBL3620216,"Resistance index, ratio of MIC for methicillin-resistant Staphylococcus aureus HEMSA to MIC for Staphylococcus aureus ATCC 25923",F,BAO_0000193,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3616416,Eur J Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,2501610,=,1,0,=,Ratio,,37.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Ratio,,,37.0
26963,,15719301,CHEMBL3620501,Antibacterial activity against Staphylococcus aureus MTCC 96 after 18 to 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3616377,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2502951,=,1,1,=,MIC,ug.mL-1,6.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,6.25
26964,,15719316,CHEMBL3620502,Antibacterial activity against Staphylococcus aureus MTCC 96 after 18 to 24 hrs by agar well diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3616377,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,2502951,=,1,1,=,IZ,mm,23.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,IZ,mm,UO_0000016,23.0
26965,,15719338,CHEMBL3620503,Antibacterial activity against Bacillus subtilis MTCC 121 after 18 to 24 hrs by agar well diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3616377,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,2502951,=,1,1,=,IZ,mm,24.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,IZ,mm,UO_0000016,24.0
26966,,15719355,CHEMBL3620504,Antibacterial activity against Bacillus subtilis MTCC 121 after 18 to 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3616377,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2502951,=,1,1,=,MIC,ug.mL-1,6.25,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MIC,ug ml-1,UO_0000274,6.25
26967,,15719372,CHEMBL3620505,Antibacterial activity against Escherichia coli MTCC 1652 after 18 to 24 hrs by agar well diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3616377,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,2502951,=,1,1,=,IZ,mm,23.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,IZ,mm,UO_0000016,23.0
26968,,15719389,CHEMBL3620506,Antibacterial activity against Escherichia coli MTCC 1652 after 18 to 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3616377,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2502951,=,1,1,=,MIC,ug.mL-1,6.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,6.25
26969,,15719406,CHEMBL3620507,Antibacterial activity against Pseudomonas putida MTCC 102 after 18 to 24 hrs by agar well diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3616377,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,2502951,=,1,1,=,IZ,mm,21.0,CHEMBL612501,Pseudomonas putida,Pseudomonas putida,303.0,,IZ,mm,UO_0000016,21.0
26970,,15719423,CHEMBL3620508,Antibacterial activity against Pseudomonas putida MTCC 102 after 18 to 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3616377,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2502951,=,1,1,=,MIC,ug.mL-1,12.5,CHEMBL612501,Pseudomonas putida,Pseudomonas putida,303.0,,MIC,ug ml-1,UO_0000274,12.5
26971,,15739791,CHEMBL3624755,Antimicrobial activity against Escherichia coli ATCC 8739 by MTT assay,F,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3621182,Bioorg Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2505445,=,1,1,=,MIC50,nM,670.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC50,uM,UO_0000065,0.67
26972,Not Determined,15739832,CHEMBL3624756,Antimicrobial activity against Staphylococcus aureus ATCC 6538 by MTT assay,F,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3621182,Bioorg Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,2505445,,1,0,,MIC50,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC50,,,
26973,,15739873,CHEMBL3624757,Antimicrobial activity against Pseudomonas aeruginosa ATCC 9027 by MTT assay,F,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3621182,Bioorg Med Chem,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2505445,=,1,1,=,MIC50,nM,100.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC50,uM,UO_0000065,0.1
26974,,15740075,CHEMBL3625773,Antimicrobial activity against Escherichia coli K-12 measured after 19 hrs,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3621188,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/Nanomolar,2504654,=,1,1,=,MIC,nM,100.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,nM,UO_0000065,100.0
26975,,15749503,CHEMBL3631812,Antibacterial activity against Micrococcus luteus ATCC 10240 after 21 hrs by Kirby-Bauer agar diffusion assay,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3627706,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,2506766,=,1,1,=,IZ,mm,0.0,CHEMBL614421,Micrococcus luteus,Micrococcus luteus,1270.0,,DIZ,mm,UO_0000016,0.0
26976,,15749504,CHEMBL3631811,Antibacterial activity against Staphylococcus aureus SG511 after 21 hrs by Kirby-Bauer agar diffusion assay,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3627706,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,2506766,=,1,1,=,IZ,mm,18.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,DIZ,mm,UO_0000016,18.0
26977,,15749546,CHEMBL3631810,Antibacterial activity against Bacillus subtilis ATCC 6633 at 1.66 microg/ml after 21 hrs by Kirby-Bauer agar diffusion assay,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3627706,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,2506766,=,1,1,=,IZ,mm,19.0,CHEMBL613907,Bacillus spizizenii,Bacillus spizizenii,96241.0,,DIZ,mm,UO_0000016,19.0
26978,,15749570,CHEMBL3631814,Antibacterial activity against Mycobacterium vaccae IMET 10670 after 44 hrs by Kirby-Bauer agar diffusion assay,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3627706,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,2506766,=,1,1,=,IZ,mm,20.0,CHEMBL613224,Mycolicibacterium vaccae,Mycolicibacterium vaccae,1810.0,,DIZ,mm,UO_0000016,20.0
26979,,15749583,CHEMBL3631818,Antibacterial activity against wild type Pseudomonas aeruginosa K799 after 21 hrs by Kirby-Bauer agar diffusion assay,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3627706,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,2506766,=,1,1,=,IZ,mm,23.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,DIZ,mm,UO_0000016,23.0
26980,,15749592,CHEMBL3631820,Antibacterial activity against Pseudomonas aeruginosa K799/61 after 21 hrs by Kirby-Bauer agar diffusion assay,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3627706,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,2506766,=,1,1,=,IZ,mm,19.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,DIZ,mm,UO_0000016,19.0
26981,,15749601,CHEMBL3631822,Antibacterial activity against Escherichia coli DC2 after 21 hrs by Kirby-Bauer agar diffusion assay,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3627706,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,2506766,=,1,1,=,IZ,mm,21.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,DIZ,mm,UO_0000016,21.0
26982,Not Determined,15749610,CHEMBL3631823,Antibacterial activity against Mycobacterium vaccae IMET 10670,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3627706,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,,2506766,,1,0,,DIZ,,,CHEMBL613224,Mycolicibacterium vaccae,Mycolicibacterium vaccae,1810.0,,DIZ,,,
26983,,15749611,CHEMBL3631824,Antibacterial activity against Pseudomonas aeruginosa K799/61 at 1.66 ug/ml after 21 hrs by Kirby-Bauer agar diffusion assay,F,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3627706,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://qudt.org/vocab/unit#Millimeter,2506766,=,1,1,=,IZ,mm,26.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,DIZ,mm,UO_0000016,26.0
26984,,15763158,CHEMBL3637176,Antibacterial activity against Pseudomonas aeruginosa 14-14 after 18 to 24 hrs,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3632558,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2511323,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.5
26985,,15763179,CHEMBL3637177,Antibacterial activity against Pseudomonas aeruginosa 14-15 after 18 to 24 hrs,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3632558,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2511323,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.5
26986,,15763200,CHEMBL3637178,Antibacterial activity against Pseudomonas aeruginosa 14-16 after 18 to 24 hrs,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3632558,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2511323,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.5
26987,,15763221,CHEMBL3637179,Antibacterial activity against Pseudomonas aeruginosa 14-19 after 18 to 24 hrs,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3632558,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2511323,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.25
26988,,15763242,CHEMBL3637180,Antibacterial activity against Staphylococcus aureus CMCC 26003 after 18 to 24 hrs,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3632558,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2511323,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.125
26989,,15763263,CHEMBL3637181,Antibacterial activity against methicillin-sensitive Staphylococcus aureus 14-1 after 18 to 24 hrs,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3632558,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2511323,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,16.0
26990,,15763284,CHEMBL3637182,Antibacterial activity against methicillin-sensitive Staphylococcus aureus 14-2 after 18 to 24 hrs,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3632558,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2511323,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
26991,,15763305,CHEMBL3637183,Antibacterial activity against methicillin-sensitive Staphylococcus aureus 14-3 after 18 to 24 hrs,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3632558,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2511323,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.125
26992,,15763326,CHEMBL3637184,Antibacterial activity against methicillin-sensitive Staphylococcus aureus 14-4 after 18 to 24 hrs,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3632558,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2511323,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
26993,,15763347,CHEMBL3637185,Antibacterial activity against methicillin-resistant Staphylococcus aureus 14-4 after 18 to 24 hrs,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3632558,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2511323,>,1,1,>,MIC,ug.mL-1,128.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,128.0
26994,,15763368,CHEMBL3637186,Antibacterial activity against methicillin-resistant Staphylococcus aureus 14-5 after 18 to 24 hrs,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3632558,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2511323,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,16.0
26995,,15763389,CHEMBL3637187,Antibacterial activity against methicillin-sensitive Staphylococcus epidermidis 14-2 after 18 to 24 hrs,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3632558,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2511323,>,1,1,>,MIC,ug.mL-1,128.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,128.0
26996,,15763410,CHEMBL3637320,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis 14-21 after 18 to 24 hrs,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3632558,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2511323,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,64.0
26997,,15763431,CHEMBL3637321,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis 14-22 after 18 to 24 hrs,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3632558,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2511323,=,1,1,=,MIC,ug.mL-1,128.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,128.0
26998,,15764052,CHEMBL3637322,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis 14-37 after 18 to 24 hrs,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3632558,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2511323,=,1,1,=,MIC,ug.mL-1,128.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,128.0
26999,,15764073,CHEMBL3637323,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis 14-39 after 18 to 24 hrs,F,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,CHEMBL3632558,Bioorg Med Chem Lett,2015.0,CHEMBL8,CIPROFLOXACIN,CHEMBL8,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2511323,=,1,1,=,MIC,ug.mL-1,128.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,128.0
